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SUMMARY
Cell mediated immunity to dietary proteins may cause
small intestinal injury and malabsorption and the work of"
this thesis was designed to investigate in an animal model,
the factors governing the induction and expression of
intestinal CMX.
Increases in crypt cell production rate and intraepithelial
lymphocyte count were found to be reliable indices of mucosal
CMI during the GvKR in neonatal and adult mice. These were
direct consequences of the CMI response and evidence was
obtained that cytotoxicity did not account for the mucosal
changes. I propose that soluble mediators released by T cells
activated in the mucosa or gut associated lymphoid tissues
are the factors responsible.
In mice fed ovalbumin, CMI was identified in the mucosa
using the CCPR and IEL count and in the GALT by a lymph node
lymphocyte migration inhibition assay. This test was shown
to correlate with systemic CMI in parenterally immunised mice.
Normal mice fed OVA did not develop intestinal CMI but became
systemically tolerant to OVA. Mice given cyclophosphamide
before feeding OVA, developed CMI in the GALT and mucosa,
and the induction of systemic tolerance was also inhibited
by CY. CMI in the GALT developed rapidly, was recalled by
oral challenge with OVA and systemic immunity was not detected
in fed mice. Systemic CMI was more readily suppressed by
feeding OVA than humoral immunity and the tolerance of CMI
was particularly sensitive to CY pretreatment. In addition,
serum from OVA fed mice suppressed the CMI response of
recipients but not their antibody response. These findings
indicated that, after feeding proteins, systemic and intestinal
CMI responses are regulated by a CY-sensitive mechanism and
I postulate that this system is activated by intestinally
derived protein moieties.
Detailed studies of the mucosa and GALT of CY treated
mice revealed minor abnormalities -which were related to
alterations in crypt cell turnover. The antigen-processing
structures of the Peyer's Patches were not damaged by CY
and intestinal uptake of OVA was not altered quantitatively
or qualitatively by CY. These findings, and published
evidence, indicate that CY had altered intestinal immunity
by its action on suppressor cells.
I have shown therefore that it is possible to measure
intestinal CMI both in the mucosa and GALT. Local responses
to fed proteins do not occur in normal animals probably due
to the action of an intestinal suppressor cell system.
Abrogation of this system allows local CMI to develop and
mucosal damage may occur as a result of the action of
lymphokines produced during these responses. Defective
suppressor cell responses to fed antigen may underly
enteropathies associated with food hypersensitivity.
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The normal small intestine has several different
functions of which the principal are the digestion and
absorption of foods. However,- the intestine also acts as
a "barrier", reducing or preventing access to the body of
potentially harmful organisms and toxins. The factors
.responsible for this protective function include intestinal
motility, production of mucus and other secretions and the
ability to mount specific immune responses. The morphology
of the small intestinal mucosa reflects in part these
functions. Thus, the epithelium includes goblet cells,
Paneth cells and enteroendocrine cells while large numbers
of lymphoid cells are found both within the epithelium and
in the underlying lamina propria. The intimate relationship
between epithelial and lymphoid elements is further under¬
lined by the fact that under certain circumstances, an
immune response in the mucosa may damage the functional
compartment of the gut. In this way, local immune reactions
may induce abnormalities of both structure and function
(Ferguson 1976).
Several small intestinal diseases are associated with
disordered mucosal architecture, including coeliac disease,
cows milk protein intolerance, tropical sprue and parasitic
infestations. In many of these conditions, an immune
response to an enteric antigen has been implicated in the
development of intestinal injury, and it is likely that
this immunity is taking place in the mucosa itself. The
lymphoid cells of the mucosa include both thymus dependent
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and independent lymphocytes as well as large numbers of
macrophages, polymorphs, eosinophils and mast cells. The
capacity therefore exists in the intestinal mucosa for the
expression of antibody dependent, reaginic and cell-mediated
immunity. (Parrott 1976).
Each of these forms of immunity can be identified during
local responses to enteric antigens and the production of
secretory antibodies is now well documented. However, in
comparison to humoral immunity at secretory surfaces, mucosal
cell mediated immunity has received little attention. Very
little is known of the factors governing the induction of
CMI in the small intestine and of the interactions between
the effector limb of mucosal CMI and the structure and
function of the intestinal mucosal itself. While villous
atrophy occurs during the CMI response involved in allograft
rejection and in graft versus host reaction (MacDonald 1976;
MacDonald & Ferguson 1977)> a possible role for mucosal CMI
in the food allergic diseases associated with villous
atrophy and malabsorption has only recently been considered.
The overall aim of the work described in this thesis
was to study, in an animal model, the factors which govern
the induction and expression of intestinal cell mediated
immunity to a dietary protein antigen. The following
approaches were used to achieve this objective,
l) Reliable parameters of the effector limb of mucosal cell
mediated immunity were sought by producing a "classical"
form of CMI in the small intestine and following the
consequences in the mucosa. The GvHR, induced in neonatal
and adult mice by the injection of parental lymphocytes,
was employed for this purpose. I have examined the hypothesis
that the intraepithelial lymphocyte count and crypt cell
production rate correlate closely with the mucosal CMI of
the GvHR and the relevant experiments and results are
presented in Chapters 6 and J.
2) Since these indices applied to the mucosa itself were
necessarily indirect parameters of CMI, a direct, immuno¬
logical assay for CMl which could be applied to the gut-
associated lymphoid tissues was developed. The experiments
described in Chapter 8 therefore deal with migration
inhibition of lymph node cells in vitro, and this assay
was shown to correlate with CMI in vivo.
3) Using these parameters of mucosal and GALT immunity, the
induction of local CMI and mucosal injury following oral
immunisation with a defined protein antigen was then
investigated. These studies are described in Chapters 9
and 10. In these experiments, cyclophosphamide was used
to abrogate the state of immunological unresponsiveness
which normally results from feeding proteins. In consequence,
Chapter 11 describes experiments designed to study the
phenomenon of oral tolerance in more detail, while in
Chapters 12 and 13> the effects of cyclophosphamide itself
on the intestinal mucosa are considered.
CHAPTER 2
T LYMPHOCYTES, CELL MEDIATED IMMUNITY AND THE SMALL INTESTINE
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The experiments described in this thesis are concerned
with the induction and expression of CMI responses in the
small intestine. In this section I shall first review the
properties of T lymphocytes and their role in the regulation
of the immune response before turning to the features of
mucosal T cells in particular. The latter part of this
section will then deal with cell mediated immunity and its
relationship to the intestinal mucosa.
T lymphocytes and regulation of the immune response
Although administration of antigen is normally associated
with an active immune response directed at eliminating the
antigen, it is clear that the consequences of antigen
exposure fall within a spectrum of reactivity, ranging from
unresponsiveness to active immunity. Immunological tolerance
may be defined as the induction of a state of specific
unresponsiveness by an antigen which under other circumstances
is capable of inducing an immune response.
Specific tolerance may be induced by a wide range of
antigens under many different experimental conditions with
resulting unresponsiveness of all limbs of the immune response.
The balance between tolerance and active immunity is delicate
and is dependent on dose, nature and route of presentation
of antigen and on the age and immune status of the animal.
(Dresser & Mitchison 1968; Waksman 1977)* Neonatal animals
appear particularly susceptible to tolerance induction
(Billingham, Brent & Medawar 1953)while unusually large
or small amounts of antigen are tolerogenic (Dresser &
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Mitchison 1968). The importance of antigenic structure
in the development of tolerance is evidenced by the ability
of deaggregated proteins to induce tolerance in contrast to
the immunogenic properties of the aggregated protein (Chiller,
Habicht & Weigle 1971; Parks & Weigle 1980a). Similarly,
the complexing of antigen with isologous gamma globulin
(Aldo-Benson & Borel 197^) or with syngeneic spleen cells
(Cheung, Sherr, Heghinian, Benacerraf & Dorf, 1978) as
non-immunogenic carrier moieties favours the induction of
tolerance. Intravenous administration of an antigen is
more likely than other routes of parenteral immunisation
to induce tolerance (Dvorak, Billote, McCarthy & Flax 1965;
Asherson & Ptak 1970; Kaufmann & Hahn 1979) while oral
administration of antigen is also suitable for tolerance
induction (Tomasi 1980). Studies of systemic tolerance
have employed a wide range of experimental conditions and
it is often difficult to extrapolate results from one model
to another. It is apparent, however, that the induction
of tolerance rather than active immunity, is favoured by
large doses of soluble antigen given intravenously or orally.
The mechanisms responsible for the state of unresponsive¬
ness may also' differ in the various systems used. There is
good evidence from the work of different groups that in
individual models, tolerance is accompanied by functional
deletion of B cells (Aldo-Benson & Borel 197^+5 Parks &
Weigle 1980a,b), deficiency of helper T cell function (Parks
& Weigle 1980b, Endres & Grey 1980b) and activation of
suppressor T cells (Basten, Miller, Sprent & Cheers 197^-;
Sy, Miller & daman. 1977)* Significantly, suppressor T
cells have been demonstrated by several groups studying
tolerance of CMI responses in mice (Phanuphak, Moonhead &
daman 197^j Sy et al 1977; Kaufmann & Hahn 1979; Asherson
& Zembala 1980). In several instances, however, the tolerant
state in vivo does not correlate with studies of individual
cellular function and several regulatory mechanisms may be
functioning in the intact animal. In this respect, the
presence or absence of suppressor T cells need not relate
to the unresponsiveness of an animal (Parks & Weigle 1980a).
The study of immunological tolerance, has in recent
years, led to the concept that the immune response of an
animal is normally under a considerable degree of control.
In particular much interest has focussed on the role of
T lymphocytes in these regulatory pathways. Thus, the full
development of the antibody response requires the cooperation
of B cells and a class of helper T cells (Mitchell & Miller
1968) while a separate class of suppressor T cells exists
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to inhibit both humoral and cell mediated immunity (Pierce
& Kapp 1976). These helper and suppressor T cells differ
in surface phenotype and other characteristics. Thus, in
mice, helper T cells are radioresistant, recognise antigen
only in the presence of macrophages and bear the Lyt 1 ' 23
phenotype (Erb & Feldmann 1975; Cantor, Shen & Boyse 1976;
Anderson & Warner 1976). Suppressor T cells on the other
hand, are sensitive to radiation, adult thymectomy, and
cyclophosphamide, are thought to bind antigen directly and
are most likely of the Lyt 1 23+ phenotype (Feldmann &
Kontiainen 1976; Cantor et al 1976; Anderson & Warner 1976;
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ROllinghoff, Starzinski-Powitz, Pfizenmaier & Wagner 1977)«
It is now apparent therefore, that the immune response is
governed by a complex interplay of lymphocyte classes each
performing an unique function. Immunological circuits
involving interactions between several precursor, inducer
and amplifier T cells are thought to be of particular
importance in the generation of suppressor T cells (Schwartz,
Askenase & Gershon 1978; Cantor & Gershon 1979)•
The final expression of cell mediated immunity is
dependent on the outcome of the balance between active
immunity and suppression following immunisation. Suppressor
T cells appear to play a major role in regulating the
induction and expression of CMI (Sy et al 1977; ROllinghoff
et al 1977; Gill & Liew 1978; L'age-Stehr & Diamantstein 1978)
while the existence of a helper cell for CMI remains unproven.
At present there is good evidence that the induction of the
T-dependent antibody response and delayed hypersensitivity
follow separate pathways. The induction of helper and DTH
effector T cells show marked differences in their dose
response to the same antigen (Ramshaw, Bretscher & Parish
1976). However, Tjj and share the same surface phenotype
(Cantor & Boyse 1975; Huber, Devinsky, Cantor & Gershon 1976;
Cantor et al 1976) and the same MHC-restricted antigen
recognition pathway (Miller, Vadas, Whitelaw and Gamble
1976; Cantor & Boyse 1975)* 16 remains to be proven
conclusively therefore that these are functions of T cells
of separate origin rather than alternative functions of
the same cell.
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The Immune response consists of an intricate network
of cellular interactions and presentation of antigen is
the trigger which commits the system to the production of
humoral immunity, CMI or tolerance. While T lymphocytes
have been shown to have a crucial role in this network,
the final outcome of immunisation is dependent on the
relationships between antigen, antigen-presenting cells
and several classes of lymphocyte. It is apparent
that there are several points in the pathway which provide
routes by which the response may be modulated.
T lymphocytes in the small intestine
In the small intestine, lymphocytes are found both in
the organised lymphoid tissues of the Peyers Patches and
mesenteric lymph nodes and are also scattered throughout
the gut wall. At birth, the Peyer's Patches and MLN are
small, undeveloped structures which rapidly become populated
by lymphoid cells in the first few days of life. At this
time the majority of these lymphocytes are thymus-derived
(Raff & Owen 1971; Chanana, Schaedeli, Hess & Cottier 1973;
Barg & Draper 1975)• Shortly after weaning these tissues
acquire the characteristic appearance of secondary lymphoid
tissues with well-developed primary follicles, germinal
centres and thymus-dependent areas (Waksman 1973; Parrott
1976).
In the mucosa itself, large numbers of lymphocytes are
found in the lamina propria and submucosa and there are
also a significant number within the epithelial layer.(Figs.2.1
& 2) .
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Intraepithelial lymphocytes form a heterogenous population
of small to medium sized lymphocytes with a few large,
lymphoblastoid cells. (Toner & Ferguson 1971j Collan 1972;
Glaister 1973a; Ferguson 1973; Marsh 1975a). The number of
IEL is substantially reduced in antigen-deprived small
intestine (Ferguson & Parrott 1972a), in athymic or
thymectomised mice (Fichtelius, Yunis & Good 1968; Ferguson
& Parrott 1972a) and in thymectomised birds (B9.ck 1970a).
In addition, the majority of IEL react positively with
reagents specific for T lymphocytes in the mouse (Guy-Grand,
Griscelli & Vassalli 197/+; 1978) and it is clear that the
IEL represent a population which consists predominantly of
T lymphocyt e s.
Origin of mucosal T lymphocytes
It has been known for several years that B lymphocytes
from the Peyer's Patches, MLN or thoracic duct will migrate
specifically to the lamina propria of the small intestine
after transfer into syngeneic recipients while peripheral
B cells will not. The GALT are especially rich in precursors
of mucosal igA plasma cells (Craig & Cebra 1971; Guy-Grand
et al 197^-j McWilliams, Lamm & Phillips-Quagliata 197^;
Rudzik, Perey & Bienenstock 197^5 Husband & Gowans 1978).
More recently, evidence has accumulated that T lymphoblasts
from the GALT will show similar specific gut-seeking behaviour
while T lymphoblasts from peripheral sites do not (Guy-Grand
et al 197^5 1978; Rose, Parrott & Bruce 1976). In contrast,
the migration patterns of small, recirculating T lymphocytes
are unclear. Gut-specific localisation of small intestinal
T cells has been reported in the sheep (Cahill, Poskitt,
Frost and Trnka 1977)> but this has not been confirmed in
other species. Studies performed recently in mice have
ascribed this phenomenon to contamination of migrating cells
with T lymphoblasts (Freitas, Rose & Rocha 1980). Significantly,
autoradiographic studies on the localisation of MLN and TDL
T lymphoblasts or of thymocytes have identified migration
of labelled cells into the gut epithelium (Goldschneider &
McGregor 1968; Sprent 1976; Guy-Grand et al 1978). In
addition, topical radiolabelling of mouse Peyer's Patches
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with HTdR results in the appearance of labelled intraepithelial
T cells during the GvHR and in normal animals (Guy-Grand et
al 1978). These studies support the concept that the IEL
are a population of T lymphocytes.
Radiolabelling studies in vivo confirm the evidence
from these lymphocyte traffic experiments that the IEL are
derived from a recently divided pool of cells (Darlington &
Rogers 1966; B&ck 1970b; Lemmel & Fichtelius 1971; Marsh
1975b; Guy-Grand et al 1978). This has been further
supported by the use of morphological criteria and electron
microscopy (Marsh 1975a), although other workers have
contested these findings (Glaister 1973a; Otto 1973)* The
IEL migrate into the epithelium from the lamina propria
and after a short stay in that position return to the lamina
propria (Meader & Landers 1967; Toner & Ferguson 1971;
Glaister 1973a). Although the possibility has not been
rigorously excluded, it is unlikely that the IEL are merely
shed from the villus along with effete epithelial cells.
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Functions of mucosal T cells
The observation that the numbers of IEL are depressed
in antigen-deprived intestine would suggest that these cells
are involved in an immune response to intestinally derived
antigens (Ferguson & Parrott 1972a). Recently, attempts
have been made in various species to investigate the functions
of isolated preparations of small bowel mucosal lymphocytes
in the hope that this might clarify the role of these cells
in vivo. However, the isolation procedures are often
technically difficult and conflicting results have emerged.
Thus, it has been reported that guinea pig IEL respond to
PHA, Con A and pokeweed mitogen, while chicken IEL do not
(Arnaud-Battandier,Wahl & Nelson 1979; Arnaud-Bat ta-ndier,
Lawrence & Bloese 1980). In addition, guinea pig IEL have
been shown to exhibit spontaneous, mitogen-induced and
antibody-dependent cell mediated cytotoxicity in vitro in
a manner similar to spleen cells (Arnaud-Battandier,Bundy,
O'Neill, Bienenstock & Nelson 1978). Several studies
employing preparations said to consist of lamina propria
lymphoid cells have identified lymphocytes which respond to
PHA and Con A and also in the mixed lymphocyte reaction, in
rabbits, humans and guinea pigs (Singal, O'Neill, Clancy
& Bienenstock 1976; Arnaud-Battandier et al 1978, 1979;
Goodacre, Davidson, Singal & Bienenstock 1979)* Antibody
dependent cell-mediated cytotoxicity has not been found in
lamina propria lymphocytes of the small intestine, however
(Arnaud-Battandier et al 1978). Although many of these
findings require confirmation, it is apparent that the
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epithelium and lamina propria of the small intestine contain
lymphocytes which have the characteristic functions of
mature T lymphocytes. This is supported by the findings
that organ cultures of small intestine may produce migration
inhibition factors for guinea pig macrophages (Gadol,
Waldman & Clem 1976) and human leucocytes (Ferguson, McDonald,
McClure & Holden 1975) although the cells producing these
factors have not been identified.
Mucosal mast cells
The majority of IEL are lymphoid cells by morphological
criteria and several workers have described a significant
proportion of XEL which contains granules of similar staining
characteristics to those of the mast cell series, although
the granules of IEL are smaller than those of true mucosal
mast cells (Murray, Miller & Jarrett 1968; Collan 1972;
Rudzik & Bienenstock 197^-) • True mast cells are found rarely
in the epithelium and in larger numbers in the lamina propria
of the gut, particularly round the crypts. Mucosal mast
cells differ from connective tissue mast cells in their
morphological appearance (Enerb&ck 1966a) and histochemical
properties (EnerbSLck 1966b). More interesting are the
findings that they may be a thymus dependent population
(Ruitenberg & Elgersma 1976) and that they are expanded
during parasitic infestations (Miller & Jarrett 1971;
Ruitenberg & Elgersma 1976) and during the GvHR (Guy-Grand
et al 1978). While these last workers have identified T cell
surface markers on mucosal mast cells and there is evidence
of thymus dependency of these cells, the exact nature of the
relationship between mucosal T cells and mast cells is
unknown.
Oral immunisation and tolerance
When an animal's first encounter with antigen is by
the oral route, it responds with the production of local
secretory antibodies of the IgA ciass (Dolezel & Bienenstock
1971a; Heremans 197^)* In addition, small amounts of antigen
are absorbed intact and may induce systemic humoral and cell
mediated immunity (Uhlehhuth 1900; Dolezel & Bienenstock 1971b;
Perrotto, Hang, Isselbacher & Warren 197^+) • However, oral
administration of antigen is also extremely effective in
inducing systemic tolerance to a subsequent parenteral challenge
with the antigen. The phenomenon was first noted by Dakin
(1829) who described the practice among American Indians of
ingesting extracts of poison ivy to alleviate the symptoms
which occurred on a subsequent, cutaneous encounter. Since
then, systemic tolerance has been described after feeding
proteins (Wells & Osborne 1911; Thomas & Parrott 197^;
Vaz, Maia, Hanson & Lynch 1977; Ngan & Kind 1978), contact-
sensitising agents (Chase 19^-6; Asherson, Zembala, Perera,
Mayhew & Thomas 1977) and heterologous red cells (Andre,
Heremans, Vaerman & Cambiaso 1975; Kagnoff 1978a,b). Furthermore,
all effector limbs of the immune response may be rendered
unresponsive in this way, including total serum antibody
responses (Hanson, Yaz, Maia, Hornbrook, Lynch & Roy 1977;
Kagnoff 1978a; Mattingly & Waksman 1978), lgE responses
(Vaz et al 1977> Ngan &. Kind 1978) and CMI responses (Chase
19^6; Asherson et al 1977; Kagnoff 1978b).
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The factors responsible for the systemic unresponsiveness
are not yet clear and serum antibody (Kagnoff 1978a), antigen-
antibody complexes (Andre et al 1975) and suppressor lympho¬
cytes (Thomas & Parrott 197^; Asherson et al 1977; Ngan &
Kind 1978; Mattingly & Waksman 1978) have all been implicated.
In addition, the liver may have an important role in this
phenomenon (Thomas & Parrott 197^)* Irrespective of the
exact nature of the regulatory mechanism,the induction of
tolerance is apparently an important consequence of antigen
feeding. This is of practical importance, since one of
the objectives of my work was to study active intestinal
immunity to a dietary antigen. In order to do so, I recognised
that it might first be necessary to interfere with the
regulatory functions which normally inhibit induction of
active intestinal immune responses.
Cell mediated immunity
Immunisation of an animal with antigen may produce an
immune response involving both humoral and cell-mediated
immunity. Cell-mediated responses in vivo characteristically
develop slowly after immunisation and the effector cells
involved include macrophages and specific thymus-derived
lymphocytes. In contrast, the humoral limb of the immune
response responds quickly to antigen by the production of
specific antibodies. In this section I shall deal with the
characteristics of effector T cells, in contrast to the
regulatory cells discussed earlier.
In the cellular response, the interaction of T lymphocytes
with antigen results in the induction of delayed type hyper¬
sensitivity or the generation of cytotoxic effector cells
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which, destroy specific target cells. In recent years the
nature of effector T cells has been the focus of much
interest, and it has become clear that these cells bear
surface phenotypes which are specific to their function.
Thus, in the mouse, T cells responsible for the phenomenon
— -f- -f -f.
of cell mediated lympholysis are of the Lyt 1 23 or Lyt 1 23
phenotype (Cantor & Boyse 1975; Beverley, Woody, Dunkley,
Feldmann & McKenzie 1976) while T cells capable of transferring
DTH and of cooperating with B cells in the antibody response
are Lyt 1'23 (Vadas, Miller, McKenzie, Chism, Shen, Boyse,
Gamble & Whitelaw 1976; Huber et al 1976; Cantor et al 1976).
It is apparent that T lymphocytes respond to antigen in the
context of cell-surface structures encoded by the major
histocompatibility complex (Katz & Benacerraf 1975; Snell
1978) and it has been shown that mouse cytotoxic T cells
react to antigens which are linked to the K and/or D regions
of the H-2 locus. 1-™™- on "the other hand are restricted byL/lxi
antigens of the I region (Cantor & Boyse 1975; Blanden,
Doherty, Dunlop, Gardner & Zinkernagel 1975; Miller et al
1976; Wolters & Benner 1979)- These findings indicate that
while cytotoxicity and DTH are both products of effector
T cell activation, these phenomena reflect the actions of
two subclasses of T lymphocyte which are quite distinct.in
nature and function. Although both forms of immunity may
be induced during a CM.I response, it is important to recognise
that either pathway, or both, may be the predominant feature
of any individual response.
In contrast to the target cell killing which results
from direct cell-cell contact and is mediated by cytotoxic
T cells, the effector mechanisms involved in the action of
Ik-^ reflect the release of soluble mediators by activatedJL) 1x1
lymphocytes (lymphokines). In this way, a CMl response is
amplified by the action of lymphokines on other lymphocytes
(T and B) and on many accessory cells including macrophages,
polymorphonuclear leucocytes and eosinophils. While it has
been shown that antibodies to lymphokines can inhibit
delayed skin lesions in the guinea pig (Yoshida, Bigazzi
& Cohen 1975)* "the in vivo role of soluble mediators in the
pathogenesis of DTH is unknown. Similarly, the significance
of circulating lymphokines in human disease is unclear
(Cohen, David, Feldmann, Glade, Mayer et al 1977)- The
production of lymphokines by sensitised lymphocytes in vitro,
however, has been invaluable in the measurement of CMl
responses. Of these, the production of mediators which
inhibit the migration of macrophages and polymorphs in vitro
correlates well with the presence of systemic DTH in vivo
(David, Al-Askari, Lawrence & Thomas 1964a,b; Bloom &
Bennett 1966; Bloom 1971) and provides a simple in vitro
assay for its assessment. (Table 2.l).
In recent years, the cells responsible for lymphokine
production have been identified and these studies have
reinforced the relation between lymphokine production and
the effector limb of DTH. Thus, lymphokines are produced
in vitro during the thymus-dependent response to mitogens
(Namba, Jegasothy & Waksman 1977)> protein antigens (Bloom &
Bennett 1966) and alloantigens (Kasakura & Lovenstein 1965)
and are therefore consistently associated with immune
responses involving T-cell activation. Furthermore, while
B cells may secrete lymphokines in response to mitogenic
stimulation, antigen-induced production of mediators is
dependent on the presence of T cells (Rocklin, McDermott,
Chess, Schlossman & David 197^+; Rasanen 1979)* More recently,
Lyt 1+ T cells have been found to be responsible for lympho-
kine production in mice (Kuhner, Cantor & David 1980), in
agreement with the subclass responsible for DTH in vivo.
In addition to the T lymphocytes and macrophages normally
associated with DTH responses in vivo, recent work has
suggested a role for additional accessory cells in the
pathogenesis of these reactions. Thus, it has been proposed
that the full expression of DTH reactions in the skin requires
the participation of mediators released by cells of the
basophil and mast cell series (Gershon, Askenase & Gershon
1975)* The precise function of such mediators in DTH
responses is unknown, but it is clear that the induction and
expression of delayed type hypersensitivity requires complex
interactions between committed T cells and several types of
accessory cell.
Cell mediated immune responses in the small intestine
The large numbers of T-cells present in the gut mucosa
(and GALT) would imply the existence of active CMI reactions
occurring locally in the small intestine. The following
two main roles for T lymphocytes in the gut mucosa are likely:
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firstly local CMI may serve to protect the gut against
pathogenic organisms and alternatively, CMI responses to
environmental antigens (e.g. food proteins) may be responsible
for intestinal damage in susceptible individuals. Evidence
that such responses do occur has come from the following
systems.
a) Allograft rejection of gut: Transplantation of allografts
of jejunum in dogs has been shown to produce villous atrophy,
crypt hyperplasia and lymphocytic infiltration of the mucosa
and subsequent invasion of the graft mucosa by bacteria
(Holmes, Klein, Winawer & Fortner 1971)• Since bacterial
infection may have been responsible for this damage, rejection
of "antigen-free" allografts of foetal gut implanted under
the kidney capsule of adult animals was studied subsequently.
In these investigations, rejection of gut occurred within
10-20 days of transplantation and was a thymus-dependent
phenomenon (Ferguson & Parrott 1973; MacDonald 1976). Although
villus atrophy did occur, this was a late feature and was
preceded by enhanced crypt mitotic activity, crypt lengthening
and lymphocytic infiltration of the mucosa and epithelium
(Ferguson & Parrott 1973; MacDonald & Ferguson 1976; 1977)*
The role of CMI in this phenomenon was underlined by the
absence of polymorphs and plasma cells in the lesions
(MacDonald & Ferguson 1976) and by the fact that rejection
preceded the anti-allograft antibody response (Elves &
Ferguson 1975)•
b) Graft-versus-host reaction: In 195^-> Barnes and Loutit
reported that lethally irradiated mice could not be reconstituted
with allogeneic spleen tissue. Subsequently, Billingham and
Brent (1957) described a runting syndrome in a proportion of
neonatal mice given allogeneic lymphocytes. Graft-versus-
host reaction is now recognised to occur in animals receiving
allogeneic lymphocytes to which they are unresponsive and
has been shown to be due to the presence of small, alloreactive
T cells in the inoculum (Cantor & Asofsky 1972; Kerckhaert,
Benner & Willers 1973)•
Diarrhoea and wasting are prominent features of the
GvHR in experimental animals (Reilly & Kirsner 1965; Cornelius
1970) and contribute significantly to the morbidity and
mortality of patients developing GvHD following bone marrow
transplantation (Slavin & Santos 1973; Glucksberg, Storb,
Fefer, Buckner, Neiman, Clift, Lerner & Thomas 197^-) • In
the small intestine of runting animals the lesions consist
of villous atrophy with crypt hyperplasia and in severe
cases, degeneration and necrosis of the mucosa may occur
(Reilly & Kirsner 1965; Cornelius 1970; Wall, Rosenberg &
Reilly 1971; Elson, Reilly & Rosenberg 1977)* This intestinal
damage has been shown to produce mucosal enzyme deficiencies
(Hedberg, Reiser & Reilly 1968), malabsorption (Palmer &
Reilly 1971) and protein losing enteropathy (Cornelius 1970)
in affected animals. Similar pathological changes and
malabsorption have been observed in patients with GvHD
(Slavin & Santos 1973; Glucksberg et al 197^; Woodruff,
Hansen, Good, Santos & Slavin 1976). In addition, examination
of the intestinal mucosa of these patients and of mice
with GvHR has revealed infiltration with lymphocytes and
other mononuclear cells (Slavin & Santos 1973; Woodruff et
al 1976; Guy-Grand et al 1978).
During the GvHR, there is a large expansion of cytotoxic
cells (Cerottini, Nordin & Brunner 1971; Singh, Sabba.dini &
Sehon 1972) and cell-mediated cytotoxicity is the conventional
explanation for tissue damage during the GvHR. However,
damage may occur during the GvHR in skin (Billingham &
Streilen 1968; Streilen 1972) and kidney (Elkins & Guttman
1968) even if the tissues are syngeneic to the injected
alloreactive cells. This "Innocent Bystander" phenomenon
has also been recently described in grafts of foetal small
intestine using conventional histology as the measure of
intestinal injury (Elson et al 1977)* Further evidence
that the mucosal lesions of the GvHR are not due to direct
cytotoxicity to epithelial elements comes from a study which
identified a stimulation of crypt mitotic activity as the
initial response during the GvHR (MacDonald & Ferguson 1977)*
The exact relationship between mucosal changes and the
GvHR remains to be clarified.
c) Parasitic infections of the small intestine: Cell mediated
immunity has been implicated in both the defence of the
intestine and in the mucosal damage during parasite infections.
Thus, the villous atrophy and crypt hyperplasia occurring
in rats infected with Nippostrongyius brasiliensis and in
mice infected with Trichinella spiralis has been shown to be
a thymus-dependent phenomenon (Ferguson & Jarrett 1975;
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Manson-Smith, Bruce & Parrott 1979) • Furthermore, in
the latter model, the mucosal alterations are preceded by
an influx of T lymphoblasts to the intestinal wall (Manson-
Smith, Bruce, Rose & Parrott 1979) and T lymphocytes are
necessary for the transfer of adoptive immunity to this
parasite (Wakelin & Wilson 1979)* Similar studies on murine
giardiasis have also indicated that T cell mediated immunity
is responsible for protection against the parasite (Roberts-
Thomson & Mitchell 1978; Stevens, Frank & Mahmoud 1978)
and for the resulting crypt hyperplasia (MacDonald & Ferguson
1978). In addit ion, increased IEL counts are found in mice
and humans with giardiasis (MacDonald & Ferguson 1978;
Ferguson, McClure & Townley 1976). Lastly, the expansion of
mucosal mast cells during N. brasiliensis infection is
transferrable by immune slg thoracic duct lymphocytes
(Nawa & Miller 1979) and is thymus-dependent during infection
with T.spiralis (Ruitenberg & Elgersma 1976).
d) Local cell mediated immune responses to fed antigen: While
it is reported that systemic CMl may result from oral
administration of antigen (Perrotto, Hang, Isselbacher &
Warren 197^+) > such studies may be complicated by the risk of
systemic immunisation, and there is little known of the
induction of CM I in the mucosa itself. Prolonged feeding
of a contact-sensitising agent,. DNCB, to mini-pigs was
shown to produce small intestinal injury including villous
necrosis, polymorph and mononuclear cell infiltration and
xylose malabsorption (Bicks, Azar & Rosenberg 1967). However,
although true contact sensitivity following topical application
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of contact agents to the colon is well documented (Bicks,
Azar, Rosenberg, Dunham & Luther 1967; Askenase, Boone &
Binder 1978) this phenomenon has not been confirmed in the
small intestine. Contact-sensitising agents are themselves
toxic to the mucosa and systemic unresponsiveness has been
shown to be the more usual immunological consequence of
feeding these substances (Chase 19^-6; Glaister 1973b;
Asherson et al 1977)•
Several workers have however, reported that oral
immunisation may induce local production of MlF in the small
intestine. Thus, MlF was shown to be produced by isolated
mucosal lymphoid cells and MLN lymphocytes from pigs fed
DNP-BGG (Huntley, Newby & Bourne 1979), while in discussion,
Bienenstock has reported the production of MXF by mucosal
and Peyer's Patch lymphocytes from BCG-fed guinea pigs
(O'Neill & Bienenstock 1977)* Similarly, migration inhibition
factors are produced by the small intestine of guinea pigs
fed cholera organisms (Gadol et al 1976) and by mucosal
lymphocytes from pigs infected orally with transmissible
gastroenteritis virus (Frederick & Bohl 1976). In none of
these instances however, have the studies .identified the
exact source of the factors produced, nor have alterations
in mucosal structure or function been reported. Furthermore,
as previously discussed, systemic tolerance is the usual
result of feeding non-viable antigens.
e) Cell-mediated immunity in small intestinal disease:
Coeliac disease involves the development of villous
atrophy and crypt hyperplasia in the small intestinal mucosa,
and probably is due to an immune response to the cereal
protein, gluten (Lancet 197^)* Evidence that this reflects
a CMl response comes from the observations of increased
numbers of IEL in coeliac disease (Ferguson 197^-j Mavromichalis,
Brueton, McNeish & Anderson 1976;) and reports of the presence
of CMl in peripheral lymphocytes of affected patients
(Bullen & Losowsky 1978). Furthermore, small intestinal
biopsies from untreated patients produce leucocyte inhibition
factor when challenged with gluten in vitro (Ferguson,
MacDonald, McClure & Holden 1975).
In childhood, severe degrees of villous atrophy and
crypt lengthening may result from an intolerance to cow's
milk protein (Visakorpi & Immonen 1967). While it is not
yet clear what the exact nature of the hypersensitivity
reaction is, these children have increases in IEL count
(Phillips, Rice, France & Walker-Smith 1979j Rosekrans,
Maijer, Cornelisse, Wal & Lindeman 1980) and crypt mitotic
activity (Kosnai, Kuitunen, Savilhati, Rapol & KiJhegyi 1980)
similar to those in coeliac disease.
Measurement of CMl responses in the mucosa and intestinal
lymphoid tissues
Since intestinal antibody responses are dissociated
from systemic humoral immunity (Dolezel & Bienenstock 1971a,b)
it is likely that assays for systemic CMl will not reflect
the presence of such immunity in the gut itself. This is
supported by the observations that local, pulmonary CMl
does not correlate with systemic CMl following inhalation of
antigen (Henney & Waldman 1970, Yamamoto, Anacker & Ribi 1970; '
Clancy & Bienenstock 197^0 • However, the relative
inaccessibility of the small intestine renders conventional
in vivo assays of CMI impractical while isolation of mucosal
lymphoid cells is not yet sufficiently established to allow
routine in vitro measurement of CMI in the mucosa itself.
It is probable, however, that the gut associated lymphoid
tissues will provide suitable organs for such studies.
Since the MLN is a rich source of gut-seeking T
lymphoblasts (Guy-Grand et al 197^> 1978; Rose et al 1976)
it is likely that the intestinal immune response develops
in the MLN and migrates subsequently to the gut wall and
immunological events in the MLN may therefore reflect immune
responses in the mucosa itself. CMI responses in lymphoid
tissues may be assayed in vitro by lymphocyte transformation
or by production of lymphokines in the presence of antigen.
Both assays require varying periods of in vitro culture and,
as in the case of lymphokine production, may necessitate
a two-step culture method. While most assays employing
migration inhibition as an in vitro correlate of CMI now
use phagocytic cells as indicators, the first descriptions
of these techniques employed entire explants of lymphoid
tissues (Rich & Lewis 1932; Carpenter, Barsales & Ganghan
1968). Subsequently, it was reported that whole lymphoid
cell populations taken from the lymphoid organs of immunised
rabbits showed migration inhibition in the presence of the
appropriate antigen and that this correlated with systemic
DTH (Likhite, Haasz, Algom & Richter 1972). A more recent
study describing a similar phenomenon in thymocytes from
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immunised mice (Hughes, Preece & Light 1980) suggests
that a migration inhibition assay of this type might be
applicable to the GALT and the MLN in particular. This
would provide a simple in vitro assay for intestinal CM1
responses.
The existence of "enteropathic lymphokines" has been
proposed to explain the features of CMI responses occurring
in the intestinal mucosa (Ferguson & MacDonald 1977)* In
addition, lymphokine production by intestinal mucosa has been
described in experimental animals (Frederick & Bohl 1976;
Gadol et al 1976) in humans with coeliac disease (Ferguson
et al 1975) and in rejected allografts of foetal gut
(Ferguson & MacDonald 1977)* These findings indicate that
specific production of lymphokines by mucosal lymphocytes
may prove a useful assay for local intestinal CM.I. However,
the source and function of such mediators is unknown and
their identification in large numbers of specimens would
be technically unsatisfactory. Furthermore, the difficulties
in isolating mucosal lymphocytes precludes the exploitation
of mucosal lymphokines as a routine assay for mucosal CMI
at present.
However, it is likely that alternative, if indirect,
parameters of mucosal CMI may exist within the mucosal
architecture itself. In the models of intestinal CMI
discussed earlier, consistent increases in crypt cell
production rate and crypt depth were demonstrated. In
addition, these were shown to be early and prolonged
responses of the mucosa in both allograft rejection and
GvHR (MacDonald 1976; MacDonald & Ferguson 1977)* These
observations indicate that alterations in crypt cell kinetics
may reflect mucosal CMl. In addition, the T cell nature
of intraepithelial lymphocytes and the fact that their
numbers are increased during allograft rejection of gut
(MacDonald 1976; MacDonald & Ferguson 1976) support the
concept that the IEL may be an additional index of intestinal
CMl. These parameters should be equally applicable in CMI
responses to both soluble antigens and cellular antigens.
J
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Factors acting on T and B lymphocytes.
1) Helper
Mitogenic factor
T cell replacing factor
Allogeneic effect factor
T cell growth factor
2) Suppressor
Soluble immune response suppressor




Factors acting on accessory cells.
Macrophage migration inhibition factor
Macrophage activating factor
Leucocyte migration inhibition factor/leucocyte migration
enhancement factor
Chemotactic factors for: neutrophils, eosinophils, basophils,
monocytes
Eosinophil stimulation promoter












Lymph Node permeability factor.
Table 2.1. Antigen non-specific factors released by activated
lymphocytes (lymphokines).
Fig. 2.1. Histology" of the normal mouse small intestine
showing intraepithelial lymphocytes (arrows).
(H & E x 500)
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Fig« 2.2. Two intraepithelial lymphocytes in mouse
jejunum (iEL). Note tail of IEL which has
crossed basement membrane (B.M.) (x 16,000)
(Ep - epithelial cell nucleus).
CHAPTER 3
EPITHELIAL CELL KINETICS IN THE SMALL INTESTINE
In many of the experiments described in this thesis,
the crypt cell production rate was chosen as one of the
principal indices of the effector limb of mucosal CMI. It
is therefore necessary to consider the epithelial cell
kinetics of the intestine and to discuss briefly the
regulation of crypt cell turnover.
The surface of the small intestinal mucosa consists of
a single layer of columnar epithelial cells which forms a
continuous sheet from the base of the crypt to the tip of
the villus. In addition to the functional absorptive cells
of the epithelium (enterocytes) this layer also contains
lymphocytes, mucus-producing goblet cells and endocrine
cells.
The architecture of the mucosa is based on the villus/
crypt unit in which cell loss from the villus tip is normally
balanced by the production of new cells in the crypts (Fig. 3«l)
Epithelial cells are formed by proliferation of slowly dividing
stem cells at the base of the crypt which thereafter migrate
upwards onto the surface of the villus (Wright 1980). During
this period terminal differentiation into functional
enterocytes occurs in the maturation zone near the mouth of
the crypts and the cells continue to mature as they move up the
villus (Cairnie, Lamerton & Steel 1965; Imondi, Balis &
Lipkin 1969)* In mice, the enterocytes remain on the villus
for 2-3 days before being shed from the mucosa into the gut
lumen (Leblond & Messier 195^)»
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Control of cell renewal in the mucosa
In the steady state of the normal small intestine
there is a delicate balance between cell loss and production,
the outcome of which determines the final architecture and
function of the mucosa. The crypt mitotic activity is
subject to a wide range of regulatory mechanisms which allow
cell production to adapt rapidly to environmental changes.
These control functions have been well reviewed recently
and include systemic and local humoral factors, neurogenic
control, dietary changes and local bacterial flora (Eastwood
1977; Williamson 1978a,b). In addition, the size of the
functional compartment of the villus may have an important
role in influencing cell production in the crypts. Thus,
depletion of villous cell numbers by ionising radiation or
ischaemia provokes a reactive increase in crypt cell
production rate which returns to normal when the villous
compartment attains its normal size (Rijke, van der Meer-
Fieggen & Galjaard 197^5 Rijke & Gart 1979)*
In addition, a similar mechanism has been proposed to explain
the increased cell turnover in the crypts of patients with
coeliac disease (Watson & Wright 197^)• While crypt
hyperplasia may frequently reflect an adaptation to villous
damage, it is also likely to occur as a result of imbalance
in the regulatory factors normally controlling crypt cell
turnover. In this respect, several humoral factors directly
influence crypt cell kinetics, while increased cell turnover
has been shown to occur in the absence of villous damage
after administration of cytostatic drugs (Roti Roti & Dethlefsen
1975).
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In addition to the epithelial elements of the mucosa,
the entire villus/crypt unit is closely invested with a
mesh of supporting fibres throughout the ground substance
of the mucosa. While the exact nature of the relationship
is not clear, it has been proposed that the ultimate
morphology of the mucosa is dependent on the function of
mucosal fibroblasts which maintain this ground tissue
(Parker, Barnes & Kaye 197^3 Marsh & Trier 197^-) • Furthermore,
abnormalities of the supporting structures have been
described in the presence of altered cell kinetics in patients
with coeliac disease (Loehry & Creamer 1969; Asquith,
Johnson & Cooke 1970).
Measurement of crypt cell proliferation kinetics
Some years ago, a simple and reliable method of
assessing the mitotic activity of rat small intestinal crypts
which avoided the need for radioisotope technology was
described (Wimber & Lamerton 1963). The technique is based
on the ability of colchicine to block all dividing cells
at metaphase, allowing metaphases to accumulate for several
hours after administration of the drug. If animals are
killed at intervals after colchicine and a significant
linear relationship can be established between metaphase
accumulation and time, the rate of cell production/crypt/
hour can then be derived from the slope obtained by
regression analysis. Although this method only assesses
cell production/crypt and cannot estimate the total cell
output per villus, it has proved a reliable means of
estimating crypt cell proliferation kinetics under many
conditions. In addition to those investigating mucosal
CMI responses (MacDonald 1976; MacDonald & Ferguson 1977)
other workers have employed the technique to monitor
epithelial cell kinetics in both experimental animals and
in human disease (reviewed by Wright & Appleton 1980).
In addition, the technique involves fixation of tissue
without shrinkage and the specimens can be used for accurate
measurement of villous and crypt size. Previous work has
shown this to be more reliable than quantifying these
parameters on histological sections (Clarke 1970) and these




Fig. 3.1. The villus/crypt unit of" the normal small
intestine. Cell loss from the villus tip is





Cyclophosphamide (2 Bi s ( 2-chloroethyl ) amino^
tetrahydro-2H-l, 3> 2-ox-azaphosphorine 2-oxide) is a potent
alkylating agent used as a chemotherapeutic agent in the
treatment of malignant and autoimmune disease.
After parenteral administration, the drug is metabolised
1961; Connors, Cox, Farmer, Foster & Jarman 1974) active
metabolites are released and are transported to target cells
via the bloodstream. In mice, CY has a serum half-life of
around 45 minutes and it has completely disappeared from
serum by 2-3 hours after i.p. injection (Mellett 1967)'
Since it acts principally on cells actively synthesising
DNA its toxic effects are on tissues with a large proportion
of dividing cells, including tumour tissue, bone marrow
and the epithelia of the urinary and gastrointestinal tracts.
In addition, it has been proposed that highly susceptible
tissues are deficient in a CY-detoxifying enzyme (van Putten
& Lelieveld 1970; Connors et al 1974).
Cyclophosphamide and immunity
The effects of CY on the immune system were first
detailed by Turk and Poulter (1972) who demonstrated that
in the dose range 300-400 mg/kg, CY depleted mainly the B
cell areas of the spleen and lymph nodes of guinea pigs and
mice. Since the thymic cortex was also depleted by the
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by microsomal enzymes in the liver (Foley, Friedman & Drolet
drug and bone marrow reconstitution accelerated recovery,
it was proposed that CY principally affected short-lived B
and T cells. The longer-lived, recirculating T cell pool
was relatively spared. This work has been confirmed by
several groups and it has been shown that maximal depletion
of B cell areas occurs within 2-3 days of a single dose,
with a regenerative phase beginning a few days thereafter.
During regeneration, the lymphoid tissues become populated
by large, dividing cells and the normal architecture is
lost (Turk & Poulter 1972; Stockman, Heim, South & Trentin
1973; Kolb, Poupon, Lespinats, Sabolovic & Loisillier 1977).
In those studies in which effects on Peyer's Patches are
reported a similar pattern and time course of events has
been observed (Chin & Hudson 1970; Mazigh, Alonso & Mollaret
1979).
When CY is given to animals shortly after immunisation,
variable effects on the immune response are reported, but
the predominant result is a dose-related suppression of
immunity which mainly affects antibody synthesis (Mitsuoka,
Baba & Morikawa 1976; Kerckhaert, Hofhuis & Willers 1977;
Ramshaw, Bretscher & Parish 1977). These results reflect
the ability of CY to prevent cellular proliferation during
an immune response. However, if CY is given 2-3 days before
immunisation, a different pattern emerges. In this case,
the antibody response may be normal or reduced, but depending
on the dose used, cell mediated immunity may be enhanced.
In the mouse, selective enhancement of CMI has been shown
to occur in doses between 20 and 200 mg/kg, with, larger
doses producing progressive depletion of CMI (Lagrange,
MacKaness & Miller 197*+; Askenase, Hayden & Gershon 1975;
Kerckhaert et al 1977; Easmo.n & Glynn 1977; Gill & Liew
1978). At first, the concomitant depletion of B cell areas
and antibody responses led authors to suggest that the
increased CMi responses were due to the loss of blocking
effects of antibody (Turk, Parker & Poulter 1972; Lagrange
et al 197*0- In recent years however, it has become
increasingly apparent that many of the immunological effects
of the drug are explicable by its inhibitory action on
suppressor T cells, and it has been shown that the suppressor
cell precursors are exquisitely sensitive to CY treatment.
Given before antigen, CY prevents the generation of TS
from short-lived precursors but does not affect the mature
effector T lymphocytes responsible for DTH and cytotoxicity
(Rollinghoff et al 1977; Schwartz et al 1978; L'age-Stehr
& Diamantstein 1978; Attallah, Ahmed & Sell 1979)* These
in vivo effects of CY have been elegantly confirmed by recent
in vitro studies which show that TS and B cells were more
sensitive to active metabolites of CY than helper and
effector T cells (Kaufman, Hahn & Diamantstein I98O;
Shand & Liew 1980). In the guinea pig, enhancement of
contact sensitivity by CY has been found to be secondary to
elimination of suppressor B cells (Asherson et al 1977)-
In contrast to the large number of studies of lymphocyte
function, the effects of CY on accessory cells have received
little direct attention. However, it has been shown by-
one group that CY has little effect on phagocytosis by
macrophages and only slightly inhibits intracellular killing
by these cells (Sharbaugh & Grogan 1969; Sharbaugh 1976).
Others have reported macrophage activation by functional
and morphological criteria after repeated CY treatment
(Buhles & Shifrine 1978). Relative sparing of these cells
is further indicated by the rapid recovery of blood monocyte
counts and macrophage stem cells following CY (Hunninghake
& Fauci 1976; Buhles and Shifrine 1978).
Cyclophosphamide and the small intestine
Since CY acts on rapidly dividing tissues, the epithelial
layer of the small intestine provides an obvious target organ.
Administration of CY in a range of doses has been shown to
produce a dose-dependent inhibition of crypt mitotic activity
within 6 hours of dosing, reaching a maximum by 2k hours.
Thereafter, a large increase in mitotic activity occurs
and above normal levels of crypt cell proliferation are
seen until 3 days after treatment (Rosenoff, Bostick & Young
1975j Ecknauer 1976; Young 1976; Sobhon, Wanichanon &
Sretarugsa 1977)* The resulting effects on the intestinal
epithelium include necrosis and extrusion of crypt cells
which is maximal within 2k hours (Ecknauer & Ltthrs 1976;
Sobhon et al 1977)* Levels of epithelial cell enzymes may
fall at later times and this is thought to reflect immature
epithelial cells reaching the villus during the period of
rapid cell turnover (Hartwich, Weisshaar & Domschke 1978).
In the gut CY affects principally the dividing crypt cell
population, and even large, sublethal doses of the drug
do not appear to injure mature enterocytes (Waldeck 1972).
This observation is confirmed in rats where it has been
shown that a single dose of 100 mg/kg had minimal direct
effects on either enzyme activity or sugar absorption
(Ecknauer 1976; Ecknauer & L8hrs 1976; Hartwich et al 1978).
Detailed studies on the functional capacity of the CY-treated
gut in vivo are lacking and there is no information on the






Mice used were of the following inbred strains:
CBA/Ca (H-2k//k Mlsb), C3H/He (H-2k/k MlsC), and BALB/c
(H—2d^d) . (CBAxBALB/c) F1(H-2k//d) and (CBAxC3H) F(H-2k/k
Mlsb^C) hybrids were bred from CBA mothers and C3H or
BALB/c fathers. NZ¥ rabbits were used to raise anti-
ovalbumin antisera and mixed strain Guinea pigs as a source
of complement. All animals were bred and maintained in the
Animal Unit, Western General Hospital, Edinburgh. Adult
mice were normally used at 6-10 weeks of age.
Diet:
Animals were normally maintained on a standard rodent
diet (Spratts Rodent Diet No.l) and had access to tap water
ad libitum.
In some experiments, groups of mice were fed 2 or 20 mg/
100 ml Ovalbumin (Sigma Fraction V) incorporated in their
drinking water, equivalent to a daily dose of 0.1 or 1 mg/
mouse.
Anae s the sia:
Procedures such as footpad injection were carried out
under light ether anaesthesia. Surgical operations were
performed using Sagatal 60 mg/ml (M & B Ltd.) diluted 1:10
in sterile water. Mice were injected i.p. with 0.1 ml/lO g
body weight and this provided adequate anaesthesia in most
cases for up to 2 hours. Where necessary this was supplemented
by light ether anaesthesia.
Sacrifice of animals:
Mice were killed by cervical dislocation.
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Bleeding of mice:
Small quantities of blood were obtained routinely
from the retro-orbital plexus under ether anaesthesia using
heparinised haematocrit tubes (Propper Ltd). In this way,
approximately 200 pi could be obtained from each mouse at
regular intervals. When larger quantities of blood were
required, mice were bled out from the axillary vein.
Removal of tissues:
Organs, especially jejunum, were obtained for histology
immediately after sacrifice. Pieces of jejunum (5 mm x 5 mm)
were removed 10 cm from the pylorus and avoiding obvious
lymphoid aggregates. These were opened and placed villous
surface upwards on pieces of card for fixation. Organs such
as spleen, thyrrus and liver were sliced and one section
placed in fixative. Intestinal grafts were removed from
the kidney capsule intact, and whenever possible opened out
with fine, pointed scissors.
Body weights:
Mice were weighed using an Oertling TP40 single pan
balance.
Organ weights:
Organs were dissected free of surrounding tissues and
weighed on a torsion balance (White Electrical Instrument Co.).
Histology:
After removal of tissues they were immediately placed
in fixative. For conventional histology, jejunum, spleen,
Peyers Patches and liver were fixed in 10% phosphate buffered
formalin, while thymus and mesenteric lymph nodes were fixed
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in Bouins' Fluid. These were embedded in paraffin wax
and sections 4 pm thick cut. Intestinal grafts were serially-
sectioned along the entire length of the graft after embedding.
Tissues processed in this way were stained with
Haematoxylin and Eosin.
Jejunal specimens were also taken for mast cell staining.
In this case, pieces of jejunum were removed as before and
fixed in Carnoy's Solution. After processing, these were
stained with Astra Blue - Safranin pH 0«3«
Histological specimens were examined using a Leitz
Ortholux II microscope.
Histological processing was carried out by Mr F. Donnelly
and Mr A. Sutherland.
Intraepithelial lymphocyte counts;
IEL were counted by the method of Ferguson and Murray
(l97l) and are expressed as the number of IEL/lOO epithelial
cells. Specimens were examined under x 4-00 magnification
and only sections with a single cell layer were counted.
Differential cell counts were performed by counting epithelial
and lymphoid cell nuclei lying above the basement membrane
and a total of 600 epithelial cells counted in each specimen.
In sections of heterotopic grafts it was occasionally
impossible to count 600 cells and in these cases, at least
200 epithelial cells were counted. Care was taken to avoid
recurring areas in serial sections of these grafts.
Mast cell counts:
Mucosal mast cells occurred predominantly in the
lamina propria round the crypts and at the base of the
villi. Occasional non-epithelial cells with positively
staining granules were seen in the epithelial layer and
these were included in the count. The cells were counted
using a square-grid eyepiece fitted to the Leitz Ortholux
microscope calibrated to give the number of cells/mm . The
eyepiece was orientated with the lower edge lying on the
upper surface of the muscularis mucosae and in areas where
the grid was almost filled with mucosa. Tissues were
examined at x ^-00 magnification, and in each specimen, five
well orientated areas were counted and the mean number of
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mucosal mast cells expressed /mm mucosa.
Processing of tissues for microdissection;
The method of Clarke (1970) was employed. Mice were
injected with 7*5 mg/kg colchicine (BDH Ltd.) i.p. and
sacrificed at intervals of 20-120 min. thereafter. Pieces
of jejunum were removed and fixed in Clarke's Fixative for
6-2k hours and then stored in 757° Ethanol before use. Tissues
were stained in bulk by the modified Feulgen reaction. The
pieces of gut were immersed in 50°fo Ethanol for 10 minutes,
followed by 10 minutes in tap water and 7 minutes in
0.1 N HC1 at 60°C. After a further 10 minutes in tap water,
the specimens were flushed x 3 with fresh tap water, stained
with Schiff reagent (Difco Ltd) for 30-^-0 minutes at. room
temperature and kept in tap water for microdissection. Under
the dissecting microscope ( x 32 Zeiss Stereomicroscope 4b)
the muscularis mucosae was first stripped off. Thin slices
of mucosa each containing a few villi and their surrounding
crypts were then cut from the edge by dissection with a
cataract knife (Veiss Ltd.) and forceps. The fragments
were then placed on a microscope slide in h^°fo acetic acid,
covered with a coverslip and examined under the Leitz
microscope with a previously calibrated eyepiece micrometer.
In each specimen, the lengths of 10 villi and 10 crypts were
measured and the means taken. The pieces were then gently
squashed under the coverslip and the number of metaphases
per crypt counted. Once again the mean of values for 10
crypts was used.
The crypt cell production rate was obtained in the
following manner: for each time interval after colchicine,
the mean number of metaphases/crypt is taken and the pairs
of results plotted by linear regression analysis. Having
established linearity, the CCPR is calculated from the
gradient of the line of best fit calculated by the method
of least squares. Fig. 5•1 shows the results from a typical
experiment.
Assessment of lymphoid follicles in heterotopic grafts of
small intestine:
Sections obtained by serial sectioning of grafts were
orientated in identical fashion on the slide and stained
with HeE. Individual lymphoid follicles were easily identifi
and those appearing in different positions in the graft
circumference were counted as separate follicles.
Assay of epithelial cell enzymes:
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5 mm pieces of jejunum were removed, gently cleaned
of adherent debris and weighed before storage at -20°C.
The brush border enzymes lactase and sucrase were assayed
by the method of Dalqvist (1964) and the results expressed
as mmol of substrate hydrolysed/minute/g wet weight of
tissue at 37°C. Disaccharidase estimations were performed
by Dr D. A1 Thamery.
Preparation of cell suspensions:
Spleens, thymus, mesenteric and peripheral lymph nodes
were removed immediately after sacrifice. After washing
in RPMI 1640 (Flow Labs) they were dissected free of
surrounding material and sliced with scissors. The pieces
were then gently passed through a fine gauge wire mesh
using the plunger of a 5 syringe (BD Ltd) and the
resultant suspension passed once through a 23 g needle to
break up clumps. The cells were allowed to stand for a
few minutes at room temperature to allow debris to settle
out and washed x 3 at 400 g in supplemented RPMI 1640.
After counting in a heamocytometer (Neubauer) the final
cell pellet was made up to the required concentration in
complete RPMI 1640 for use. Cell viability was assessed
by exclusion of 2% eosin and was normally greater than 90%.
Purification of T cells by nylon wool columns:
The method of Julius et al (1973) was followed. 0.6 g
nylon wool which had previously been washed in distilled H^O
for 1 week at 37°C was packed loosely into a 10 ml syringe
and the column washed through with complete RPMI 1640
supplemented with 5% foetal calf serum (Flow Labs). The
column was drained, and incubated at 37°C for 1 hour before
use. Lymphoid cell suspensions in RPMI 164-0 + 5% FCS were
passed over a glass wool column to remove debris and dead
cells and after washing in fresh medium, were allowed to
pass into the nylon wool column which was then incubated
for ^5 minutes at 37°C. Non-adherent cells were then flushed
out with warm RPMI 1640 + FCS, washed once and resuspended
for use. This was found to produce populations of 97%
T cells from lymph nodes as assessed by fluorescent staining
for the Thy 1.2 marker.
Elimination of T cells from cell suspensions;
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2 x 10 lymphoid cells/ml of complete RPMI 1640 were
incubated for 30 minutes, at room temperature in l/lOOO
dilution of monoclonal IgM anti-Thy 1.2 antiserum (F7D5 -
Olac 1976). The cells were then washed x 3 in medium,
resuspended in a l/lO dilution of fresh guinea pig serum
as a source of complement and incubated at 37°C for 40
minutes. Cells were washed 3 times before use. In cyto¬
toxicity assays, killing was assessed by eosin exclusion.
Identification of lymphocyte classes by immunofluorescence:
+ 7
To identify slg cells approximately 10 lymphoid cells
in phosphate buffed saline pH 7*2 were incubated in a few
drops of FITC-labelled goat anti-mouse Fab^ (Gibco Ltd), for
45 mins at 4°C and washed x 3 in PBS. Cells were examined
for positive fluorescence using a Wild M20 microscope fitted
with dark-ground condenser and HBO-200 mercury vapour lamp
with, exciting filter for light of k-95 ™ wavelength and
barrier filter for light of 525 nm wavelength.
Thy 1.2-bearing cells were identified indirectly.
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Approximately 10 lymphoid cells in PBS were suspended xn
a few drops of a 1:200 dilution of monoclonal anti-Thy 1.2
for k-3 minutes at room temperature, washed x 3 in PBS and
resuspended in FITC-labelled goat anti-mouse Fab^. Further
steps were as above. The proportion of Thy 1.2 positive
cells was determined as follows:
% Thy 1.2 positive = °/o staining after (anti-Thy 1.2 +
anti-mouse Fab^) - 0/> staining with anti-mouse Fab^ alone.
Induction of Graft-versus-host reaction:
Adult CBA mice were used as sources of donor spleen
cells in all cases. Recipients were either (CBA x BALB/c) F
or (CBA x C3H) F^adults or neonatal (CBA x BALB/c) F^mice.
7
Adult mice received 6 x 10 CBA spleen cells in 0.2 ml
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intra-peritoneally while neonatal animals received 2.5 x 10
CBA cells in 0.1 ml RPMI iGhO i.p. 5-7 days after birth.
Control mice received either equivalent numbers of F^cells
or medium alone. In the case of neonatal mice, care was
taken to ensure that littermate controls were used for each
individual experiment.
Graft-versus-host reaction assay:
The Spleen Weight assay of Simonsen was used (Simonsen
1962). On the day of sacrifice, mice were weighed, the
spleen removed and weighed, and the relative spleen weight
expressed as mg/lO g body weight.
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The Spleen Index is given as
Mean Relative Spleen Weight in Mice with GvHR
Mean Relative Spleen Weight in Control Mice.
In addition, differences between mean relative spleen weights Qf
each group were compared by Student's t-test.
Implantation of foetal grafts of intestine under the kidney
capsule;
This technique has been described in detail previously
(Ferguson & Parrott 1972; Ferguson 1973) and is briefly
as follows: Foetuses were removed from pregnant mice on
the 18th or 19th day of gestation, the small intestine
removed and 5-10 mm segments cut and placed in ice-cold
saline. The kidneys of anaesthetised adult mice were exposed
through lateral incisions in the abdomen and the kidney
capsule incised with a scalpel blade (Gillette Scimitar).
One segment of foetal gut was placed under each capsule
using a plastic cannula (Argyle Medicut) and the peritoneum
and skin closed. Grafts were allowed to grow for 4 weeks
before GvHR was induced in the host animals.
Cyclophosphamide:
Mice were given 100 mg/kg cyclophosphamide (Endoxana
WB Ltd) in saline intraperitoneally.
Antigens:
Five times recrystallised fractions of ovalbumin,human
serum albumin and bovine serum albumin (Sigma Ltd) were
used to immunise experimental animals. In addition,
oxazolone (4 ethoxymethylene-2-phenyl-oxazol-5-one BDH Ltd)
was dissolved in olive oil at 37°C for oral immunisation.
In practice, however, this proved unsatisfactory for routine
oral administration, since it was impossible to obtain
accurate concentrations of oxazolone in solution.
Parenteral immunisation of animals:
Mice were immunised for studies of systemic immunity
with either 2 mg antigen in Complete Freund1s Adjuvant
(H37Ra-Difco Ltd) i.p. or 100 pg antigen in CFA intradermally
to one rear footpad. In studies of local immunity, mice
were immunised with either 100 pg or 10 pg in OVA in CFA
distributed between three or four footpads, and
the draining lymph nodes subsequently removed. In one
experiment, mice were immunised with 100 pg OVA in Incomplete
Freund1s Adjuvant (Difco Ltd) distributed between all
footpads.
Rabbits were immunised with 2 mg OVA in CFA intra-
musculary at monthly intervals for 3 months and bled out
2 weeks after the last injection.
Oral immunisation of mice:
Unanaesthetised mice were fed OVA in distilled water
intraoesophageally using a rigid, steel feeding tube with a
rounded end.
Passive haemagglutination assay:
Sera were tested for the presence of haemagglutinating
anti-OVA Ab by passive haemagglutination. Sheep red blood
cells in Alsever's solution were washed three times in saline
at room temperature, and 200 pi packed cells mixed with
1.4 ml saline and 200 pi protein solution (15 mg/ml OVA or
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1 mg/ml HSA in saline). 2 ml of 0.01% chromic chloride
(Analar BDH Ltd) in saline at pH 5 was then added dropwise
with continuous agitation and the mixture allowed to stand
at room temperature for 10 min. After stopping the reaction
by addition of phosphate buffered saline
the coated cells were then washed twice in PBS and finally
resuspended at 1%.
Sera to be tested were inactivated at 56°C for 30 min.
and absorbed with 10% SRBC before use. 25 pi serum was
doubly diluted in round-bottomed microtitre plates (Titertek
Ltd) and 25 p.1 coated SRBC added to each well. The plates
were allowed to settle for 90 min. at room temperature and
the titre taken as the last dilution to show complete
agglutination. All sera were tested with or without the
presence of 25 pi 0.1M. 2-mercaptoethanol (Sigma Ltd) to
obtain levels of both IgM and IgG class antibodies.
Haemagglutination assays were performed in collaboration
with Mrs H. Drummond.
Assays for systemic delayed-type hypersensitivity:
Mice were tested for DTH by one of two intradermal skin
test methods. In the first instance, mice were shaved on
both flanks, and the double skinfold thickness measured
before and 2k hours after 100 pg Ag in 0.05 nil saline intra-
dermally using a pair of skin calipers (Pocotest A -
Carobronze Ltd). Other mice were tested by the increase in
footpad thickness 2k hours after 100 pg Ag in 0.05 ml saline
intradermally, measured in a similar fashion. In each case,
immunised mice were also tested with 0.05 ml saline as controls.
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Detection of sensitisation in local lymphoid tissues by
lymphocyte migration inhibition:
Mesenteric lymph nodes were removed from orally immunised
animals while the popliteal, axillary and brachial lymph
nodes were taken from animals immunised in all footpads with
antigen in CFA. After processing, cell suspensions were
g
adjusted to 1.5 x 10 /ml in complete RPMI 1640 and 10 pi
capillary tubes (Drummond Microcaps) filled with the cells.
After sealing one end with paraffin wax (Cristaseal-Hawksley
Ltd), these were pelleted at kOO g for 5 min's. and the tubes
cut just above the cell pellet. The parts containing the.
cells were then placed in wells of migration inhibition
plates (Sterilin Ltd), being held in place with silicone
vacuum grease (Edwards Ltd). The wells were then filled
with 0.5 ml complete RPMI 1640 alone or medium containing
various concentrations of Ag, sealed with a coverslip and
incubated for 21 hours at 37°C. Af"ter culture, the areas of
cell migration were drawn using a camera lucida (Zeiss Ltd)
attached to a Zeiss stereomicroscope and measured by plani¬
metry. The results are expressed as a Migration Index
obtained as follows:
-j- _ Area of migration in wells containing antigen
Area of migration in medium alone
A minimum of 6 wells was used for each Ag concentration.
Morphological characteristics of migrating cells:
After overnight incubation and 'measurement of migration
areas, the coverslips were removed from the wells, and the
capillary tubes discarded. The migrated cells remaining in
the wells were then removed by Pasteur pipette, and aliquots
spun on a cytocentrifuge (Shandon Cytospin) at 1000 rpm
for 5 mins. The resulting preparations were dried in air,
stained with Giemsa (Gurr Ltd) for 10 minutes and mounted
in D.P.X (BDH Ltd) for examination.
In addition, cells were pelletted at ^-00 g, resuspended
in fresh RPMI 1640 and adherent cells allowed to settle on
glass coverslips at 37°C for b hours in 5% CO^ in air. The
coverslips were then gently washed in PBS, fixed in methanol
and stained with Giemsa as before.
Detection of circulating antigen in ovalbumin-fed mice:
To detect circulating OVA a passive haemagglutination
inhibition assay was employed. Serial dilutions of 25 pi
test serum or normal mouse serum containing 2 mg/ml OVA
were made in microtitre plates (Titertek Ltd) and 25 pi
l/lOOO rabbit anti-OVA added to each well. After incubation
for 30 minutes at room temperature, 25 pi OVA-coated SRBC
(prepared as above) were added, and the wells allowed to
settle. The titre of the test sera was taken as the last
well to show complete absence of haemagglutination, and the
OVA concentration calculated from the titre of a standard
OVA containing serum.
Assay for the detection of ovalbumin in mouse diet:
20 g of dry mouse pellets were ground up to a fine
power before stirring overnight in 100 ml phosphate-buffered
saline pH 7«2 at b°C. The resulting suspension was
spun at 15,000 g for 30 minutes, the supernatant removed
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and a small aliquot stored at 4°C for use after filter
sterilisation (Millipore 0.22 pm) . The remaining supernatant
was adjusted to the isoelectric point of OVA, pH 4.6 and
saturated ammonium sulphate pH 4.6 added dropwise to a
final concentration of 60°/o ammonium sulphate. The precipitate
obtained was centrifuged at 15,000 g for 30 minutes, washed
in fresh 60% ammonium sulphate pH 4.6 and resuspended in
20 ml PBS at pH 7»2. The solution was extensively dialysed
against distilled water, pH 7*0, to remove remaining salts,
and a final volume of 25 nil obtained. A crude estimate of
protein content was obtained by measuring the 0®280nm on a
UV spectrophotometer (Pye Unicam SP 800A) previously
calibrated with dilutions of ovalbumin in PBS. Both the
crude supernatant and the ammonium sulphate fraction were
assayed for the presence of OVA by the haemagglutination
inhibition assay previously described.
Processing of tissues for transmission E.M.;
1 mm pieces of tissue were fixed immediately in 5°f°
glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7»3
for 2-24 hours. Tissues were embedded in fresh araldite
(Agar Aids Ltd), polymerised at 6o°C for 3 days and 60 nm
sections cut on an ultramicrotome (LKB 111). After staining
in saturated uranyl acetate and lead citrate the sections
were viewed using a Phillips 300 electron microscope.
All tissue processing for TEM was performed by Mr A.
Sutherland.
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Processing of tissues for scanning E.M. :
Pieces of jejunum, 1-2 cm in length., containing a
Peyer's Patch, were fixed in 2.5% gluteraldehyde in caco-
dylate buffer pH 7»3 for at least 2k hours at k°C after
pinning out, villous surface upwards, on a cork base.
After washing for one hour in fresh cacodylate buffer and
then distilled water, tissues were taken to 100% acetone
and subjected to critical point drying in CO^ using acetone
as the transition medium. They were then mounted on
aluminium stubs, coated with gold in a sputter coater and
examined on an ISI 60 Scanning Electron Microscope.




Results are expressed as means - 1 standard deviation,
unless otherwise stated. Student's t-test was used to
compare differences between groups in most cases. In
experiments including haemagglutination assays, non-parametric
distributions were observed and results were compared by
Vilcoxoii's Rank Sum test in addition to the Student t-test.
In practice, similar significance levels were usually
obtained.
Crypt cell production rates, calculated by linear
regression were compared by covariance analysis to detect
differences between the slopes. All calculations were
performed on a Texas T1-5I-1H calculator.
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Solutions:




Complete RPM1 l6kO Medium
RPM1 1640 (Flow Labs) 100 ml
Penicillin (5000 u/ml)/Streptomycin (5000 pg/ml) (Flow Labs) 2 ml
Hepes Buffer (Flow Labs) 1M. 1. 5 ml
Glutamine (Flow Labs) 0.2M- 2 ml
10% Buffered Formalin - 1 litre
Formaldehyde 100 ml
Distilled Water 900 ml
NaH2P0v2H20 k g
Na2HP0^ 6.5 g
Clarke's Fixative - 1 litre
Ethanol 750 ml
Glacial Acetic Acid 250 ml
Bouin's Fluid - 1.050 litre
Saturated aqueous picric acid (2,k,6-trinitrophenol) - 750 ml
Formaldehyde 250 ml
Glacial Acetic Acid 50 ml
Carnoy's Fixative - 1 litre
Ethanol 600 ml
Chloroform 300 ml
Glacial acetic acid 100 ml.
TIME AFTER 7.5mg/kg COLCHICINE i.p. (Minutes)
Fig. . 1. Metaphase accumulation in normal mouse jejunum
following injection of colchicine. Each, point
represents mean number of metaphases in 10 crypts
from one mouse. Animals were killed at various
intervals after colchicine and slope is calculated
by method of least squares.
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CHAPTER 6
EVOLUTION OF MUCOSAL CHANGES DURING THE GRAFT-VERSUS-
HOST REACTION IN NEONATAL MICE
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Introduction
Shortly after the induction of a GvHR in mice, a state
of delayed hypersensitivity to host histocompatibility
antigens develops in the animal (Wolters & Benner 1978).
In addition, small intestinal damage is one of the principal
pathological consequences of GvHR in experimental animals
(Reilly & Kirsner 1965; Cornelius 1970; Hedberg et al 1968).
This association indicates that the intestinal phase of the
GvHR provides an important model of mucosal CMI in the
small intestine.
The earliest response of the mucosa during a GvHR has
been shown to be a stimulation of crypt cell mitotic activity
with a subsequent increase in crypt length (MacDonald &
Ferguson 1977)• Similar changes in CCPR during allograft
rejection of gut are associated with a rise in IEL count
(MacDonald & Ferguson 1976; 1977) and lymphocytic infiltration
of the gut mucosa is a feature of the GvHR in mice (Guy-
Grand et al 1978) and humans (Woodruff et al 1976). These
observations suggest that enhanced crypt cell production and
lymphocytic infiltration are predictable consequences of a
GvHR occurring in the intestine. However, earlier workers
have not related these features to other, systemic indices
of the GvHR and have not followed the mucosal changes for
longer than 1^4- days after induction of the GvHR. I have
therefore tested the hypothesis that the CCPR and IEL count
provide reliable parameters of mucosal CMI by correlating
changes in mucosal architecture and IEL count with the progress
of the GvHR over a prolonged period, using the Spleen Index
(Simonsen 1962) as a measure of the proliferative phase of
the GvHR. Irradiation itself damages the small intestine
and I wished to assess only the effects of the CM I involved
in the GvHR on the mucosa. Thus, the mice used as hosts
in these experiments were unirradiated F^ neonates injected
with parental spleen cells for induction of the GvHR.
Increased numbers of mucosal mast cells and granulated
lymphocytes have also been described in the intestinal phase
of the GvHR in mice (Guy-Grand et al 1978). Since these
cells are reported to be thymus-dependent (Ruitenberg &
Elgersma 1976), the relationship of mucosal mast cells to
the other features of the GvHR in the intestine has also
been investigated in these experiments.
Experimental design
Malp and female (CBA x BALB/c)F^ mice were injected
7
with 2.5 x 10 CBA spleen cells i.p. at 5-7 days of age and
sacrificed at intervals from 1-62 days thereafter. The mice
were weighed, the Spleen Index calculated and pieces of
jejunum processed for histological examination and micro¬
dissection as described previously. At all times, a group
of littermate controls which had received F^ spleen cells
or medium alone were also sacrificed.
Development of the GvHR
As assessed by the Spleen Index, significant splenic
hypertrophy occurred from 3 days after transfer of parental
spleen cells, reached a peak of ^.58 on day 11 and declined
thereafter to a level of I.65 which was maintained until the
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end of the experiment (Fig. 6.1 ). This plateau of splenic
hypertrophy most likely represents a continued non-specific
hyperplasia of myeloid and erythroid elements in the spleen.
The growth rate of neonates with GvHR was identical to their
littermate controls, confirming that the increase in relative
spleen weight was a reflection of splenic hypertrophy only.(Fig.
6.1)
Mucosal architecture during the GvHR
Subjective examination of histological sections revealed
only crypt lengthening and mononuclear infiltration of the
mucosa between 8 and 14 days after induction of the GvHR.(Figs.6.
& 6.3)
However, objective measurements made by microdissection
showed significant alterations in mice with GvHR. Fig. 6.A-
shows that the CCPR was markedly increased to k.l/crypt/hour
in these animals 3 days after induction and that a significant
increase was found by 4 days (5«^ vs 1.6 p < 0.005)» The
upward trend reached a peak after 11 days (10.6 vs l.k
p < O.OOl), after which the CCPR declined, although values
significantly greater than controls were maintained until
day 18. Thereafter, the CCPR was consistently higher in
mice with GvHR until normal values were reached on day 62.
Associated with this increased crypt mitotic activity there
was an accompanying increase in crypt length (Fig. 6.5)»
The crypt length of controls remained constant until day 8
of the experiment, after which the onset of weaning provoked
a steady increase in crypt length. A similar pattern was
seen in the CCPR of control mice. In mice with GvHR, there
was already a significant increase in crypt length 2 days
after induction of GvHR (64.9 - 1«7 mp. vs 59*5 - 1.4 mp
p < 0.02). A steady rise to a maximum of 128.5 - 8.3 mp
on day 8 (Controls 64.7 - 1«7 mp p < 0.001) was followed by
a decline in crypt length from day 11. It should be noted
however, that minor but significant increases in crypt
length were observed until day 29 (106.2 I 0.9 mp vs 99-9 - 3•2mp
p < O.Ol). Normal values were found on day 62. In contrast
to these crypt changes, villous shortening was not observed at
any time during the GvHR (Fig. 6. 6).
Cellular infiltration of the mucosa in GvHR
Intraepithelial lymphocytes were counted on H&E stained
sections of jejunum, while mucosal mast cells were assessed
on Astra Blue/Safranin stained sections fixed in Carnoys1
solution.
Fig. 6.7 shows that there was an increased IEL count
already 24 hours after induction of the GvHR (4.92 - 0.79/100
+
epithelial cells vs 2.72 ~ 0.35 P < O.Ol). This result was
rather surprising, and it was necessary to exclude random
migration of injected spleen cells as a cause of a non-specific
7
rise in IEL numbers. Injection of F^ neonates with 2.5 x 10 F^
spleen cells i.p. did not give a similar rise in IEL count
24 hours after transfer (1.96 - 0.16 IEL/lOO Ep Cells) and
it must therefore be assumed that the high IEL count after
1 day of the GvHR represents a true consequence of the
response to F^ tissues. After a small drop in IEL count on
day 2, there was thereafter a steady rise in the IEL count
to a maximum of 13*1 ~ 2.14 compared to controls 2.8 - O.85
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(p < O.OOl) on day 11. Significant increases in IEL count
continued to be seen until day 18, despite a falling trend,
but from then onwards, IEL numbers in GvHR and control mice
were increasingly similar. On day 62, identical values
were found in the two groups.
Mast cell numbers showed greater variability, particularly
in younger animals where the small size of specimens made
counting difficult. Thus no definite pattern can be observed
in mast cell numbers until 6-8 days after induction of the
GvHR (Fig. 6.8). However, after this time, there was a large
expansion of mast cells reaching a peak at 14 days of k6.9
2 "f" 2
6.8/mm compared to 8.5 ~ 8.0/mm for controls (p < O.OOl).
In contrast to the other indices investigated, mast cell
numbers remained significantly increased until day 29
(34.7 + 17«6/mm^ vs 9-8 - ^-.8/mm^ p < 0.05)« By 62 days
however, both groups had identical values. It is also
noteworthy, that in the villi of control animals, intra¬
epithelial lymphocytes were never found to stain positively
for mast cell granules. In mice with GvHR however, occasional
positively staining cells could be seen in the villous
epithelium at x kOO magnification from day 1^- onwards, while
under oil immersion (x 1000), such cells were frequently
identifiable in these sections. These stained IE cells did
not resemble the more easily visible mast cells of the
lamina propria. (Eigs. 6.9 & 6.10).
Correlation of mucosal indices with progress of the GvHR
While assessment of the values on mice with GvHR gave
clear patterns of development during the GvHR, it was essential
to correlate certain of the parameters with the Spleen Index,
in order to assess their value as reproducible indices of
mucosal CMl. Since most of the indices in control mice
changed with age, particularly after weaning, the values in
mice with GvHR have been expressed as a ratio to that of
their littermate controls and these ratios compared with
the Spleen Index. The ratios for indices of mucosal architect
ure compared with the Spleen Index are shown in Fig. 6.11
those relating to cellular infiltration in Fig. 6.12. It will
be seen from these figures that the CCPR, crypt length and
IEL count showed a close relationship to the Spleen Index
throughout the experiment and the following correlations were
obtained: CCPR vs Spleen Index r = 0.7^ (p < 0.005)> crypt
length vs Spleen Index r = O.76 (p < 0.005) and IEL vs Spleen
Index r = 0.86 (p < O.OOl). During the proliferative phase
of the GvHR, up to day 11, the correlations between these
features and the Spleen Index were even closer: CCPR r = 0.88
(p < 0.005); crypt length r = 0.82 (p < O.Ol) and IEL r = 0.99
(p < 0.001). Finally, Fig.6.12 shows clearly the delayed
mast cell response compared to the other parameters.
Conclusions
The results of these experiments have shown that when
a Graft-versus-host reaction is induced in neonatal F^ mice
by i.p. injection of parental spleen cells, consistent and
significant effects may be observed in the small intestinal
mucosa. The principal of these are an expansion in crypt
cell proliferation and crypt size, an increased number of
lymphocytes in the epithelium and infiltration of the mucosa
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by mast cells. The morphology of the villi are unaltered
by this process.
Of these indices, the CCPR and IEL.count show a response
which occurs early in the GvHR, and which parallels the
proliferative response in the host spleen. These findings
confirm and extend an earlier report of an enhanced CCPR
in the GvHR in F^ mice (MacDonald & Ferguson 1977) and
support the hypothesis that the CCPR and IEL count are
reliable and sensitive parameters of the local CMI occurring
in the intestinal mucosa of animals with GvHR. In future
studies in this thesis, these indices will be used to
identify the presence of mucosal CMI in the jejunum of mice
with intestinal immune responses.
The observations that the IEL count and mucosal mast
cell infiltration were increased during the GvHR are similar
to those made in irradiated F^ mice with GvHR (Guy-Grand
et al 1978). Although the mast cell response was delayed
in comparison to the IEL count, the results support the
hypothesis that mucosal mast cells are a thymus-dependent
population. The present study does not however resolve the
controversy as to whether these are descendents of mucosal
T cells themselves (Guy-Grand et al 1978).
Fig. 6.1. Progress of the GvHR in neonatal (CBA x BALB/c)F
mice. Spleen Indices in mice with GvHR and growth
rates of GvHR and control mice. Mice were injected
with 2.5 x 10^ CBA spleen cells or RPMI 1640 at
5-7 days of age. Bars represent means - 1 s.d. for
each group. Lower panel gives numbers of mice/group
and age at time of sacrifice.
Fig. 6.2. Jejunal morphology in normal (CBA x BALB/c)F mouse
aged 17 days. Crypts are short and intraepithelial
lymphocytes rarely seen (H & E x 320).
Fig. 6.3. Jejunal morphology in 17 day old (CBA x BALB/c)F
mouse 11 days after induction of GvHR. Crypts
are longer than in age-matched control (Fig. 6.2)
and IEL are more numerous (H & E x 320).
Time after Induction of GvHR (Days)
Fig. 6«k* Crypt cell production rate in neonatal (CBA x BALB/c)
F1 mice with. GvHR and in littermate controls at
intervals after transfer of parental cells.
Time after Induction of GvHR (days)
'Fig. 6.5« Crypt lengths in neonatal (CBA x BALB/c)F1 mice
with GvHR and, in littermate controls. Bars
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Time after Induction of GvHR (days)
Fi^.t 6 f 6. Villus lengths during the GvHR in neonatal
(CBA x BALB/c)F1 mice and in littermate controls*
Bars represent mean - 1 s.d. for each group.
Time after Induction of GvHR (Days)
Fig« 6.7« Effect of GvHR on intraepithelial lymphocyte
counts in neonatal (CBA x BALB/c)F mice and in
littermate controls. Means - 1 s.d. for each
group.
Fig. 6.8. Effect of GvHR on mucosal mast cell counts in
neonatal (CBA x BALB/c)F^ mice and in littermate
controls. Means «r 1 s.d. for each, group.
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Fig. 6.9. Mucosal mast cells in 27 day old (CBA x BALB/c)F^
mouse, 18 days after induction of the GvHR (arrows).
MMC are found predominantly in the lamina propria
round crypts. Similar fields in control mice had 1
or fewer MMC.(Astra Blue/Safranin x $00.)
Fig. 6.10. Intraepithelial cell staining positively for mast
cell granules in villus of (CBA x BALB/c) mouse
shown above (arrow). Cells of this kind were not
seen in control mice and granules were smaller than
in lamina propria MMC.(Astra Blue/Safranin x 1250.)
Time after Induction of GvHR [Days)
'Fig. 6.11. Correlation of induces of mucosal architecture
with the Spleen Index throughout the course of the
GvHR in neonatal (CBA x BALB/c)F^ mice. At each
time, values for villus length, crypt length and
CCPR in mice with GvHR were expressed as a ratio
to the value in littermate controls. Crypt length
and CCPR closely follow the Spleen Index.
IJ
Time after Induction of GvHR (Days)
'Fig. 6.12. Correlation of cellular infiltrates with, the
Spleen Index throughout the course of the GvHR.
Values for IEL count and MMC count in mice with
GvHR are expressed as ratio to control values.
Note that the IEL count follows the Spleen Index
exactly while the rise in MMC count is delayed
and prolonged.
CHAPTER 7




The results of the previous chapter confirm that the
GvHR has significant effects on the small intestinal mucosa
of mice and showed that the CCPR and IEL count were closely-
related to the proliferative response in the GvHR. During
the GvHR, there is a large expansion of cytotoxic cells
(Cerottini et al 19715 Singh et al 1972; Fung & Sabbadini
1976) and cytotoxic damage to the intestinal epithelium
could be responsible for the mucosal features noted earlier.
However, villous shortening was not observed in these
experiments and in an earlier study, occurred after the
stimulation of CCPR was fully developed (MacDonald & Ferguson
1977)* These facts strongly indicate that cytotoxicity does
not account for the mucosal alterations due to the GvHR,
and are consistent with the hypothesis that "enteropathic
lymphokines" released during mucosal CMI reactions cause
these changes (Ferguson & MacDonald 1977)*
The further definition of the mechanisms of intestinal
injury in the GvHR was important for my work and the experiments
described in this section had two principal objectives;
firstly to examine the possibility that soluble factors,
released by activated lymphocytes, were responsible for the
mucosal injury of the GvHR and secondly to eliminate intestinal
bacteria and other local factors as causes of the mucosal
changes observed.
Damage to skin (Billingham & Streilen 1968) and kidney
(Elkins & Guttman 1968) has been described in the GvHR, even
if these tissues are syngeneic to the alloreactive donor
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lymphocytes. More recently, this "innocent bystander"
phenomenon has been described in grafts of foetal small
intestine using measurements of mucosal morphology on
conventional histological sections (Elson et al 1977)*
I have therefore re-examined the "bystander" phenomenon in
intestinal mucosa using the CCPR and IEL count as parameters
of mucosal CMI, measured in antigen-free heterotopic grafts
of parental small intestine implanted in F^ mice with GvHR.
Additional evidence to support a role for soluble mediators
was sought by performing these experiments in both an H-2
incompatible and in an H-2 compatible, Mis incompatible
strain combination, since cytotoxic cells are not generated
by Mis differences (Wolters, Brons, van der Kwast & Benner
1980).
In addition, by using antigen-free grafts of intestine,
it is possible to exclude an effect of local intestinal
factors on the CCPR and IEL count and this approach should
confirm these as sensitive parameters of mucosal CMI itself.
Experimental details
Adult F^ mice were given bilateral grafts of either F^
(Groups 1 and 2) or parental-type (Groups 3 and k) foetal
small intestine, implanted under the kidney capsule. These
were allowed to grow for k weeks and a GvHR was then induced
in the host animals of groups 2 and b by i.p. injection of
76 x 10 parental spleen cells. Two weeks later, the foetal
grafts and pieces of host jejunum were removed for examination.
In most cases, the results of mice in control groups 1 and 3
were combined, and results for the host jejunum in groups 2
83
and k were also combined. (Table 7»l)»
The numbers of specimens suitable for examination in
each group are shown in Table "J. 2.
Spleen Indices
The group of (CBA x BALB/c)F^ animals injected with CBA
spleen cells had significantly greater relative spleen
weights than controls (58.7 - 10.6 mg/lO g body weight vs
^•0.1 ~ 7.2 mg/lO g weight) giving a Spleen Index of 1.^7
(p < 0.001) and confirming the presence of the GvHR (Table
7»3)« In the H-2 compatible, M Is incompatible (CBA x C3H)F^
combination, GvHR mice have no increase in relative spleen
weight. This concurs with previous findings in GvHR using
H-2 compatible combinations (Eichwald, Hart & Eichwald 1969;
Cantrell & Hildemann 1972).
It should be noted that none of the animals with GvHR
showed any loss of weight.
Mucosal changes during the GvHR
1. Host jejunum
Histology: Conventional H & E sections revealed no differences
between the groups and no obvious damage to the mucosa of
animals with GvHR.
Microdissection: Significant alterations in mucosal architect¬
ure in both (CBA x BALB/c)F^ and (CBA x C3H)F^ mice with GvHR
were observed by this technique (Fig. 7«l)» In (CBA x BALB/c)F^
mice with GvHR there were significant increases in CCPR
(10.6 vs 6.1 p < 0.02) and crypt length (12^.2 - 5-6 mp vs
109.9 - 5•3 mp p < 0.005) compared to controls. In (CBA x C3H)F
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mice, the GvHR has induced similar increases in both CCPR
(7 • 8 vs 4.9 P < 0«05) and crypt length (127*7 - 9*2 mp. vs
109-7 - 6.9 mn p < O.OOl). In neither experiment were
alterations in villous length observed.
Intraepithelial lymphocyte counts: Fig. 7-2 shows that in
(CBA x BALB/c)F^ mice with GvHR, the IEL count was increased
to 16.0 - 1.2 IEL/lOO Epithelial cells compared to controls
9.9 - 2.1 IEL/lOO Epithelial cells (p < O.OOl). Similarly,
(CBA x C3H)F^ mice with GvHR had 20.5 - 2.5 IEL/lOO Epithelial
cells compared to 14.2 - 1.6 IEL/lOO Epithelial cells in
controls (p < O.OOl).
Disaccharidase levels; In (CBA x C3H)F^ mice with GvHR,
there was a mild, but insignificant fall in jejunal lactase
activity compared to controls (2.0 - 1.0 vs 2.9 - 1-9 mmol
lactose/min/g). Sucrase levels were identical in both groups
(12.3 - 2.5 vs 11.8 i 4.6 mmol sucrose/min/g).
2. Allografts and isografts of foetal gut implanted in control
animals
The growth and development of heterotopic grafts of
foetal gut has been described elsewhere (Ferguson & Parrott
1972b; Ferguson 1973 )> where it has been shown that these
grafts develop mucosal structures of normal appearance.
Histology: When removed 6 weeks after implantation, grafts
were distended by collections of extruded matter, but
histology confirmed that the majority of grafts were
morphologically intact with growing mucosa at the time of
sacrifice. (Fig. 7-5)-
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Microdissection: As described previously, these antigen-free
grafts have lower values than adult jejunum for all indices
(Fig. 7•3) • There were however, no differences between F^
type grafts (Group l) and parental-type grafts (Group 3)
implanted in control animals in either experiment, and these
results were therefore combined for comparison with results
from GvHR animals.
Intraepithelial lymphocyte counts: Once again results from
groups 1 and 3 are combined since there were no differences
between parental and F^ grafts (Fig. 7*4). In addition, the
values were low compared to the host jejunum with means of
3«7 - 0.8 IEL/lOO Epithelial cells in grafted (CBA x BALB/c)F1
mice and 2.4 - 0.6 IEL/lOO Epithelial cells in grafted
(CBA x C3H) F^ animals. This again confirms earlier findings
(Ferguson and Parrott 1972a).
3 • Foetal gut grafts in animals with GvHR
Histology; Once again, the majority of grafts had viable
mucosa and neither graft type showed microscopic evidence of
mucosal damage. However, when serial sections through the
entire length of each graft type from (CBA x BALB/c)F^ mice
with GvHR were examined, there appeared to be an increased
frequency of Lymphoid follicles in both F^ and parental
grafts compared to grafts in control animals (Table 7*4 Fig. 7*6)
Thus, four lymphoid follicles; were seen in 10 grafts from
control mice while five follicles were seen in six F^ grafts
and five in 10 parental grafts in GvHR mice. The differences
between control mice and mice with GvHR were not however
statistically significant (X test).
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Microdissection: The values for the different parameters of
mucosal architecture in grafts in groups 1 and 3 (Controls),
group 2 (F^ grafts + GvHR) and group 4 (Parental grafts +
GvHR) are shown in Fig. 7*3» In the (CBA x BALB/c)F^
combination, there was significant lengthening of the crypts
in both F^ type (Group 2 118.2 - 15*6 mp p < O.OOl) and
parental type grafts (Group 4 109"» 6 i 10.6 mp. p < O.OOl)
compared to controls (93«7 ± 3»9 m1-0> while the CCPR was
also raised in F^ grafts (Group 2 8.6 p < O.Ol) and in
parental grafts (6.2 p < 0.05)> compared to the value of 3*1
for controls. Villus lengths remained normal.
In (CBA x C3H)F1 mice, the results were similar. Crypt
lengths increased during the GvHR in both F^ type (Group 2
111.9 - 17 • 1 mp, p < 0.02) and parental-type grafts (Group 4
120.5 - 22.9 nip. P < 0.005) compared to controls (98.0 - 7«2 m
There was a concomitant increase in CCPR in parental type
grafts (6.5 P < 0.10) compared to 4.0 for controls. On this
occasion, F^ type grafts did not have an increased CCPR (3*3)
Again no villous abnormalities were observed.
Intraepithelial lymphocyte counts: Once again, the GvHR in
the host animals had similar effects on both graft types
with respect to the IEL count (Fig. 7*4). In (CBA x BALB/c)F
animals, F^ grafts (Group 2) showed an increase in IEL count
to 6.9 - 1»0 IEL/lOO Epithelial cells compared to 3«7 - 0.8
IEL/lOO Epithelial cells in controls (p < O.OOl). Parental-
type grafts (Group 4) had a similar, highly significant rise
in IEL count (7.2 - 1.1 IEL/lOO Epithelial cells p < O.OOl).
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Fiq 7.4: In both experiments, the results for Group 2 have
been plotted above Group 4, and vice versa.
An identical pattern was observed in (CBA x C3H)F^
mice during the GvHR. Here, F^ grafts (Group 2) had an
increased IEL count of 5«3 - 0-5 IEL/lOO Epithelial cells
(p < O.OOl). In this case, controls had 2.4 - 0.6 IEL/lOO
Epithelial cells.
Conclusions
In summary, these experiments have shown that, as in
neonatal F^ mice injected with parental spleen cells, there
are increases in CCPR, crypt length and IEL count in adult
F^ mice with GvHR. Similar changes were also observed in
antigen-free grafts of foetal gut of both F^ and parental-
type when the host animal had GvHR.
Thus, these experiments have confirmed the CCPR and IEL
count to be. reliable and sensitive indices of the mucosal
phase of the GvHR. In adult F^ mice with a moderate form of
GvHR and little evidence of intestinal injury as shown by
histology or epithelial enzyme levels, these parameters
showed consistent and highly significant increases in the
jejunum of both (CBA x BALB/c)F^ and (CBA x C3H)F^ mice.
Furthermore, identical alterations were also found in the
mucosa of F^ foetal gut grafts during the GvHR, despite the
fact that these grafts are sterile and antigen-free. Thus,
although intestinal bacteria have been implicated in the
lesions of the GvHR (Van Bekkum & Knaan 1977)> it is apparent
that alterations in CCPR and IEL count are not dependent on
direct contact with a local bacterial flora. These findings
are strong support for the hypothesis that alterations in
CCPR and IEL count are direct consequences of mucosal CMI.
In addition, the results of this chapter are consistent
with the idea that soluble factors are responsible for the
mucosal changes in CMl reactions (Ferguson & MacDonald 1977)*
Parental-type grafts of foetal gut were damaged during the
GvHR despite being syngeneic to the injected donor cells
and identical mucosal changes were found in both host jejunum
and foetal gut grafts during the GvHR in the Mis incompatible,
(CBA x C3H) strain combination. Direct cytotoxic action
by donor cells is therefore unlikely to be responsible for
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Fig. 7«1• Effect of the GvHR on mucosal architecture in the
jejunum of adult (CBA x BALB/c)F and (CBA x C3H)F
mice. Villus length, crypt length and CCPR 14 days
after injection of 6 x 10' parental (GvHR) or F^
spleen cells (controls). Bars represent means
- 1 s.d. for villus/crypt length and arrows show
CCPR (19-20 mice/group).




[ CBA.x C3HIF, Hosts
: p <o.ooi j
I p <0.0011
2 -
Grafts : F] Fi Parental Fi Fi Parental
Spleen Cells: F] Parental Parental F] Parental Parental
Host Effect: Control GvHR GvHR Control GvHR GvHR
Groups : 1*3 2 t 1*3 2 L
Fig. 7-2. Effect of the GvHR on intraepithelial lymphocyte
counts in the jejunum of (CBA x BALB/c)F and
^CBA x C3H)F .mice. Results are mean IEE count
- 1 s.d. Ik days after injection of 6 x 10^ parental
(GvHR) or F^ spleen cells (controls). (20 mice/group)
ERRATUM pp 94 and 96
The graphs for Figs 7.2 and 7.4 have been transposed.









































Fig. 7»3« Effect of the GvHR occurring in host animals on the
mucosal architecture of F^ and parental-type grafts
of foetal gut. Villus length, crypt length and CCPR
in grafts of foetal gut implanted in GvHR mice and
implanted in control mice. Bars represent means +1 s.d
for villus/crypt length and arrows show CCPR lb days
after induction of the GvHR. 7-10 grafts were examined








I EL/100 Epithelial Cells
(CBAxBALB/c) F; Hosts
ip(p<0.001)
CBA XC3H} F, Hosts
—(p<0.001]
Controls GvHR Controls GvHR
Fig. 7-4. Effect of the GvHR occurring in host animals on
the IEL count in F-. and parental-type grafts of
foetal gut. Results are mean IEL count - 1 s.d.
in grafts implanted in GvHR mice and implanted in
control mice; 14 days after induction of the GvHR.
6-10 grafts were examined in GvHR mice and 10 grafts
in controls.
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Fig. 7 O« Histology of graft of F^ foetal small intestinek-2 days after implantation under the kidney capsule
of a control (CBA x C3H)F^ mouse. The mucosal
appearances were normal in these grafts, although
the values for all indices were lower than in
normally sited intestine (H & E x l6o).
Fig. 7*6. Lymphoid follicle in graft of F gut implanted in
(CBA x BALB/c)F-^ mouse with GvHK (H & E x 50)•
CHAPTER 8
MIGRATION INHIBITION OF LYMPH NODE LYMPHOCYTES AS AN
ASSAY FOR CMI
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The CCPR and IEL count have been shown to be sensitive
and reliable indices of a known CMX reaction occurring in
the intestinal mucosa. However, these have the disadvantage
of being indirect parameters of the immune response and in
addition, may be affected by many non-immunological factors.
Since my aim was to induce local intestinal cell mediated
immunity to a dietary antigen, it was important to be able
to monitor local immunity by an in vitro immunological test
which would complement mucosal measurements in vivo.
In vitro assays of CMI are of two main types: those
involving antigen-induced transformation of sensitised
lymphocytes and those which depend on the release of
lymphokines from antigen-stimulated lymphocytes (Bloom 1971)•
For practical reasons of cost and culture facilities, I
decided to use a migration inhibition technique. In the
mouse, migration inhibition tests have normally been performed
with a mixture of the sensitised cells and a migrating
indicator cell population. However, a recent report
describing a direct migration inhibition test using thymo¬
cytes from immunised mice as an in vitro test for DTH
(Hughes et al 1980) prompted my attempt to use mouse lymph
node cells in a direct inhibition assay.
The object of this group of experiments was therefore
to validate migration inhibition of lymph node cells as an
in vitro correlate of DTH in vivo by using lymph nodes
draining the footpads of mice immunised "there with antigen
in adjuvant. Ultimately, my intention was to employ the
mesenteric lyrnph nodes of mice immunised orally with a
dietary protein.
Outline of experiments
Lymph node cells were obtained from the popliteal and
axillary lymph nodes of BALB/c mice at intervals after
intradermal immunisation with OVA in adjuvant into each
footpad. In this way, large numbers of sensitised lymphoid
cells could be obtained from each mouse. Pooled cells from
the lymph nodes of 2-3 mice were used in each test.
Determination of time course and dose dependence of migration
inhibition
Initial experiments indicated that lymph node cells
would migrate well from capillary tubes and that migration
inhibition could be observed after overnight incubation with
antigen. I next performed a series of experiments to define
optimum culture conditions suitable for routine use.
Fig. 8.1 shows the development of migration inhibition
in lymph nodes taken from mice at intervals after immunisation
with 100 pg OVA in CFA, assayed with 0.01, 0.1, 1, 10 and
50 mg/ml OVA in the culture medium. Several points emerged
from these results. Firstly, 50 mg/ml OVA produced inhibition
of migration in all cases and this is likely to be due to a
cytotoxic action of this high concentration of OVA. This
was not seen at lower concentrations of antigen. No migration
inhibition was observed with cells taken 1 week after
immunisation, but by 2 weeks there was inhibition in the
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wells containing 0.1 mg/ml OVA (M.I. = O.78), although
this was not statistically significant.At 3 weeks, statistically
significant inhibition was observed with all test concentrations
of OVA. It was found that 0.1 mg/ml OVA gave the best
sensitivity and reproducibility (M.I. = 0.49 - 0.10) with
good results also being obtained with 1 mg/ml OVA (M.I. =
0.66 - 0.17). Significant inhibition was found with all
concentrations of OVA used at 4 weeks, at a level similar
to that observed at 3 weeks. Even by 9 weeks after immunisation,
significant migration inhibition was obtained with 0.01 mg/ml
OVA (M.I. = 0.53 P < 0.01) and 10 mg/ml OVA (M.I. = O.56 p < 0.01
In subsequent experiments, I therefore used 0.1 and/or
1 mg/ml OVA as the concentrations of antigen in inhibition
assays.
Specificity of migration inhibition
This was investigated in two ways. Firstly, lymph node
cells from OVA immunised mice were migrated in the presence
of HSA and secondly, direct inhibitory effects of the antigens
were excluded by testing cells from mice immunised with
saline in CFA against different concentrations of OVA and HSA.
0.1 mg/ml and 1 mg/ml HSA did not produce significant
migration inhibition of cells from OVA immunised mice (Fig. 8.2:
M.I. = O.98 - 0.09 and O.89 - 0.01 respectively) and this
figure also shows that cells from saline immunised mice were
not inhibited by either OVA or HSA at concentrations of 0.1
or 1 mg/ml. m other experiments 0VA did not inhibit
migration of saline immunised cells at any time after
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immunisation except when the highest, toxic concentrations
of" antigen were used.
Correlation of migration inhibition with systemic immunity
In these experiments, mice were immunised with either
100 pg or 10 pg OVA in CFA or with 100 pg OVA in Incomplete
Freund's Adjuvant distributed between three Footpads. The
animals were tested for haemagglutinating antibodies, systemic
DTH and migration inhibition in the presence of 0.1 mg/ml OVA
at intervals thereafter. The results are shown in Fig. 8.3*
When mice were immunised with 100 pg OVA in CFA,
humoral antibodies were not consistently detected until 2
weeks and a further small increase was seen at 3 weeks. A
similar pattern was found with DTH, as measured by the specific
increase in footpad thickness 2k hours after an intradermal
injection of 100 pg OVA in saline, which as I have found in
other experiments, was fully developed by 3 weeks. As shown
here and in Fig. 8.1, migration inhibition was also fully
developed only by 3 weeks after immunisation, and it is
apparent that all parameters were in step in this instance.
A different pattern emerged after immunisation with
10 pg OVA in CFA however. In this case, no animals were
found to have antibodies at 1 week, but there was a good
antibody response 2 and 3 weeks after immunisation. In
contrast excellent systemic DTH could be elicited at 1 week
in these animals and it thereafter declined to low levels.
Migration inhibition was already significant by 1 week after
immunisation with 10 pg OVA (M.I. = 0.72) and continued to
develop to a high level thereafter (M.I. = 0.18, 3 weeks).
Thus, immunisation with 10 }ig OVA in CFA produced systemic
DTH and migration inhibition 1 week afterwards in the absence
of antibody formation, although migration inhibition continued
to develop while DTH declined in vivo.
Finally, mice were tested for these parameters 3 weeks
after immunisation with 100 pg OVA in IFA. These mice have
high titres of antibody at this time, but have systemic DTH
responses which are substantially less than other groups.
No migration inhibition could be elicited in the lymph nodes
of these mice, despite the very high Ab levels.
Identification of migrating cells
It is usually assumed that cells migrating from cultures
of lymphoid tissues are predominantly macrophages or polymorphs,
while lymphocytes are the cells responsible for the production
of factors which modulate this activity. The large numbers
of lymph node cells which appeared to migrate in the cultures
here, led me to believe that the migrating cell was
predominantly a lymphocyte. This was confirmed when Giemsa-
stained preparations of cells which had migrated from the
capillary tubes were examined. It can be seen from Fig. 8.b
that these cells are mostly lymphocytes with only occasional
macrophages and other cells to be seen. Furthermore, when
migrated cells were allowed to adhere to glass coverslips,
Giemsa staining revealed only a small number of glass -
adherent cells.
Similar results were obtained when cells were examined
by fluorescent labelling for T and B cell markers. Thus, 55%
of cells were positive for Thy 1.2 alone and 37% positive
for slg, with the remaining 8°/o negative for both markers
(Table 8.l). Proportions of these cells in the lymph node
cell population before migration were k6% T cells, 36% B cells
and 18% other cells. Lymphocytes are therefore the predominant
migrating cell type in the migration assay.
Migration characteristics of individual lymphocyte populations
Having observed that lymphocytes were the predominant
migrating cell, I then wished to determine whether both T cells
and non-T cells were involved in migration and whether
individual cell populations would exhibit inhibition. The
results described here are migration assays performed with
lymph node T cells purified by nylon wool,or with non T cells
obtained by treatment of lymph node cells with aThy 1.2 + C',
3 weeks after immunisation with 100 pg OVA in CFA.
Fig. 8.5 indicates that purified T cells showed migration
inhibition in the presence of 0.1 and 1 mg/ml OVA which was
identical to that of the whole cell population. When non T cell
were examined in the assay however, conflicting results were
obtained. Although overall, these cells showed significant
inhibition with both 0.1 mg/ml OVA (M.I. = 0.72 - 0.17) and
1 mg/ml OVA (M.I. = 0.80 - 0.17)> the results varied from
excellent inhibition (M.I. = O.60) to complete absence of -
inhibition (M.I. = 0.99) in individual tests. These variable
results could be explained if T cells had been incompletely
eliminated from the cell suspensions used. That this was
indeed the case was confirmed by separate cytotoxicity assays
in which killing of BALB/c thymocytes by aThy 1.2 + C' varied
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from 70-98% (Table 8.2) in individual tests.
Conclusions
These experiments show that migration of lymph node
cells in vitro was consistently inhibited in the presence of
the appropriate antigen. Inhibition developed slowly after
immunisation with OVA in CFA, was long-lasting and was
optimal when 0.1 mg/ml OVA was used in the test system.
Migration inhibition was shown to be antigen-specific and
the absence of non-specific inhibition by OVA gives the
test a high degree of sensitivity for this antigen. Although
not absolutely clear-cut, the results from different immunis¬
ation schedules show that migration inhibition of lymph node
cells is an in vitro correlate of systemic DTH as measured
by skin-testing in vivo. Thus, mice immunised with 10 p,g OVA
in CFA have migration inhibition in the absence of serum
antibodies while immunisation with OVA in IFA produces high
titres of antibody but no migration inhibition and minimal
DTH. However, the continuing development of migration
inhibition as systemic DTH declines suggests that the in vitro
and in vivo tests are not assaying identical aspects of DTH.
The majority of migrating cells were shown to be
lymphocytes and it is clear that nylon wool purified T cells
showed identical migration inhibition to whole lymph node
cells. However, both B and T cells were found to migrate in
the assay and the results of assays using non-T cell populations
were difficult to interpret. The results are compatible with a
residual T cell population being required for migration
inhibition, and this study indicates that lymph node lymphocyte
migration inhibition provides a sensitive in vitro method of
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Time after Immunisation with 100 (jg OVA in CFA
•Fig. 8.1. Development of" migration inhibition in the presence
of different concentrations of OVA in draining
lymph nodes of mice immunised with 100 pg OVA in
CFA injected into the footpads.Where shown, bars
represent mean Migration Index +1 s.d. of 4
experiments. In all experiments, lymph node cells
were pooled from 2-3 mice and at least 6 wells
assayed for each concentration of OVA.
>
1U /
100fig OVA/CFA Saline + CFA Immunised
Immunised
Fi£j__8j_2. Specificity of migration inhibition in draining
lymph nodes of mice immunised with 100 pg OVA
) or with saline in CFA. Significant migration
inhibition was observed only when OVA/CFA immunised
lymph nodes were tested with 0.1 mg and 1 mg/ml OVA
(p < O.OOl and p < 0.005 respectively). Each bar
represents mean + 1 s.d. of 2—4 experiments using
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Immunised with lOOpgOVA/CFA 10pg0VA/CFA 100pg0VA/IFA
n 8 8 6
■Fig. 8«3« Development of migration inhibition, systemic DTH
and serum antibody responses in mice immunised with,
10 pg or 100 pg OVA in CFA or with IOO pg OVA in
IFA. Systemic DTH was measured by the specific
increment in footpad thickness 2k hours after IOO pg
OVA in saline i.d. and antibody levels by passive
haemagglutination. Bars represent means + 1 s.d.
(6-8 mice/group).
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Fig. 8.^-. Morphology of lymph node cells migrating from
capillary tubes in vitro. The majority of
migrating cells were lymphocytes. (Giemsa x 500).
Migration Index
1.2- CZ\ + 0.1 mg /ml OVA
EZ22 + 1 mg / ml OVA
All LN cells T-cells Non T-cells
Immunised with 100 (jg DVA/CFA
Fig.- 8« 5» Migration inhibition of" whole lymph node cells,
T cell enriched populations and non-T cells in
presence of OVA 3 weeks after immunisation with
100 ]ig OVA in CFA. Significant inhibition of T
cells was observed with both concentrations
(p < 0.02 vs saline immunised controls in Fig.
8.2). Means + 1 s.d. of 3—k experiments.
Lymph Node Cells Migrating Cells
Thy 1.2 +ve 81. 5^ (79-86)
slg +ve 35.5^ (28-4l)




Table 8.1. Identification of lymph, node cells before
and after migration in vitro as assessed
by immunofluorescence. (Mean + range of
3 experiments).
Thymus Peripheral Lymph Nodes
°fo Cytotoxicity 70-98^ 24-55^
Table 8.2. Ability of aThy 1.2 + C' to kill BALB/c
lymphocytes in 3 experiments.
CHAPTER 9




Although, the graft-versus-host reactions discussed
in Chapters 6 and 7 provide useful models of intestinal CMI,
such reactions are not normally encountered during life
whereas the intestinal mucosa is constantly exposed to a
range of dietary proteins. My aim was to investigate the
possibility that local CMI responses could be induced to
a newly introduced fed protein and that this immunity might
damage the small intestinal mucosa.
Feeding proteins to animals induces both local and
systemic antibody responses (Crabbe, Nash, Bazin, Eyssen &
Heremans 1969; Dolezel & Bienenstock 1971a,b) while systemic
CMl has also been reported, although this is a rare consequence
of protein feeding (Goldberg, Kraft, Peterson & Rothberg
19715 Perrotto et al 197^-) • la addition, local CMI has
been described after feeding hapten-protein conjugates -
demonstrated by production of MIF by mucosal and MLN
lymphocytes (Huntley et al 1979)* However, previous feeding
of a protein antigen usually suppresses subsequent CMI
responses to that antigen and this is related to the "
induction of suppressor T cells (Miller & Hanson 1979;
Challacombe & Tomasi 1980). I reasoned that the induction
of suppressor cells by fed antigen could explain previous-
failures to induce local CMI to a dietary antigen and so
designed experiments in which mice depleted of suppressor
cells were immunised orally with ovalbumin.
114
As discussed earlier, murine suppressor T cells are
sensitive to certain doses of cyclophosphamide and enhanced
CM.I may be found when CY is given shortly before antigen
(Rfillinghoff et al 1977; Gill & Liew 1978; Attallah et al 1979).
I have therefore tested the hypothesis that abrogation
of gut-associated suppressor cells by CY would allow the
development of active local CMl in the gut and its lymphoid
tissues after oral immunisation with OVA. The presence of
CMl has been tested in two ways: firstly, in this section,
the induction of local Immunity in the MLN was studied using
the lymph node migration inhibition assay described in
Chapter 8. In Chapter 10, CMl in the mucosa itself was
investigated using the CCPR and IEL count as indices of
mucosal immunity.
In addition to studies on the induction of local immunity
in orally immunised mice, the systemic CMl and antibody
responses of these animals have also been assessed. This
has allowed me to investigate the possibility that the
presence of a local immune response in the gut need not
also involve systemic immunity.
Experiments and Results
In the first series of experiments, local CMl was
investigated in the MLN of mice immunised and challenged
orally with OVA. Female BALB/c mice were fed 2 mg OVA by
intragastric tube and 28 days later were commenced on
0.1 mg OVA/day/mouse in their drinking water. After 10
days of challenge, mice were sacrificed and the MLN used
in migration inhibition tests. In addition, one group of
OVA fed mice received 100 mg/kg CY 2 days before the first
feed of OVA, while a further group were given CY alone as
controls (Fig. 9*1)• Migration inhibition assays were also
performed on the MLN from three similar groups of mice
which were immunised once with 2 mg OVA and sacrificed at
intervals thereafter. In studies of systemic immunity,
additional groups of mice were subjected to the same protocols
and tested for CMl and antibody levels. In each experiment
employing MLN cells, lymph nodes from 3-^- mice from each
group were pooled.
Local CMI in the MLN of mice immunised and challenged orally
with ovalbumin
MLN cells from the groups described above were cultured
in the presence of 1 mg/ml OVA (Fig. 9-2). There was no
inhibition of migration with either MLN cells from mice fed
OVA alone (M.I. = 1.00 - 0.06) or given CY alone (1.12 i 0.13)»
However, there was significant inhibition of migration of
MLN cells from mice pretreated with CY and fed OVA when
these mice were subsequently challenged orally with OVA
(M.I. =0.63 - 0.18 p < 0.01).
Induction of local CMI in the MLN of CY treated mice after a
single feed of ovalbumin
The;results above indicated that CY pre-treated, OVA fed
mice developed local CMl after a secondary challenge with
OVA, and also confirmed that the migration inhibition assay
could be applied to the MLN. I therefore decided to investigate
whether a similar state of CMl would develop after a single
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feed of OVA to CY treated mice and to study its time of
onset and duration.
Figure 9*3 shows that significant inhibition of migration
in the presence of 0.1 mg/ml OVA was apparent within 2k hours
of feeding OVA and that a similar level of sensitisation
persisted until at least 14 days after feeding (M.I. = O.65).
Sensitisation was then lost, but as the previous experiments
showed, this could be recalled by a period of secondary oral
challenge. Migration inhibition was never demonstrable in
the MLN of mice fed OVA alone or given CY alone and these
studies confirm the need for combining oral immunisation
with CY treatment for the demonstration of local CMI.
Finally, migration inhibition of MLN cells from OVA
immunised mice did not occur in the presence of HSA, nor
did OVA itself inhibit migration of MLN cells from un-
immunised controls (Table 9«l)«
Systemic CMI responses in mice immunised and challenged orally
with ovalbumin
The presence of systemic CMI was investigated either
5 or 21 days after a single feed of OVA or on completion of
the 10 day oral challenge programme. CMI was assayed by
the increase in double skinfold thickness 2k hours after
100 pg OVA intradermally.
' A group of mice were immunised with 100 pg OVA in CFA
intradermally as positive controls in these studies and
when skin tested 21 days later, these mice had excellent DTH
responses as measured by skin-testing (Fig. $.k). However,
no DTH could be elicited in any of the groups of orally
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immunised mice. In particular, CY treated OVA fed mice
had no systemic DTH either 5- days after oral priming nor
on completion of the challenge protocol, despite the
presence of local CM.I in the GALT at these times.
Serum antibody responses in mice immunised and challenged
orally with ovalbumin
The three groups of OVA-immunised mice were also tested
for the presence of haemagglutinating anti-OVA antibodies
on completion of the 10 day challenge period (Table 9*2).
None of these mice had detectable serum antibody at this
time, while sera from mice immunised parenterally with OVA
had excellent antibody levels when tested in parallel.
Conclusions
These experiments support the hypothesis that presumptive
abrogation of suppressor T cells by CY will allow the
development of local CMI in the GALT following oral immunisation
with a protein antigen. Thus, only mice treated with CY
before initial exposure to oral OVA had OVA-dependent
inhibition of migration of their MLN cells after secondary
oral challenge with ovalbumin in the drinking water. Controls
given CY or fed OVA alone had no evidence of CM I in their
GALT. It was also shown that sensitisation could be
demonstrated in the MLN of CY treated, OVA fed mice within
1 day of a single feed of 2 mg OVA. This primary sensitisation
was transient and was no longer demonstrable by 21 days
after feeding. Nevertheless, it is apparent .that the MLN
of these mice remains primed after this time, since local CM.I
was found in the MLN of mice challenged 28 days after
initial exposure to antigen. The loss of sensitisation
from the MLN of mice fed a single dose of OVA may reflect
emigration or differentiation of the cells required to
induce migration inhibition to OVA.
In addition, the observations that mice sensitised
and challenged orally with OVA can develop GALT immunity
in the absence of systemic immune responses, underline the
segregation of intestinal and systemic immunity.
ORAL IMMUNISATION WITH OVALBUMIN AND CYCLOPHOSPHAMIDE PRE-TREATMENT
IN BALB C MICE
PROTOCOL OF IMMUNISATION '
Day - 2 Cyclophosphamide lOOmg/Kg I.P.
Day 1 2mg ovalbumin by intra-gastric tube
Days 28-37 0.1mg ovalbumin daily in drinking water
Day 37 Sacrifice
Fig. 9«1» Protocol of oral immunisation and cyclophosphamide
pretreatment used to demonstrate local CMI in the







Day_ h2o cy cy
OayJ. 2mg OVA orally Nil 2 mg OVA orally
Days 28-37 0.1 mg OVA Nil 0.1 mg OVA
Fig. 9.2. Migration inhibition in the MLN of" mice immunised
and challenged orally with OVA. MLN cells from
3-4 mice were pooled in each experiment and were
i obtained after 10 days of oral challenge with OVA.
Bars represent means + 1 s.d. of 3 experiments
in which cells were assayed in presence of 1 mg/ml
OVA.
MIGRATION INDEX
x x OVA Alone
x x CY Alone
J i i i i 1
1 2 3 5 13 22
DAYS AFTER 2mg OVALBUMIN ORALLY
Fig. 9•3• Development of migration inhibition in the MLN of
mice fed 2 mg OVA after CY pretreatment, in mice
fed OVA alone, and in mice given CY alone. Cells
were assayed with 0.1 mg/ml OVA and, where shown,
bars represent mean - 1 s.d. of 3 experiments
(OVA/CY groups vs others p < O.Ol). Other results
are for one experiment and statistical analysis
between groups is not possible. However, within
each experiment at times up to 13 days, significant
migration inhibition was observed in OVA/CY mice
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Fig. 9.k. Systemic cell mediated immunity after primary
and secondary oral immunisation with. OVA in
mice given OVA - CY or CY alone. A group of
mice was also immunised with 100 pg OVA in CFA
as positive controls. Results are mean specific
increment in double skinfold thickness, 2k hours





3 OVA (0.1 mg/ml) 1.01 - 0.08
Normal MLN
3 OVA (l mg/ml) 1.0k - 0.06
MLN-OVA alone 2 HSA 0.95 - 0.06
mln-ova/cy 3 HSA 0.92 - 0.07
Table 9«1» Specificity of migration inhibition of MLN cells.
Migration indices (means - 1 standard deviation)
of normal MLN cultured with OVA and of MLN from
OVA immunised mice cultured with 0.1 mg/ml HSA.
MLN were obtained from immunised mice 5 days
after feeding OVA.
Group n Antibody Titre
OVA/CFA 4 4.39 - 0.29
OVA fed 8 Not detected
CY alone 6 Not detected
OVA/CY 8 Not detected
Table 9-2. Haemagglutinating antibody responses (mean
loglO antibody titre - 1 standard deviation)
in OVA-immunised mice. OVA/CFA mice received
2 mg OVA in CFA intradermally followed by
1 mg OVA in saline 30 days later and were
bled 1 week afterwards. See text for details
of orally immunised mice.
CHAPTER 10
INDUCTION OF CMI IN THE MUCOSA BY FEEDING OVALBUMIN
TO CYCLOPHOSPHAMIDE TREATED MICE
Introduction
In the previous chapter, a regime of oral immunisation
with ovalbumin, combined with cyclophosphamide pretreatment
which led to the induction of active local immunity in the
GALT was described. Since activated T cells migrate from
the MLN to the intestinal mucosa (Guy-Grand et al 197^> 1978
Rose et al 1976) it is likely that cell mediated immunity
in the MLN will extend to the mucosa itself. The aim of
the experiments in this section was to investigate the
possibility that a mucosal CM.I response could be induced to
the dietary protein and that mucosal damage would result
from this local immunity.
I have therefore monitored the development of local CMI
in the mucosa of mice immunised and challenged orally with
OVA following CY treatment. The CCPR and IEL count were
used as indices of mucosal CMI since these had proved
reliable parameters of local immunity during the GvHR.
Examination of the small intestine by microdissection should
also identify any morphological abnormalities following
antigen-feeding.
In addition, feeding contact sensitising agents has
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been reported to induce mucosal damage (Bicks et al 1967b).
However, oral tolerance is the normal result of feeding
these agents (Chase 19^-6; Glaister 1973^ ? Asherson et al
1977) and this unresponsiveness may be blocked by CY (Polak,
Geleick & Turk 1975)• In order to reinforce the studies
using a protein antigen, I have also conducted a pilot study
to investigate the mucosal changes after feeding oxazolone
to CY pretreated mice.
Experiments and Results
The basic outline of the experiments on OVA immunised
mice is described previously (Fig. 9«l)« Thus, mice were
fed OVA by intragastric tube and were challenged 28 days
later with OVA in the drinking water for a period of 10 days.
Additional groups were given 100 mg/kg CY 2 days before the
initial feed or were given CY alone as controls. In all
experiments, female BALB/c mice were used and tissues were
removed for examination on completion of the 10 day challenge
programme.
Mucosal changes in mice immunised and challenged orally
with OVA after CY treatment
In the first experiments, mice were sensitised with
2 mg OVA and received the equivalent of 0.1 mg/mouse/day
as a challenge, as described in Chapter 9«
On completion of the challenge protocol, histological
examination revealed no abnormalities in any of the 3 groups
of animals. However, the more sensitive microdissection
technique revealed significant differences between the
groups (Fig. 10.l). Mice given CY alone, or sensitised
and challenged alone with OVA had values for villus length,
crypt length and CCPR which were similar to those of a
group of untreated, normal controls included in this
experiment. In mice receiving CY combined with OVA
immunisation, however, the 10 day challenge resulted in
significant increases in crypt length (132.4 - 4.3 vs*
119.1 - 4. 7 11m, 118.4 - 7.8 11m and 118.7 - 5-^ lim p < O.OOl)
and CCPR (12.0 compared to 6.6, 8.4 and 6.8). Villus
lengths were similar in all groups.
Mice given CY alone or fed OVA alone had identical
IEL counts to untreated controls (15.8 - 3*0, 14.5 - 1.2
and 14.1 - 2.0 respectively). However, CY treated, OVA
fed mice had a significant increase in IEL count after oral
challenge with OVA (25*9 - 2.9) (Fig. 10.2).
Effects on the mucosa of higher doses of oral ovalbumin
The mucosal alterations, although statistically
significant, were not at all similar to the severe villus
and crypt abnormalities seen in diseased patients. If
mucosal changes reflect the magnitude of the mucosal immune
response, higher challenge doses of ovalbumin might be
expected to produce more striking alterations in the
mucosa. Therefore, using the same protocol, mice were
sensitised with 20 mg OVA orally and challenged orally with
the equivalent of 1 mg/mouse/day for 10 days. Once again,
mice given CY alone or immunised and challenged with OVA
alone had similar values for villus length (802.2 - 49 mp
and 790.9 - 37•5 mp), crypt length (ll7«7 - 7•2 mp and
112.1 - 2.2 mp) and CCPR (7*3 and 5*6), while CY treated,
OVA fed animals showed a significant increase in CCPR (12.5)
and crypt length (125*3 - 5-7 mp). In addition, these mice
also had a minor, but significant increase in villus length
(852.7 - 20 mp p < 0.02) (Fig. 10.3)» Intraepithelial
lymphocyte counts (Fig. 10.4) in CY treated and OVA fed
controls were similar (17.8 - 0.9 and 16.2 i 1.00), while
mice receiving both had a significantly raised IEL count
in comparison (25«5 - 3«5)« Once again, there were no
histological abnormalities in these animals.
The tenfold increase in dose of fed antigen has thus
had no significant effect on the resulting mucosal
alterations in CY treated mice.
Antigen specificity of mucosal responses to fed antigen
It was important to ensure that the changes described
did not merely represent a non-specific response of the CY
treated mucosa to dietary proteins. Mice were therefore
fed 2 mg BSA on day 1 and challenged as before with 0.1 mg/day
OVA in the water. Again, one group of BSA fed mice received
100 mg/kg CY 2 days before feeding and another group received
CY alone. As shown in Fig. 10.5> all 3 groups of mice had
similar values for all indices of mucosal architecture.
Mice receiving CY before oral immunisation with BSA and
challenge with OVA had no increase in crypt length
(100.6 - 2.7 nxp) or CCPR when compared to CY treated or
BSA/OVA fed controls which had similar values for crypt
length (99*7 - 2.8 mp and 99*6 i 2.8 mp) and CCPR. In
addition, all three groups had identical IEL counts
(Fig. 10.6).
Thus, the alterations in mucosal architecture and in
lymphocytic infiltration found after oral immunisation and
challenge of CY treated mice are specific to the antigen
used to first immunise the animal.
Transfer of syngeneic thymocytes to CY treated, orally
immunised mice
In order to investigate the possibility that the
observed effects of CY were due to its action on suppressor
cells, I decided to perform a preliminary study on the
effects of reconstituting CY treated mice with normal
thymocytes.
Mice were immunised with 2 mg OVA orally i CY
treatment and challenged with 0.1 mg/day OVA as usual.
In this experiment, one additional group of CY treated,
OVA fed mice received 4 x 10 syngeneic BALB/c thymocytes
i.p. immediately before primary immunisation. Once again,
CY treated and OVA fed controls had similar values for
villus length (763.2 - b8.2 mp and 693*1 - 49*0 mp), crypt
length (103.4 - 2.5 mp and IO3.3 - 2.9 mp) and CCPR (3.4 and
3.7) while CY treated, OVA fed mice had normal villus lengths
but significant increases in crypt length (ll6.6 - 4.9 m1-0
and CCPR (10.3) (fig* 10.7)* Similarly, Fig. 10.8 shows
that CY treated and OVA fed controls had identical IEL counts
(13.8 i 0.6 and 13*7 - 1*3) while mice receiving both had
a significant elevation of their IEL count (22.7 - 2.9)*
These results therefore confirm the findings of the previous
experiment. In addition, transfer of syngeneic thymocytes
did not prevent the mucosal alterations induced by CY treatment
and oral immunisation and challenge with OVA. These mice
had villus lengths similar to all other groups, but had
significant increases in crypt length (114.6 i 3*0 mp),
CCPR (lO.l) and IEL count (23*0 - 1.9)* These values were
identical to those obtained in the CY treated, OVA fed group.
Pilot study on feeding oxazolone to CY treated mice
In this study, mice were fed 10 mg oxazolone in 0.3 ml
olive oil followed by a second feed of 2 mg oxazolone in
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olive oil 7 days later. The mice were sacrificed 2 days
after the challenge dose. One group of oxazolone-fed mice
also received 100 mg/kg CY 2 days before the first feed.
It can be seen from Table 10.1 that mice fed oxazolone and
given CY had a significant increase in crypt length and a
large increase in CCPR compared to oxazolone-fed controls
(9-5 vs. 2.7) • In addition, CY treated, oxazolone-fed mice
had a significantly raised IEL count compared to their
controls.
The results from this pilot study with small numbers of
mice appear to confirm the ability of CY to induce mucosal
changes consistent with local CMI following oral immunisation
and challenge with a non-protein antigen.
Conclusions
These experiments support the concept that treatment of
mice with 100 mg/kg CY 2 days before primary oral immunisation
with antigen, allows the development of specific alterations
in the intestinal mucosa on subsequent oral challenge with
antigen. The mucosal changes observed included significant
increases in CCPR, crypt length and IEL count and were
therefore similar to those found during the intestinal phase
of the GvHR. These changes were found only on challenge
with the antigen used to immunise the animals and it is
probable that they represent the induction of a mucosal CMI
response to a dietary antigen. This is supported by the
results of the previous chapter which demonstrated the presence
of local CMI in the GALT of CY treated mice immunised and
challenged orally with OVA.
The mucosal abnormalities observed were not severe
and were not increased by the use of larger doses of fed
antigen. It is possible that more prolonged exposure of
the mucosa to antigen will be required for the induction
of more severe intestinal damage, such as villous atrophy.
Although depletion of suppressor cells is the presumed
mechanism for the action of CY, transfer of normal thymocytes
did not prevent the mucosal changes in CY treated, OVA fed
mice. In these experiments, thymocytes were transferred
at the same time as the initial feed of OVA and are therefore
unlikely to have been present in the intestine to encounter
the fed antigen. It is therefore probable that this transfer
did not' reconstitute the animals with functioning suppressor













Nil 2mpOVA orally 2mc OVA orally
Nil 0. lmg OVA 0. lmu OVA orally
orally
Fig. 10.1. Mucosal architecture in jejunum of BALB/c mice
fed 2 mg OVA after CY pretreatment, in mice
given OVA or CY alone, and in normal controls. >
Mucosal changes measured after 10 days of oral
challenge with 0.1 mg OVA/day. Bars show means
+ 1 s.d. for villus/crypt length and arrows
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Fig. 10.2. Intraepithelial lymphocyte counts.' in jejunum of
BALB/c mice fed 2 mg OVA after CY pretreatment,
in mice given OVA or GY alone,- and in normal 1
controls. IEL counts measured after 10 days of
oral challenge with 0.1 mg OVA/day. Results are
means - 1 s.d. for each group'of 6-8 mice.
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Day-2 100mg/kgCY - lOOmg/kgCY
Day 1 - 20mg OVA orally 20mg OVA orally
Days 28-37 - 2mg OVA daily 2mg OVA daily
Fig-. 10. ?. Effect of feeding larger doses of OVA on the
induction of mucosal CMI in BALB/c mice. Mucosal
architecture in jejunum of CY pretreated mice fed
20 mg OVA and challenged with 1 mg OVA/day orally
for 10 days and in mice given CY or OVA alone.
Bars represent means + 1 s.d. for villus/crypt













20 mg OVA orally
1 mg OVA orally
100 mg/kg CY
20 mg OVA orally
1 mg OVA orally
Fig. 10.4. Effect of feeding larger doses of OVA on the
induction of mucosal CMI in BALB/c mice.
Intraepithelial lymphocyte counts in jejunum
of CY pretreated mice fed 20 ing OVA and challenged
with 1 mg OVA/day orally for 10 days and in mice
given CY or OVA alone. Bars represent means - 1 s.d.
for groups of 6-8 mice.
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Fig. 10. 5» Specificity of mucosal CMI to fed OVA. Mucosal
architecture in CY pretreated mice fed 2 mg BSA
and challenged orally with 0.1 mg OVA/day and
in mice given CY alone or. fed BSA and OVA.
Bars represent means + 1 s.d. for villus/crypt
length and arrows represent CCPR. No significant
changes were observed (7—8 mice/group)..









2 mg BSA 2 mg BSA
0.1 mg OVA daily 0.1 mg OVA daily
Fig. 10.6. Specificity of mucosal CMI to fed OVA. Intra¬
epithelial lymphocyte counts in CY pretreated
mice fed 2 mg'BSA and challenged orally with
O.l mg OVA/day and in controls. Bars show means
- 1 s.d. for each group of 7-8 mice. No













Crypt Depth (mp) /
Day - 2 - lOOmg/kgCY lOOmg/kgCY lOOmg/kgCY
Day 1 1 mg OVA orally — 2 mg OVA orally 2 mg OVA orally
+ 40x106 Thy
Days 28-37 0.1 mg OVA daily - 0.1 mg OVA daily 0.1 mg OVA daily
Fig. 10.7. Effect of syngeneic thymocytes on the induction
of mucosal CMI to fed OVA. Mucosal architecture
in BALB/c mice pretreated with CY and injected
i.p. with k x 10 normal thymocytes before feeding
2 mg OVA and oral challenge with 0.1 mg OVA/day.
Controls received CY + OVA, or were given CY or
OVA alone. Bars represent means + 1 s.d. for
villus/crypt length and arrows show CCPR for each
•group of 5-8 mice.








Oay-2 - 100mg /kg CY 100mg/kgCY lOOmg/kgCY
Day 1 2mg OVA - 2mgOVA 2 mg0VA+40x10sThy
Days2B-37 0.1 mg OVA daily - 0.1 mg OVAdaily 0.1 mg OVA daily
Fig. 10.8. Effect of syngeneic thymocytes on the induction
of mucosal CMI to fed OVA. Intraepithelial
lymphocyte counts in BALB/c mice pretreated with
CY and injected i.p. with k x 10' normal thymo¬
cytes before feeding 2 mg OVA and oral challenge
with O.l mg OVA/day. Controls received CY + OVA
or were given CY or OVA alone. Bars represent
mean - 1 s.d. for each group of 5-8 mice.
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Group n Villus Length Crypt Length CCPR IEL
OXAZ 4 601. 8 - 66. 6 my, 104.5 - 4.2 my 2.7 7.6 ± 1.5
0XA.Z/CY 4 598.6 - 40.0 my 126.4 + 5«3 my* 9-5** 14.6 - 2.1*
Table 10.1. Mucosal changes in mice fed and challenged orally
with oxazolone after CY treatment, (means - 1
standard deviation).





ABROGATION OF ORAL TOLERANCE TO OVALBUMIN BY CYCLOPHOSPHAMIDE
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Introduction
Within the spectrum of immunological responses to
fed antigen, systemic unresponsiveness is more often
encountered than active immunity (see Chapter 2). In the
preceding Chapters, however, I found that cyclophosphamide
allowed the induction of active, local CMI in the GALT
and intestinal mucosa of mice immunised orally with oval¬
bumin .
In these experiments, the consequences of CY treatment
were considered to be secondary to its inhibitory action
on suppressor lymphocytes. Since suppressor T cells have
been implicated in the induction of oral tolerance by
feeding OVA (Richman, Chiller, Brown, Hanson & Vaz 1978;
Ngan & Kind 1978; Miller & Hanson 1979)> I wished to
investigate whether CY would also interfere with oral
tolerance to OVA as well as allowing local priming for CMI.
The first objective of the experiments described here was
thus to study the effect of feeding OVA to CY treated mice
on the subsequent systemic immune response.
Systemic CMI and humoral immunity may differ in their
susceptibility to tolerance induction by intravenous antigen
and may therefore be subject to different regulatory
mechanisms in the unresponsive animal (Neveu & Borduas 197^-;
Silver and Benacerraf 197^+) • It has also been proposed
that several regulatory factors, including suppressor cells,
may be responsible for oral tolerance after feeding OVA
(Hanson, Vaz, Maia & Lynch 1979)* The second objective of
these experiments was therefore to investigate whether
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systemic CMI and humoral immunity would differ in their
susceptibility to tolerance induction by feeding OVA. In
this way, I hoped to find evidence for the regulation of
these responses by different mechanisms and to clarify the
role of suppressor cells in the regulation of CMI. Therefore,
in these experiments, CY treated mice were fed two different
doses of OVA and their systemic CMI and antibody responses
measured after subsequent parenteral immunisation with OVA.
Experiments and Results
Protocol of oral tolerance induction and cyclophosphamide
pre-treatment
This is shown in Fig. 11.1. Mice in Group 1 were
controls immunised with 2 mg OVA in CFA i.p. and bled weekly
for antibody levels or with 100 pg OVA in CFA intradermally
and tested for DTH by intradermal footpad test 3 weeks later.
Group 2 mice were fed either 2 mg or 25 mg OVA as tolerising
procedure 2 weeks before immunisation, while Group 3 mice
received 100 mg/kg CY 2 days before feeding OVA. Where
appropriate, results in Group 2 and 3 are expressed as %
suppression of control values given as:
/Control Value - Value in Fed Micex
°fo Suppression = ^ Control Value ' x 100%
Effects of OVA prefeeding on serum antibody responses to
parenteral OVA
1. IgM levels. Figs. 11.2 and 11.3 show the mercaptoethanol-
sensitive antibody responses in mice immunised intraperitoneally
with 2 mg OVA in CFA, two weeks after feeding 2 mg or 25 mg
OVA respectively. The peak of the IgM response occurred
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two weeks after immunisation in animals fed 2 mg OVA and
at one week in mice fed 25 mg OVA, at which, times virtually
all antibody was of the IgM class. It is seen that at
these times, both doses of oral antigen suppressed the
subsequent IgM response compared to controls, with 93%
suppression (p < O.Ol) in 25 mg OVA fed animals (Fig. 11.3a)
and 60% suppression in 2 mg OVA fed mice (p < 0.05) (Fig. 11.2a).
The groups of mice pretreated with CY, before OVA feeding,
had IgM levels which were identical to controls after
feeding 25 mg OVA and were not significantly different from
controls in the 2 mg OVA fed group (36% suppression).
2. IgG levels. In contrast to the results with the IgM
responses in OVA fed mice where both doses of OVA suppressed
the response, there was a marked discordance in the effect
of 2 mg or 25 mg OVA on subsequent IgG responses (Figs. 11.2
and 11.3) • Mercaptoethanol-resistant antibody accounted
for the majority of the antibody three weeks after immunisation
and it can be seen that at this time, feeding 25 mg OVA had
markedly suppressed the IgG response of fed mice compared
to controls (93% suppression p < 0.005) (Fig. 11.3f)» Mice
fed 2 mg OVA on the other hand had IgG responses which were
identical to controls. CY pretreatment of mice fed 25 mg OVA
returned their IgG response towards normal (77% suppression)
although this was not significantly different from either
tolerant or control animals. CY pretreated, 2 mg OVA fed
mice, had IgG levels which were the same as both other
groups in this experiment.
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3• Time course of antibody responses in mice fed 25 mg OVA.
It was of interest to know if the maturation of the
antibody response was also altered in the mice rendered
tolerant by oral protein. In the three groups of mice fed
25 mg OVA, serum IgM and IgG levels could be followed
from 1-3 weeks after immunisation and these can be seen
in Figs. 11.3a-e. All groups showed the characteristic
early peak of IgM production at one week (Fig. 11.3a) with
higher levels of IgG later in the experiment (Figs. 11.3d-f).
However, it is notable that after the marked suppression of
IgM levels early in the response of the OVA fed mice,
there was in addition a late rise in IgM antibody in these
animals (Fig. 11.3c). This secondary rise in IgM three
weeks after immunisation was mirrored by a decline in IgG
at this time (Fig. 11.3f) and was in marked contrast to
the responses of control animals in whom IgM levels were
very low by then. CY pretreated mice, after an early
IgM response similar to controls (Fig. 11.3a) had at later
times a pattern of IgG and IgM responses which was midway
between the control and tolerant animals (Figs. 11.3c and
11.3f). When the results at two weeks were compared, the
pattern of this response in the three groups was already
emerging and was clearly associated with the switch from
IgM and IgG production in the controls (Figs. 11.3h and
11.3e).
Thus, the results in Figs. 11.2 and 11.3 indicate
that the IgM responses of mice could be tolerised by even
low doses of oral protein while larger amounts were required
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to achieve suppression of the IgG response. Also the
tolerance of IgM responses appeared more susceptible to
abrogation by CY pretreatment. Variation between individual
groups at each time in this experiment was quite large;
however, the overall trend of the results in Fig. 11.3
indicates that the larger dose of oral OVA interfered
with the maturation of the primary antibody response as
well as suppressing absolute levels of antibody.
DTH responses in OVA fed mice
Figure 11.4 shows the DTH responses in mice fed 2 or
25 nig OVA, assessed three weeks after immunisation by
measuring the specific increase in footpad thickness 24 hours
after an intradermal injection of 100 pg OVA in H^O. The
results in this figure illustrate that both doses of oral
OVA suppressed a subsequent DTH response, with 88% suppression
(p = 0.05) in 25 mg OVA fed mice and 64°[o suppression in the ' .
mice fed 2 mg OVA (p = 0.05) compared to controls. CY given
to mice fed 25 mg OVA returned their systemic DTH response
to a value which is midway between the control and tolerant
mice and which was not significantly different from either.
It is important to note, however, that the mice receiving
1
CY before feeding 2 mg OVA had completely normal DTH responses,
and showed no residual tolerance. Similar results were
obtained 48 hours after testing (Fig. 11.4), confirming the
DTH nature of the reactions measured, and the consistency of
the tolerant state. Thus, feeding 25 mg OVA suppressed the
humoral IgM, IgG and CMI responses while 2 mg OVA orally
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was effective only in reducing CMX and to a lesser extent
the IgM antibody response. Furthermore, while both doses
of oral OVA used produced significant suppression of
subsequent DTH responses, the tolerance after feeding 25 mg
OVA was only partially susceptible to CY pretreatment.
Tolerance found after 2 mg OVA orally on the other hand
was completely abrogated by CY.
Antigen specificity of oral tolerance induced by feeding OVA
To confirm that the state of tolerance induced by
feeding OVA was specific to the fed protein, mice were
also immunised with 2 mg HSA in CFA two weeks after feeding
25 mg OVA. Fig. 11.5 shows the haemagglutinating anti-HSA
responses one and three weeks after immunisation. The OVA
fed mice exhibited antibody responses to the unrelated
protein which were the same as those of the H^O fed controls.
Similarly, Figure 11.6 indicates that three weeks
after intradermal immunisation with 100 pg HSA in CFA, mice
fed 25 mg OVA also had normal DTH responses to HSA, assessed
as the specific increase in footpad thickness 2b hours after
100 p,g HSA in H^O intradermally.
Effect of cyclophosphamide on systemic immunity
Since CY had been found to increase the systemic
immune response of mice fed tolerogenic doses of OVA, it .
was important to exclude a residual effect of CY acting on
systemic immunity at the time of parenteral immunisation.
Thus, mice were given 100 mg/kg CY 16 days before
intradermal immunisation with 100 pg OVA in CFA. Serum
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antibodies and systemic DTH were assessed as before, and
Figures 11.7 and 11.8 show that CY pretreatment had no
significant effect on these responses. In the case of the
humoral response, reduction rather than enhancement of
antibody levels was observed. It is therefore unlikely
that the effect of CY on oral tolerance can be explained
by a stimulatory action or systemic immunity.
Ovalbumin was not a constituent of the mouse diet
Since the studies in these Chapters were based on the
assumption that OVA was a new dietary protein in the mice
investigated, it was essential to ensure that the normal
laboratory rodent diet did not contain OVA. The diet used
in the Animal Unit at the Western General Hospital contained
no ingredients of obvious egg origin (Spratts Ltd. - personal
communication). However, trace amounts of OVA were sought
by analysing both a crude extract and a salt precipitated
fraction of the mouse diet. Antigenic OVA was identified
using the haemagglutination inhibition assay described in
Materials and Methods and this was shown to detect levels
of 1 pg/ml OVA.
Neither extract of diet was found to cause haemagglutination
inhibition of OVA coated SRBC, despite the fact that the
extracts used were highly concentrated preparations containing
the equivalent of 20 g food.
Summary and Conclusions
These experiments have shown that feeding 25 mg OVA two
weeks before parenteral immunisation will reduce both humoral
149
and cell mediated immunity to OVA. However, when mice were
fed 2 mg OVA, only CMI and IgM antibody responses were
suppressed, and IgG antibody levels were unaffected.
Cyclophosphamide was found to block partially the tolerance
induced by feeding 25 mg OVA and to abrogate completely the
induction of tolerance of CMI found after feeding 2 mg OVA.
Thus, 100 mg/kg CY 2 days before feeding OVA modulates
the resulting state of systemic unresponsiveness as well as
permitting the development of active CMI in the GALT and
mucosa.
The results indicate that systemic CMI is readily
tolerised by even low doses of fed OVA and that this tolerant
state is fully sensitive to CY. This finding is compatible
with the theory that a CY-sensitive suppressor cell system
is normally activated by small amounts of a new dietary
protein and that this mechanism is important in the phenomenon
of oral tolerance. These cells may also inhibit the
development of local CMI in the gut and its lymphoid tissues.
In addition, the results underline the multiple
consequences of feeding protein antigens. Hence, suppression
of systemic CMI and antibody responses were dependent on
the dose of OVA fed and CY had differing effects on these
tolerant states. These findings suggest that oral tolerance
is dependent on the induction of several regulatory factors,
including suppressor cells. The outcome of feeding antigen
will depend on the dose and nature of antigen and the
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Fig. 11.2. Effect of CY on the induction of tolerance by-
feeding 2 mg OVA to BALB/c mice. Serum haemagglut-
inating TgM and IgG antibody levels 7,14 and 21 days
after 2 mg OVA in CFA i.p. Mice were fed 2 mg OVA
14 days before immunisation. Bars represent mean
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Fig. 11.3« Effect of CY on the induction of tolerance by-
feeding 25 mg OVA to BALB/c mice. Serum haemagglut-
inating IgM and IgG antibody levels 7> 1^- and 21 days
after 2 mg OVA in CFA i.p. Mice were fed 25 mg OVA
14 days before immunisation. Bars represent mean
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Specific Increment in Footpad Thickness (mm)
Fig. 11.4. Effect of CY on the induction of tolerance by-
feeding 2 or 25 mg OVA to BALB/c mice. Systemic
CMI responses 3 weeks after 100 pg OVA in CFA
i.d. in CY treated OVA fed, OVA fed mice and in
control mice. Results are mean specific increment
in footpad thickness 2k and 48 hours after 100 pg
OVA in saline i.d. + 1 s.e.m. (8 mice/group).
, (p values in mice fed 25 mg OVA are vs. controls).
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Fig. 11.5. Antigen-specificity of induction of tolerance by
feeding OVA to BALB/c mice. Serum haemagglutinating
anti-HSA responses in mice fed 25 rng OVA 14 days
before immunisation with 2 mg HSA in CFA i.p. and
in controls. Bars represent mean log antibody
titres + 1 s.e.m. for each group of o-8 mice. No
significant' differences were observed.
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Specific Increment in Footpad Thickness (mm)
Fig. 11.6. Systemic CMI responses to HSA in mice fed 25 mg OVA
and immunised with 100 pg HSA in CFA i.d. Bars
represent mean specific increment in footpad thickness
24 hours after 100 pg HSA in CFA i.d. + 1 s.e.m.
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Fig- 11-7. Effect of CY on immunity to OVA. Serum haemagglut-\
inating IgM and IgG responses in mice given CY 16 days
before IOO pg OVA in CFA i.d. and in immunised
controls. Bars represent mean log10 antibody titres
+ 1 s.e.m. for each, group of 8 mice. No significant
differences were observed.
Specific Increase in Footpad Thickness (mm)
Assay Group 310 120
Oay_L Day 16
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lOOmg/kgCYip in CFA
Fig. 11.8. Effect of CY on immunity to OVA. Systemic CMI
responses in mice given CY 16 days before IOO pg OVA
in CFA i.d. and in immunised controls, 3 weeks after
immunisation. Results are mean specific increment in
footpad thickness 2k hours after IOO pg OVA in
saline i.d. + 1 s.e.m. No significant differences.
CHAPTER 12
EFFECTS OF CYCLOPHOSPHAMIDE ON THE ARCHITECTURE
OF THE SMALL INTESTINE AND ITS LYMPHOID TISSUES
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Introduction
In the experiments described earlier, cyclophosphamide
was used in its role as an inhibitor of suppressor T cell
function in mice. However, like other cytotoxic agents, CY
may damage all rapidly dividing tissues including the small
intestinal epithelium. In any study of the immunological
and morphological consequences of oral immunisation in CY
treated animals it is therefore essential to assess carefully
the effects of CY itself on the mucosa. In this Chapter I
have performed parallel studies on the morphology and cell
kinetics of the jejunal mucosa and on the structure of the
GALT in CY treated mice so that the results of previous
chapters can be more accurately interpreted. These features
were examined in some detail by microdissection and light
microscopy and also by transmission and scanning electron
microscopy. For this chapter T have selected only those
results which I consider to be of particular relevance to
my work on oral immunisation with ovalbumin. (To present the
results in full would create an imbalance in the thesis).
While CY does not appear to damage mature enterocytes
directly (Waldeck 1972; Ecknauer & LOhrs 1976), it does affect
crypt cells and may produce secondary deficiencies of brush
border enzymes (Hartwich et al 1978). Theoretically, such
epithelial injury could interfere with handling of protein
antigens and the effects of CY on intestinal immune responses
could be due to this process. In addition, CY has profound
effects on epithelial cell kinetics and I had used studies
of cell kinetics to measure mucosal CMI. It was essential,
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therefore, to follow alterations in mucosal architecture
and CCPR after treatment with CY in the same dose as X had
used in earlier experiments. Furthermore, I have examined
changes in IEL count in CY treated mice, since the IEL count
was also used to assess mucosal CMI.
In the lymphoid tissues, CY depletes B cell areas with
relative sparing of T cell areas in both peripheral lymphoid
organs and Peyer's Patches (Turk & Poulter 1972; Mazigh et al
1979)• There have been no previous studies on the fate of
antigen-processing structures of the GALT in CY treated
animals, although protein uptake by the bursal epithelium
is depressed by CY in chickens (Sachs, Beezhold & van Alten
1979)• The lymphoepithelial structures of the Peyer's Patches
are thought to be responsible for antigen uptake in mammals
(Owen 1977) and I have paid particular attention to these
structures in the present light and electron microscopic
studies of the GALT in CY treated mice.
In all the experiments reported here, it was of special
interest to learn the consequences of CY treatment on the
intestine k8 hours after administration of the drug, since
this was the time of OVA feeding in earlier experiments. In
addition, mucosal architecture was examined 6 weeks after CY
since this represented the time when orally immunised mice
were sacrificed for mucosal assessment. In the next chapter,
the effects of CY on antigen uptake by the gut are described.
Experiments and Results
Female BALB/c mice were given 100 mg/kg CY i.p. and the
jejunum removed for microdissection and histology 1,2t kt7
21 and k-2 days thereafter. To avoid an influence of colchicine
1.59
*
6n E.M. appearances and on lymphoid tissue architecture,
separate groups of" 4 mice were killed 1,2,4,6 and 12 days
after CY for examination of lymphoid organs and all E.M.
studies.
General Appearances
During the course of these studies, few systemic effects
of CY were observed. Animals showed no evidence of weight
loss, haematuria or frank diarrhoea. However, faecal pellets
were softer than normal and the mice easier to handle in the
first 48 hours after treatment.
Small intestinal morphology
Macroscopic features: 24 hours after CY, the jejunum was
thinned and there was an apparent increase in mucus. These
changes were less noticeable by 48 hours and resolved quickly
thereafter.
Histology; Few significant abnormalities could be demonstrated
on histological examination of the jejunum. Of these, the
most prominent was the presence of dense, basophilic inclusion
bodies in the crypts which were most numerous 24 hours after
CY (Figs. 12.1 & 2). By 48 hours after CY, these were less
in number and were virtually absent from this time. In all
cases, the crypt cells themselves appeared normal. Villus
epithelial cells showed slight subnuclear vacuolation until
4-6 days after CY, but were otherwise normal. The overall
structure-of the villi was never altered. Depletion of
lymphoid cells in the lamina propria was marked in most mice
examined up to 4 days after CY. Thereafter, repletion of
the lamina propria became apparent.
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Morphometric studies of the .jejunum
Control animals were studied at the start of the
experiment and a second group at 28 days. Crypt length
(Fig. 12.2), and CCPR (Fig. 12.4) remained constant during
the study while villus length decreased over the period
(Fig. 12.3).
Experimental Animals
Villus length: There was a steady fall in villus length
in the first 7 days after CY, reaching a minimum of 456.6 - 35*
on day 7 (fig* 12.3)* Thereafter, villus length recovered and
was comparable to controls from day 14 onwards.
Crypt length: On day 1 there was a small, but significant
decrease in crypt length to 99*6 — 2.2 mp compared to controls
104.9 - 3*3 (p < O.Ol). This recovered by 2—4 days and
significant crypt lengthening was observed on day 7 (118.2 i
6.9 mp) . This was not detectable 14 days after CY and normal
values were then maintained until the end of the study.
(Fig. 12.2).
Crypt cell production rate: The most dramatic effects of CY
on the small intestine were on the kinetics of crypt cell
proliferation (Fig. 12.4). After a profound fall in CCPR
at 24 hours (l.2 vs 4.8 in controls) a rapid, rebound increase
was observed by 48 hours. At this time, CY treated mice had
a CCPR of 13*2 (p < 0.02). This was the maximum GCPR attained
during the experiment, but the CCPR remained significantly
elevated until day 14 (8.7 P < 0.025)* Thereafter, the CCPR
fell to 2.5 on day 21 and was normal at 42 days.
These results indicate that the principal alterations
in mucosal morphology are secondary to the effects of CY on
crypt cell proliferation kinetics.
Transmission electron microscopy of* the small intestine
Ultrastruetural examination of the jejunum from control
animals revealed the characteristic maturation of enterocytes
as they migrated from the crypts onto the villus. Intra¬
epithelial lymphocytes were observed at all levels of the
villus and the lamina propria contained large numbers of
lymphocytes, plasma cells and eosinophils. Macrophages,
basophils and mast cells were observed less often.
Cyclophosphamide treated mice: Once again, the crypts were
the principal site of CY-induced alterations. The inclusion
bodies seen on light microscopy were prominent in all tissues
examined 2k hours after CY, but were less numerous thereafter
and absent after 48 hours. The inclusions consisted of
cellular material of unidentifiable origin and were frequently
found lying within lysosomal structures inside normal crypt
cells (Fig. 12.2). The crypt cells themselves appeared normal
throughout the study other than exhibiting features consistent
with the alterations in cell kinetics.
The majority of villus enterocytes were also undamaged
by CY. However, from day 2-12, cells at the base of the villus
and crypt mouth had evidence of mitochondrial damage (Fig. 12.5)
This consisted of mitochondrial dilatation - disruption and
occasionally inclusion bodies were seen in these mitochondria.
Mitochondrial damage was variable in extent and degree and
the majority of cells had normal mitochondria at all times.
These changes became less severe at later times in the study.
Similar changes could occasionally be seen in control mice,
but were not as prominent and did not show the same site
distribution. Otherwise villus enterocytes were normal,
with no visible damage to junctional complexes or the micro¬
villous border.
The pattern of depletion and repopulation of the lamina
propria seen on light microscopy was confirmed by E.M.
examination. In addition, the number of IEL was decreased
2k hours after CY but recovered rapidly thereafter.
Effects of cyclophosphamide on the morphology of the GALT
Histology: The alterations observed in the MLN and Peyer's
Patches of CY treated mice were similar to those seen in
the spleen and were consistent with previous studies.
Progressive depletion of B cell areas became maximal k days
after CY with subsequent regeneration and fibrosis occurring
from day 6 onwards. T-dependent areas in all tissues were
relatively spared by the drug and regeneration began in
these areas at an earlier time. This early recovery was
parallelled by massive regeneration of the thymic cortex
from day k onwards.
In the Peyer's Patches, CY-induced damage was similar
but appeared less than in other tissues and recovery was
quicker (Fig. 12.6). As far as could be assessed, the lymphoid
cell populations of the dome and dome epithelium were unaffected
by CY.
Intraepithelial lymphocytes after cyclophosphamide
IEL counts in the jejunum were performed in parallel
with histological studies of the jejunum. Fig. 12.7 shows
that there was an immediate fall in IEL count 2k hours after
CY to 7-6 - 1.2 IEL/100 Epithelial cells (Controls 1^.1 - 1.9).
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This had returned to control levels by k8 hours and was
normal thereafter. The IEL in CY treated mice were of
normal histologic and ultrastruetural appearance throughout.
Ultrastrueture of Peyer's Patches after cyclophosphamide
In control mice, the dome epithelium contained many
lymphoid cells and enterocytes and some macrophage-like cells.
M cells were characterised by sparse surface folds in clear
contrast to the regular microvillus border of columnar cells
and were found rarely in control specimens. The deeper,
lymphoid areas of the Patches showed the characteristic
appearance of organised lymphoid tissues.
Cyclophosphamide treated mice: The enterocytes in the dome
epithelium showed changes after CY which were similar to
those of villus epithelial cells. Mitochondrial damage was
however, less severe and found less consistently. Epithelial
M cells rarely showed this kind of damage at any time, even
when adjacent epithelial cells were damaged. (Fig. 12.8).
In addition, surface protrusions of the M cells were more
prominent and more frequently seen from day 2 onwards. In
contrast to control animals it was easy to identify several
M cell protrusions in each CY treated mouse. In the sections
examined it was not possible to trace the entire course of
these cells throughout the depth of the epithelial layer. .
It was not clear whether there was a real increase in M cell
numbers. Epithelial lymphoid cells appeared unaltered in
number and structure after CY.
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Scanning Electron Microscopy of the /jejunum and Peyer's Patches
in cyclophosphamide treated mice
The normal appearance of a Peyer's Patch and its
surrounding jejunal villi is shown in Fig. 12. 9> while Fig. 12.10
shows an area containing several columnar cells and one M cell.
SEM examination confirmed the relative lack of M cells in
control mice.
After CY, the overall surface area of the dome epithelium
appeared similar to controls at all times. Examination of
the surface at higher magnifications revealed a large number
of M cells in all CY treated mice, confirming the impression
obtained by T.E.M. (Fig. 12.ll). Although difficult to
quantify accurately, M cells appeared to comprise a greater
proportion of the total epithelial cell population as well
as an increased number/area. In addition, the surface folds
I
were more prominent and hyperplastic than in controls. These
features were apparent 24 hours after CY and maximal on
days 2-6.
Major alterations in villous structure were not found in
these studies. However, 24-48 hours after CY, some villi
showed evidence of lateral collapse. This may have been due
to the hypocellularity of the lamina'propria seen on sectioned
material.
Summary and Conclusions
The results of these experiments indicate that cyclo¬
phosphamide has minor, but significant effects on the small
intestinal mucosa and its lymphoid tissues. These may be
prolonged for up to 14 days, after a single dose of 100 mg/kg.
In the jejunal mucosa, CY affected principally the
rapidly dividing crypt cells. Its action on cell proliferation
was evidenced by the initial inhibition of CCPR which was
followed by a rebound recovery in crypt cell mitotic activity
which persisted for at least 14 days. Electron microscopy
and histological examination revealed evidence of crypt
damage in the first 24-48 hours after CY, but recovery
occurred rapidly after this time. Damage to villous epithelial
cells was restricted to those cells in the basal regions of
the villus, and was confined to alterations in mitochondrial
appearance. These were present at all times after 24 hours
and considerable variation in extent and severity was observed.
The significance of these lesions is not clear.
CY was shown to exert its principal effects on the B cell
areas of lymphoid tissues, with maximal damage by day 4 and
substantial recovery 6-12 days after CY. The GAI/T showed a
similar pattern of events and the outstanding finding in
the Peyer's Patches of CY treated mice related to the dome
epithelium. Here, both T.E.M. and S.E.M. indicated that the
specialised M cells of the dome epithelium were relatively
spared by the drug. ;Indeed, it appeared that CY had induced
an increase in number and activity of these cells, while the
columnar enterocytes showed minor changes similar to those
in villous cells.
In contrast to the effect of CY on the organised lymphoid
tissues of the GALT, the IEL showed a rapid return to normal
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levels after CY. In addition, destruction of IEL could
not be demonstrated at any time. The rapid recovery of the
IEL was more similar to the pattern seen in the thymus, and
the results are consistent with the IEL being derived from
a pool of rapidly dividing T cells.
These results are important to my work from two points
of view. Firstly, they indicate that CY alone had no
residual effects on the parameters of mucosal CMI when
measured at the time when OVA immunised mice were sacrificed
for intestinal examination (40 days after CY). However,
they also show that consistent alterations were present
in the mucosa ^8 hours after CY, when mice were normally
fed OVA for the first time. It is possible that this mucosal
injury may have contributed to the observed effects of CY on
oral immunisation with OVA.
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24 hours after CY. Large numbers of inclusion
bodies are seen in the crypts (arrows)(H & E x 320).
Fig. 12.2. Electron micrograph of crypt cell inclusion body
which has been engulfed by a crypt cell in mouse
jejunum, 24 hours after CY (x 63OO).
t
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Villus Height (my) Crypt Depth(mp)
Fig. 12.3» Effect of CY on mucosal architecture of BALB/c
mice. Villus and crypt lengths at intervals after
100 mg/kg CY and in age-matched controls. Bars
represent means - 1 s.d. for each group of 6 mice.
Accumulation of metaphases/
12^. Effect of CY on mucosal architecture of BAEB/c
mice. Crypt cell production rate at intervals
after CY and in age-matched controls. 6 mice/
group.
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Fig. 12.5. Mitochondrial damage in jejunal crypt cells
48 hours after CY. Note that in damaged cells,
some mitochondria still appear normal (x 7800).
171
Fig. 12.6. Light microscopic appearance of Peyer's Patch.
4 days after CY. There is depletion of B cell
areas (b) with relative sparing of T-dependent
areas (TDA). (C = crypts).(H & E x 160.)
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Fig. 12.7« Effect of CY on intraepithelial lymphocyte counts
in jejunum of BALB/c mice. Bars represent means
- 1 s.d. for each group of 6 mice.
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Fig. 12.8. Transmission electron micrograph of M cell in
Peyer's Patch 2 days after CY. M cells are easily
identifiable by their short surface folds in
comparison to the long microvilli of surrounding
epithelial cells (Ep). Mitochondrial damage was





Fig. 12.10. Scanning electron micrograph of the dome epithelium
of a normal Peyer's Patch. An M cell (arrow) is
clearly identifiable from the surrounding, hexagonal
enterocytes (x 1500).
Fig. 12.11. SEM appearance of the dome epithelium of a Peyer's
Patch 6 days after CY. Compared to the Peyer's
Patch in control mice (Fig. 12.10), M cells' were








As discussed above, the effects of CY pretreatment
on the immune responses to fed ovalbumin could have been
due to altered uptake and processing of proteins by the
gut mucosa. In my experiments, mice were always fed OVA
two days after CY and, in Chapter 12, minor but consistent
epithelial abnormalities were found in the jejunum at this
time. It was essential therefore to investigate the effect
of CY on the intestinal processing of OVA.
There are several mechanisms by which CY could alter
immune responses to fed antigen via an effect on the mucosa.
Firstly, the CY-damaged intestine might allow increased
uptake of antigenic material, allowing local or systemic
priming rather than tolerance. Alternatively, defective
uptake of protein could result in diminished absorption of
tolerogens. Finally, qualitative changes in antigen-handling
could alter the nature of the antigenic molecules absorbed.
This might disrupt the balance between the amounts of
immunogenic and tolerogenic protein present after feeding.
The aim of the experiments described in this chapter was
to investigate these possibilities.
This objective was achieved in two ways. The total
amount of antigenic OVA was measured in the serum of CY
treated mice after oral administration of OVA in the first
experiment. In a further experiment, the immunogenic
properties of the absorbed material were assessed by
adoptive transfer into syngeneic recipients.
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Experiments and Results
Serum levels of ovalbumin after feeding
Serum was obtained from mice 1 hour after feeding
100 mg OVA and one group of mice received 100 mg/kg CY two
days before feeding. The sensitivity of the haemagglutination
inhibition assay used to test sera for the presence of OVA
was shown earlier to be 1 pg/ml OVA and the concentrations
of OVA in sera of fed mice are shown in Figure 13*1« It can
be seen that there was a wide scatter of OVA concentrations
after feeding (^--1280 pg/ml) in each group. The upper limit
of » 1 mg/ml OVA in the serum represents absorption of
approximately 1 °fo of the fed dose and this result is similar
to those of other studies (Warshaw, Walker & Isselbacher 197^)•
The results show that QY had no significant overall effect
on the uptake of OVA by the gut.
Immunological effects of serum from ovalbumin fed mice
The protocol of this experiment is shown in Fig. 13•2.
Each group of donors comprised 20 BALB/c mice, each mouse
receiving either 25 mg OVA (Groups 2 and 4) or 0.2 ml H^O
(Groups 1 and 3) orally. The mice were bled out from the
axillary vein 50-70 minutes after feeding. In addition,
Groups 3 and k received 100 mg/kg CY two days before feeding.
The sera from each group were pooled and 0.8 ml transferred
i.p. into each of six BALB/c recipients. The recipients
were immunised 1 week later with 100 pg OVA in CFA intra-
dermally, bled weekly for haemagglutinating antibodies and
tested for systemic DTH by footpad testing 3 weeks after
immunisation. Recipients were also assayed for antibody
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levels immediately before immunisation.
Figure 13*3 shows that all recipient groups had
identical levels of. IgM and IgG antibody, measured 2 and 3
weeks after immunisation respectively. Thus, serum from
OVA fed donors (Group 2) had no effect on the humoral
immune response of naive recipients. In addition, CY
treatment of the donors (Group ^4-) did not alter the properties
of the transferred serum.
There was no evidence of priming in the recipients of
OVA fed serum and this was confirmed by the absence of
detectable antibody before immunisation.
A rather different pattern emerged when the CMI responses
of recipients were considered (Fig. 13 •'+)• Here, serum from
OVA fed donors markedly reduced the recipients' CMI responses,
measured 3 weeks after immunisation. This corresponded to
71% suppression compared to controls (Group 2 vs Groups 1
and 3, p < 0.02). Recipients of serum from CY treated, OVA
fed mice (Group ^-) also had significantly reduced CMI
responses (93% suppression, p < O.Ol) which were not
significantly different to the results in recipients of
Group 2.
J
Finally, it should be noted that CY did not alter the
properties of serum from H^O fed donors, either for humoral
or cell-mediated immunity (Groups 1 and 3)» There were
therefore no residual effects of CY in the serum of mice
given the drug two days before.
180
Conclusions
It is apparent from these results that CY had no
effect on the quality or quantity of protein antigen
absorbed by the gut. Concentrations of OVA in the serum of
CY treated mice were similar to those of untreated, OVA fed
mice. Furthermore, serum from OVA fed donors had identical
effects on the immune responses of recipients, irrespective
of whether the donors had received CY or not. Thus, the
epithelial damage observed in CY treated mice has no
apparent effect on the handling of protein antigens by the
gut. It is possible that these results reflect the relative
resistance of Peyer's Patch M cells to CY which was noted
earlier.
The results of this study also confirm that humoral
and cell-mediated immunity are affected differently by
intestinally-absorbed antigen. Thus, serum from OVA fed
donors markedly reduced the CMI response, but not the
antibody response, of recipient mice. These findings
support the results of Chapter 11 where it was shown that
these li-mbs of the systemic immune response responded
differently to the induction of oral tolerance and CY
pretreatment, after feeding OVA.
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Effect of CY on tlie uptake of OVA by the intestine,
Serum concentrations' of OVA, measured by
haemagglutination inhibition, 1 hour after feeding
100 mg OVA to BALB/c mice. No significant
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Fig. 13«2. Protocol of experiment designed to investigate










| | s Serum IgMAb, 2/52 after immunisation
= Serum IgG Ab, 3/52 after immunisation
Fig. 13.3» Effect of serum from OVA fed mice and from CY
pretreated OVA fed mice, on tlie immune response
of recipients. Haemagglutinating XgM and IgG
antibody levels, 2 and 3 weeks after 100 pg OVA"
in CFA in groups of 6 recipient mice (Mean log-^Q
titres + 1 s.e.m.). No significant differences
between the groups were observed. See Fig. 13»2











* P<?'vs Groups 1 and 3
** p<0.01
Fig. 13«^« Effect of serum from OVA fed mice and from CY
pretreated OVA fed mice, on the immune response
of recipients. Systemic CMI in groups of 6
recipients, measured 3 weeks after 100 pg in CFA.
i.d. Bars represent mean specific increments in
footpad thickness 2k hours after 100 pg OVA in




The overall objective of this study has been achieved,
in that I have been able to induce local cell mediated
immunity in the gut mucosa and its lymphoid tissues to a
dietary protein antigen, ovalbumin. An important aspect of
these findings was that intestinal CMI could only be induced
after pretreatment of the animals with cyclophosphamide
before oral immunisation. The likely explanation for this
is that cyclophosphamide prevented the induction of suppressor
cells by fed antigen. I was also able to show that CY also
inhibited the development of systemic tolerance normally
resulting from feeding antigen.
While the induction of intestinal CMI to a dietary antigen
required manipulation of the host immune response, mucosal
CMI occurred as an integral part of a graft-versus-host
reaction. In the GvHR in both adult and neonatal mice, I found
significant alterations in mucosal morphology in parallel
with the local immune response. The principal of these
were enhancement of crypt cell mitotic activity and increased
lymphocytic infiltration of the epithelium and these features
proved to be reliable parameters for the assessment of mucosal
CMI. Using these indices, evidence was obtained that
^V- lymphokines may be responsible for the expression of CMI
in the intestinal mucosa.
Since the measurement of CMI in the mucosa and GAUT
was a critical component of most of the experiments described
in this thesis, I shall first consider the experiments
designed to assess these responses. I shall then discuss
the work relating to the intestinal immune response to
dietary antigens.
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Mucosal alterations during the intestinal phase of the GvHR
It has proved extremely difficult to measure local CMI
in the small intestinal mucosa directly, due to its
contamination and inaccessibility. For this reason,
measurable features of intestinal pathology have been sought
as indirect indices of mucosal CMI. Previous studies had
identified an increased CCPR in neonatal F^ mice with GvHR
and increases in CCPR and IEL count during allograft rejection
of foetal gut (MacDonald & Ferguson 1976; 1977)- However,
in their work on the GvHR, these authors did not assess
the alterations in mucosal architecture in parallel with
direct measurement of the proliferative phase of the GvHR.
I therefore proceeded to do so, and my results confirm and
extend the previous, limited study of the effect of the GvHR
on the mucosa of neonatal mice (MacDonald & Ferguson 1977).
In addition, I have been able to examine the intestinal
phase of the GvHR in the jejunum of adult mice and in
antigen-free grafts of small intestine.
The earliest mucosal change in neonatal mice with GvHR
was shown to be an increased IEL count within 2k hours of
transfer of parental spleen cells and the IEL count continued
to rise and fall in direct parallel with the Spleen Index.
Increased IEL counts were also found in the jejunum of adult
F^ mice and in antigen-free grafts of gut during the GvHR.
The alterations in the IEL count are therefore not merely
a feature of the response by the immature gut to injury and
are not influenced by bacterial contamination of the mucosa.
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These findings, together with the T cell nature of the IEL
(Ferguson & Parrott 1972a; Guy-Grand et al 197^5 1978;
Janossy, Tidman, Selby, Thomas, Granger, Kung & Goldstein
.1980) and their increase during allograft rejection of gut
(MacDonald & Ferguson 1976) suggest that the increased IEL
count is directly related to mucosal CMI. The present
results cannot identify the cause or the source of the
continued rise in IEL count in neonatal mice. Since increased
numbers of IEL are also found during the GvHR in irradiated
mice, it is probable that these cells are of donor rather
than host origin (Guy-Grand et al 1978).
The rapid rise in IEL count in neonatal hosts is of
some interest. This did not occur when F^ animals were
injected with F^ spleen cells and this increase must be a
specific consequence of the interaction between donor cells
and host tissues. This idea is supported by the continuing
increase in IEL count which paralleled the Spleen Index
exactly. The exact role of the IEL in the GvHR is also
unclear. In humans, the majority of IEL are reported to be
of the suppressor T cell phenotype (janossy et al 1980) and
suppressor T cells do proliferate during the GvHR in mice
(Pickel & Hoffman 1977)- Nevertheless the early rise in
IEL count and their close relationship with the Spleen Index
would argue against this phenomenon being a proliferation
of suppressor T cells.
Mucosal mast cells undergo a thymus-dependent proliferation
during parasite infections of the small intestine (Ruitenberg &
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Elgersma 1976; Mayrhofer 1979) axid this response is
transferrable using slg TDL from Nippostrongylus-immune
rats (Nava & Miller 1979)• In addition, large numbers of
lymphoid cells containing mast cell-like granules and bearing
a T cell marker have been described in the mucosa of mice
with GvHR (Guy-Grand et al 1978). It is therefore of note
that prolonged hyperplasia of mucosal mast cells was observed
during the GvHR in the present study. In addition, this was
accompanied by an expansion of intraepithelial cells staining
positively for mast cell granules. It is clear that the
proliferation of mucosal mast cells played no part in the
development of the other mucosal changes observed since the -
mast cell response was delayed in relation to the other
indices. The MMC response during infection with Nippo-
strongylus brasiliehsjs is similarly delayed after the onset
of wo.rm expulsion (Miller & Jarrett 1971) and the MMC may
not necessarily be effector cells in intestinal immune
responses. In addition to the thymus-dependency of the MMC
response to intestinal parasites, there is considerable
evidence to support a close relationship between mast cells
and CMI. Mast cell infiltration has been reported during a
local GvHR In hamster skin (Billingham & Streilen 1968)
while mast cell degranulation occurs in DTH reactions in the
skin of mice (Askenase, Bursztajn, Gershon & Gershon 1980).
Lymphokine-dependent mastocytosis and histamine synthesis has
also been observed during the allograft reaction in mice
(Dy, Lebel, Kamoun and Hamburger 1981) and recently ah
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Lyt 1 23 clone of T cells has been reported to produce a
factor which stimulates in vitro differentiation of mast
cells (Nabel, Galli, Dvorak, Dvorak & Cantor 1981). Thus
CMI responses in the mucosa and elsewhere may specifically
recruit and activate mast cells. It is tempting to speculate
that histamine released by these cells may then suppress
further extension of the local CMI reaction (Rocklin 1978).
Alternatively, it has been suggested that MMC may themselves
be derived from mucosal T cells (Guy-Grand et al 1978). The
present results may either reflect recruitment of long-lived
mast cells by mucosal T cells or differentiation of T cells
into mast cells.
Soon after the initial rise in IEL count, neonatal mice
with GvHR developed an increased crypt cell mitotic activity,
confirming an earlier report (MacDonald & Ferguson 1977)*
This also correlated significantly with the Spleen Index and
was found in both the host jejunum and in sterile, antigen-free
F^ grafts in adult mice with GvHR. These features indicate
that a raised CCPR may also be a direct consequence of mucosal
CMI during the GvHR. During allograft rejection of foetal
gut, a similar, early increase in CCPR is found (MacDonald &
Ferguson 1977)> while the crypt hyperplasia which occurs
during infection with Nippostrongylus brasiliensis (Ferguson
& Jarrett .1975) or with Trichinella spiralis (Manson-Smith
et 'al 1979) is thymus-dependent. Furthermore, crypt changes
in the last case are preceded by migration of T lymphoblasts
into the mucosa (Manson-Smith et al 1979)* It is apparent
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therefore that enhancement of crypt cell mitotic activity
is a specific, if indirect parameter of local CMI in the
intestinal mucosa.
The results of Chapters 6 and 7 indicate that the IEL
count and CCPR are sensitive and reliable indicators of the
mucosal CMI during the GvHR, correlating closely with the
proliferative phase of the GvHR. Other studies show that
these findings may be applicable to intestinal CMI in general
and these parameters were therefore used in studies on the
induction and expression of CMI to orally administered
antigens.
Pathogenesis of mucosal lesions during the GvHR (Fig. l4.l)
Influence of intestinal bacteria
In the experiments described in Chapter 7» alterations
in IEL count and mucosal architecture were found in sterile,
antigen-free grafts of foetal F^ small intestine during the
GvHR and these were identical to the changes in IEL count
and mucosal architecture in normally sited jejunum. This
confirms other work which used less sensitive methods of
assessing mucosal damage (Elson et al 1977> Van Bekkum &
Knaan 1977) and indicates that direct bacterial contact is
not required for the mucosal changes of the GvHR. It has
been reported that an intact intestinal flora in the host
may be required for damage to occur in heterotopic grafts
of gut (Van Bekkum & Knaan 1977) and endotoxin may contribute
to the early mortality of the GvHR (Jones, Wilson & Bealmear
1971; van Bekkum, Roodenburg, Heidt & van der Waal 197^+) •
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During the GvHR bacterial invasion of the mucosa occurs
(Woodruff et al 1976) and intestinal flora may influence
both epithelial cell kinetics (Abrams, Bauer & Sprinz 1963)
and host CMI (MacDonald & Carter 1979)* It is possible
therefore that increased absorption of bacterial products
through an already damaged intestine may amplify the mucosal
lesions initiated by local CMI. In this way, more severe
forms of intestinal damage, including villous atrophy, may
result from local CMI in the intestinal wall.
Roles of cytotoxicity and delayed-type hypersensitivity
During the GvHR in mice, large numbers of cytotoxic cells
are generated by the recognition of host, H-2 coded antigens
by alloreactive T cells (Cerottini et al 1971; Singh et al
1972; Fung & Sabbadini 1976). Theoretically, direct cell-
mediated cytotoxicity might result in epithelial cell damage
in the intestine. However, several pieces of evidence would
argue against this idea. As discussed before, the initial
response of the mucosa in the GvHR is enhanced crypt mitotic
activity, while epithelial cell damage is only a late feature
of allograft rejection of gut (Ferguson & Parrott 1973;
MacDonald & Ferguson 1976). Of greater significance is my
finding that foetal grafts of parental type gut are damaged
during the GvHR, despite being syngeneic to the injected
alloreactive spleen cells. This confirms similar reports of
"bystander" damage during the GvHR in skin (Billingham &
Streilen 1968), kidney (Elkins & Guttman 1969) and more
recently in the small intestine (Elson et al 1977; van Bekkum
& Knaan 1977)* Direct cytotoxicity by donor cells cannot
account for these findings. Further evidence against a
major role for cytotoxicity is the finding of identical
intestinal changes in the H-2 compatible, Mis incompatible
(CBA x C3H) F^ mice with GvHR. Mis incompatibility does not
generate cytotoxic cells in vitro (Peck & Bach 197^) while
in the GvHR, DTH responses are induced in the absence of
cytotoxicity (Volters et al 1980). Finally, mucosal changes
in the GvHR correlated closely with the proliferative phase
of the GvHR, while in Chapter 10 similar alterations were
found during the local CMI response to a protein antigen.
There is thus strong evidence that the effector limb of
mucosal CMI is related to DTH rather than the action of
cytotoxic cells and it is likely that this DTH is mediated by
mucosal T cells proliferating in response to foreign antigen.
It would therefore be of interest to monitor the development
of mucosal CMI in parallel with the presence of DTH effector
cells in the host animal and its mucosa.
Pathways of mucosal T cell activation in GvHR (Fig. l^-.l)
In the experiments described in Chapter 7> the epithelial
elements of parental-type grafts could not have provided
targets for either the induction or expression of alloreactive
T cells. During growth under the kidney capsule however,
foetal gut grafts become populated with host lymphoid cells
(Ferguson & Parrott 1972a,b) and both F^ and parental-type
grafts will contain F^ cells capable of stimulating the donor
T cells known to populate such grafts during the GvHR (Guy-
Grand et al 1978).
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Proliferation of alloreactive T cells in the GvHR
is stimulated by the I-A region of the H-2 complex in mice
(Klein 1977) and this region is also important for the
development of DTH during the GvHR (Wolters & Benner 1979)*
I-A bearing, recirculating host cells in the grafts may
therefore provide the signal for donor T cell proliferation
and development of mucosal CMI. In addition, the Peyer's
Patches have recently been shown to contain I-A bearing cells
(Challacombe, Krco, David & Tomasi 1979) and are important
sources of gut-infiltrating cells in the GvHR (Guy-Grand et al
1978). This may provide an additional pool of activated
T cells which reach the mucosa via the thoracic duct where
gut-seeking T lymphoblasts are abundant in the GvHR (Sprent
& Miller 1972; Sprent 1976). The present results indicate
that this immigration of lymphocytes occurs rapidly after
induction of the GvHR, since neonatal mice had raised IEL
counts within 2k hours. The significance of this finding is
reinforced by previous work which showed that specific
activation and trapping of parental lymphocytes occurs within
18-24 hours after transfer into hosts (Ford, Simmons &
Atkins 1975)» while maximal localisation of MLN lymphoblasts
in the mucosa occurs within k hours (Sprent & Miller 1972;
Ottoway & Parrott 1980). Detailed autoradiographic studies
are required to elucidate fully the migration patterns of
T cells during the intestinal phase of the GvHR.
Gut epithelial cells have recently been found to bear
surface I-A (Curman, Kampe, Rask & Peterson 1979) and it is
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theoretically possible that these cells could provide a
further site of T cell activation in the mucosa itself.
Finally, random migration to the gut of T cells activated
in other lymphoid organs may also contribute to the
accumulation of proliferating T cells in the small intestine.
Role of soluble factors in the expression of mucosal CM1
The evidence discussed above indicates that the mucosal
lesions of the GvHR are due to DTH mediated by proliferating
mucosal T cells, suggesting that soluble mediators are
responsible for many of the mucosal alterations observed.
This is supported by the "bystander" lesions found in
parental-type grafts of foetal gut, since these are likely
to be secondary to the release of soluble factors by donor
T cells encountering F^ passenger leucocytes in the graft
mucosa. "Enteropathic lymphokines" have already been proposed
to account for the mucosal changes in intestinal CMI responses
(Ferguson & MacDonald 1977) and it has been suggested that
lymphokines are mainly responsible for the pathological
lesions of the GvHR (Grebe & Streilen 1976). In support
of this concept, lymphokines are produced by Lyt 1+ T cells
in mice (Ktlhner et al 1980), a subset whose activation is
controlled by the I-A subregion, the part of the H-2 complex
important for the proliferative response in the GvHR (Cantor &
Boyse 1975j- Alter & Bach 1979)• It is also likely that
lymphokines are essential for the mucosal alterations found
when local CMI was induced to a dietary protein antigen.
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These lymphokines would have several properties
(Fig. l4.l). Firstly, they should have a stimulatory effect
on crypt stem cell proliferation and it is possible that
this effect is analagous to the influence which T cell
products have on bone marrow stem cells (Schroder, Arnold &
Clark-Lewis 1980). In addition, lymphokines will recruit
and trap further specific and non-specific effector cells in
the mucosa, including macrophages, mast cells, polymorphs
and additional lymphocytes. Finally, these mediators may
alter the function of the pericryptal fibroblasts thought to
be responsible for the skeletal framework of the mucosa
(Marsh & Trier 197^-j Parker et al 197^-) • Lymphokines which
alter the metabolism of fibroblasts in vitro have been
described (Wah.1, Wah.1 & McCarthy 1978; Postiethwaite & Kang
1979) and a mechanism of this kind would accentuate disruption
of the mucosal architecture. Evidence for this type of lesion
comes from the basement membrane abnormalities seen in
allograft rejection of the gut (Ferguson, Carr, MacDonald &
Watt 1978).
In addition to acting on cells of the immune system,
lymphokines are known to act on non-lymphoid tissues including
fibroblasts, osteoblasts (Horton, Oppenheim, Mergenhagen &
Raisz 197^) skin (Pick, Krejci, Cech & Turk 1969), vascular
tissue (Nishioka & Katayama 1978) and brain (Fontana, Grieder,
Arrenbrecht & Grob 1980). As in these tissues, lymphokines
released during an intestinal CMI response seem to provide
the links between the lymphoid and non-lymphoid elements of
_ l
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an organ which, are essential factors in the repair of an
organ damaged by a local immune response. As discussed in
Chapter 2, there is strong evidence that lymphokines are
produced in the intestinal mucosa after various schedules of
oral immunisation and during allograft rejection. This is
further support for a crucial role for lymphokines in .
intestinal immune reactions.
The question of the cells producing the postulated
lymphokines is of some interest. Since mucosal CMI is
associated with an increased IEL count, it might be thought
that these cells are responsible for this phenomenon. In man
(Janossy et al 1980) and mice (Micklem H.S., Davies, M.D.J.
& Parrott, D.M.y* personal communication) the majority of IE
T cells are of the suppressor/cytotoxic phenotype and it is
more likely that the abundant helper/inducer T cells of the
lamina propria (Janossy et al 1980) perform this function.
Very recently, however, it has been found that IEL are
capable of transferring DTH to a protein antigen (Shields, J.G.
& Parrott, D.M.V. - unpublished observations). Thus, the
nature of the mucosal effector T cell remains to be established.
Migration inhibition of lymph node cells as an assay for CMI
j
In the experiments described in this Chapter, it was shown
that migration inhibition of lymph node cells correlated with
DTH in vivo. In practice, the most reproducible results were
obtained when cells were, tested against 0.1 and 1 mg/ml OVA
3 weeks after immunisation and the migrating cells were
predominantly lymphocytes.
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The correlation of the in vitro assay with in vivo
immunity was obtained by studying the development of systemic
humoral and cell mediated immunity in parallel with the
development of migration inhibition. When mice were immunised
with 100 pg OVA in CFA, all measures of the immune response
developed simultaneously. However, migration inhibition and
systemic DTH occurred in the absence of serum antibodies, 1
week after 10 pg OVA in CFA, while mice immunised with OVA
in IFA had excellent antibody responses but negligible DTH
and no migration inhibition. Although immune complexes are
reported to inhibit cell migration in vitro (Bloom & Bennett
1966; Carpenter et al 1968), the results indicate that
migration inhibition is more closely related to systemic DTH
in vivo rather than the antibody response. Since migration
inhibition continued to develop after systemic DTH had
disappeared in mice immunised with 10 pg OVA it is likely
that footpad testing and migration inhibition are measuring
parallel but non-identical aspects of DTH. It is possible
that the results reflect the presence of locally developing
immunity in regional lymph nodes rather than systemically
disseminated CMI.
The results concur with previous reports of migration
inhibition of lymphoid cell populations. Direct migration
inhibition assays using protein antigens have been described
for spleen (Rich & Lewis 1932; Carpenter et al 1968; Likhite
et al 1972; Hughes et al 1980), lymph nodes (Thor & Dray 1968;
Likhite et al 1972), thymus (Bakker, Engelhart, Mulder &
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Hoedemaeker 1975; Hughes et al 1980) and tonsil (Mazuran,
Rabatic, Sabioncello & Dekaris 1979) and have been correlated
with DTH in vivo in several cases (Thor & Dray 1968; Likhite
et al 1972; Mazuran et al 1979; Hughes et al 1980). In
addition, migration inhibition of peripheral blood lymphocytes
has been associated with other measures of CMI (Kowalczyk &
Zembala 1978; Bradsher, Sutcliffe & Alford 1979)* The present
study differs from others employing lymphoid organs in some
important details; firstly, the in vitro assay was performed
in the absence of serum, since unreliable results were found
in the presence of serum. Secondly, many other groups have
used considerably larger concentrations of protein to induce
migration inhibition, while the present test was shown to
have a high level of sensitivity. Finally, I have been able
to identify with some certainty that the predominant migrating
cell was the lymphocyte. This confirms the report of Likhite
et al and also supports recent evidence that lymphocytes are
capable of migration in vitro (Parrott 1980). It has been
reported that T lymphocytes migrate particularly well
(Kowalczyk & Zembala 1978) and in my experiments, nylon wool
purified T cells did show excellent migration areas. However,
fluorescent analyses of migrating cells indicated the presence
of B and T cells in proportions similar to those in the
original lymph node. The results indicate that migration
inhibition of lymphocytes is analogous to the parallel tests
employing accessory cells as indicator cells and is an
in vitro correlate of DTH.
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A point of practical interest is that addition of
antigen to non-immune cells was found to stimulate migration
in many cases. This confirms earlier reports (Bakker et al
1975> Hughes et al 1980) but contrasts with other work in
which enhanced migration of macrophages has been described
as a variant form of in vitro CMI (Weisbart, Bluestone,
Goldberg & Pearson 1976). My results indicate that this may
be a non-specific effect of antigen.
This study was unable to identify conclusively the
migrating cell or the cells responsible for inducing migration
inhibition. In other studies, T cells accounted for the
migration inhibition of human lymphocytes (Kowalczyk &
Zembala 1978) and enhanced migration of mouse spleen cells
(Castes, Borderie & Orbach-Arbouys 1978) and were also the
predominant migrating cell in each case. Purified T cells
showed excellent migration inhibition in this study, but
results with "non-T cell" populations were inconsistent.
While evidence was obtained to suggest that these populations
were contaminated with T cells, the possibility remains
that lymphoid cells in addition to T cells take part in
this phenomenon. The presence of lymphokines was not
demonstrated in these experiments. In addition to the
factors responsible for migration inhibition of accessory -
cells (see Chapter 2), lymphokines which inhibit (Kowalczyk &
Zembala 1978) and stimulate (Castes et al 1978) in vitro
migration of T cells have been described. While it is likely
that similar factors are operating in the assay described
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here, further studies are required to elucidate fully the
exact nature of the cells and mediators involved.
Influence of cyclophosphamide on small intestinal structure
and function
In order to allow rational discussion of the experiments
involving local intestinal immune reactions in cyclophosphamide
treated mice, I shall first discuss the experiments on the
effects on the small intestine and GALT of CY itself.
The mice concerned were given a single dose of 100 mg/kg
CY. Whereas no gross pathology was found and histological
examination revealed few pathological changes in the.small
intestine, measurements of mucosal architecture and electron
microscopy did reveal significant abnormalities. The
principal effects of CY on the mucosa were seen in the rapidly
dividing crypt cells and other abnormalities were probably
secondary to this action. Crypt cell inclusion bodies were
seen by both light and electron microscopy only within the
first 48 hours after CY, in agreement with previous studies
(Waldeck 1972; Sobhon et al 1977; Hartwich et al 1978).
These appeared to be contained within lysosomal bodies in
crypt cells themselves, but it was not possible to identify
their nature or origin. Other workers have classified
these as being of nuclear material (Waldeck 1972) and it has
been suggested that this represents debris of lymphoid cells
or eosinophils rather than crypt epithelial cells (Sobhon
et al 1972). The rapid rebound recovery of CCPR indicates
that the crypt cells suffered only transient damage in
these studies.
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In contrast to an earlier report, inclusion bodies
were not seen in villus epithelial cells (Waldeck 1972)
and light microscopy showed no damage to these cells.
However, mitochondrial changes were seen consistently in
cells near the mouth of crypts and base of villi at all
times after CY. It is difficult to assess the significance
of this feature however. Mitochondrial swelling has been
described in response to agents which interfere directly or
indirectly with oxidative phosphorylation (King, Godman &
King 1972; Porter, Mikles-Robertson, Kramer & Dane 1979)
and it is conceivable that CY may have induced these
alterations via its effect on DNA synthesis and hence on
protein synthesis. Yet there are several pieces of evidence
which argue against this. In other reports of drug-induced
mitochondrial damage, the changes were consistent throughout
each cell. This was not the case in my study and in addition,
epithelial cells were otherwise normal. Furthermore, CY is
eliminated from the mucosa within 5 days (Tew & Taylor 1977)
and it would be unusual to observe direct toxicity up to 12
days. Finally, mitochondrial swelling was not reported in
a study of duodenal morphology in humans given 100 mg/kg CY
(Wolf, Ley & Klein 1968). It may be that the lesions observed
are artefacts. Mitochondria are exquisitely sensitive to -
damage during fixation and processing (Toner, P.G. - personal
communication) and their structure is closely related to the
metabolic state of their membrane enzymes (Lehninger 1962;
Hackenbrock 1966). Cells leaving the hyperactive crypts
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during the recovery phase after CY will be metabolically
active and it is possible that their mitochondria may be
particularly fragile and sensitive to damage during fixation.
This phenomenon would disappear as cells mature on the villus,
and as observed here, villus cell mitochondria would appear
normal. Detailed studies of mitochondrial ultrastructure
and enzyme function are required to confirm the theory that
these changes are secondary to a high level of proliferation
during the recovery from CY.
The period of enhanced CCPR was found until days
after CY, during which time mitochondrial lesions were observed.
Although earlier studies have identified this rebound pheno¬
menon these were usually terminated within a few days and the
prolonged nature of the recovery phase has not been appreciated
(Rosenoff et al 1975; Young 1976; Ecknauer & Lohrs 1976;
Sobhon et al 1977)* This rebound recovery of CCPR is a well--
recognised response of the mucosa to injury and has been
ascribed to two different mechanisms. It may occur in
response to a decrease in the functional compartment of the
villus (Rijke et al 197^5 Rijke & Gart 1979) or as a
consequence of the action of a drug on the crypt cell
compartment itself. In this case, an agent like hydroxyurea
inhibits crypt cell proliferation and causes shrinkage of
the crypt-cell compartment. Slowly-dividing stem cells are
spared by the drug and repopulate the crypt by entering a
synchronous cycle of rapid cell division (Roti Roti &
Dethlefsen 1975; Hanson, Henninger, Fry & Saltese 1980).
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CY also spares crypt stem cells and repopulating cells
show similar evidence of synchrony (Schenken, Burholt,
Hagemann & Lesher 1976; Phillips, Ross & Goldstein 1979)*
These features support the hypothesis that the effects of
CY on the mucosa are not due to a toxic action on villus
epithelial cells but reflect its cytostatic action on crypt
cells. In the present study, however, villus length was
found to be decreased 7 days after CY, presumably secondary
to the initial inhibitory effect on CCPR. The continued
enhancement of CCPR after this time may then be directed at
repairing this villus cell depletion. Further evidence that
the consequences of CY on the mucosa are prolonged was the
unusually low CCPR seen 21 days after CY. While this was not
statistically significant, it may be that this is a further
phase of feedback inhibition of crypt cell mitotic activity.
The findings therefore agree with previous studies which
failed to find damage to mature epithelial cells after CY
and indicate that changes in CCPR are responsible for the
minor, morphological changes observed. In addition, no
residual effects on mucosal architecture were seen at the
time when OVA fed mice were sacrificed for assessment of
mucosal CMI.
Effects of cyclophosphamide on the lymphoid tissues of the.
small intestine
In this part of my study, attention was paid particularly
to the antigen-processing structures of the Peyer's Patches
and to the IEL count in CY treated mice. The overall pattern
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of damage to the MLN and Peyer's Patches showed selective
depletion of B cell areas in agreement with previous studies
of the effect of CY on lymphoid tissues (see Chapter 4).
The IEL count fell sharply 24 hours after CY but returned
to control levels thereafter. This pattern has been described
previously although formal IEL counts were not done (Ecknauer
& Lfthrs 1976). The rapid recovery of IEL is remarkable,
especially in comparison with the prolonged depletion of
lamina propria lymphoid cells and of other lymphoid organs.
Rapidly dividing T cells are probably sensitive to CY
(Kumararatne, Gagnon & Smart 1980) and the immediate fall in
IEL count is consistent with the IEL being derived from a
rapidly dividing pool of T cells, these precursors then
recovering quickly after CY. Of interest in this respect is
the fact that many IEL seen 2-4 days after CY had the appear¬
ance of recently divided cells. Finally, IEL counts were
again normal at the time equivalent to that when mice in
Chapter 10 were examined for mucosal CMI.
The M cells of the Peyer's Patches are thought to be
specialised epithelial cells responsible for uptake of protein
antigens and are probably important elements of the mucosal
immune apparatus (Owen 1977)* It is notable therefore that
CY induced less marked mitochondrial changes in these cell's
than in surrounding epithelial cells. In addition, both
scanning and transmission electron microscopy revealed an
apparent increase in their number after CY, while the surface
folds were hypertrophied in CY treated mice. I did not attempt
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to do formal counts of M cells and the observations could be
due either to true hyperphasia of M cells or merely to an
increase in the numbers of surface projections from an
unchanged number of cells. A similar increase in prominence
of M cells is described in germ-free animals in whom the
underlying lymphoid tissues are depleted, as they were here
(Owen & Nemanic 1978). The cause of this phenomenon is
unknown and clearly detailed morphological studies should
yield important information on the relationship between these
cells and the lymphoid elements of the intestine. If M cells
are indeed epithelial in origin, my results would indicate
that they are derived from a CY-insensitive precursor which
may therefore be more slowly dividing than conventional
enterocyte precursors. Alternatively, the M cell may be of
reticuloendothelial origin, and related to the dendritic cells
and Peyer's Patch macrophages which were not visibly damaged
by CY. This would also explain the relative resistance of
these cells to the drug.
Antigen uptake by the cyclophosphamide-treated gut
The results discussed above indicated that consistent
alterations were detectable in the jejunal mucosa k8 hours
after CY, at the time when mice were fed OVA in studies of
intestinal immunity. However, I had not performed studies on
the function of the CY-treated intestine and others had
reported epithelial enzyme deficiencies (Waldeck 1972;
Ecknauer 1976; Hartwich et al 1978). Although all these
changes are probably related to alterations in crypt cell
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proliferation rather than cytotoxicity, I felt it essential
to exclude a direct effect of CY on protein uptake by the
intestine.
The results of Chapter 13 indicate that CY had no overall
effect on the uptake of OVA by the gut. Absolute levels of
OVA in serum after feeding were similar in CY treated and
normal mice, while serum from OVA fed donors had identical
effects on the immune response of recipients irrespective of
whether the donors had received CY or not. These results are
in contrast to the decrease in protein uptake by the epithelium
of the Bursa of Fabricius in CY treated chickens (Sachs et al
1979) but may be related to the apparent preservation of M
cells seen in my own experiments.
In addition to an effect on the intestinal absorption of
antigen, it is possible that CY may have altered the antigen-
presentation function of lymphoid accessory cells in the
intestine. However, CY has been reported to have only a
minimal enhancing action on phagocytosis by reticuloendothelial
cells (Sharbaugh. 1976; Buhles & Shifrine 1978) and there are
no studies on presentation of antigen by these cells after CY.
It would seem unlikely that an action of this kind could
explain the effects of CY intestinal immune responses to a
dietary protein. Furthermore, it has recently been reported
that the suppressor T cells induced after feeding OVA to
mice are eliminated by 100 mg/kg CY (Hanson, D.G. personal
communication). The evidence thus indicates that the effects
of CY on intestinal immunity which I have described are due
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to its specific inhibitory action oil suppressor lymphocytes
and not to non-specific toxic damage to the mucosa or GALT.
Induction of local CMI in the GALT and mucosa of orally
immunised mice
In Chapters 9 and 10 it was demonstrated that under
appropriate circumstances, oral immunisation of mice with a
new protein antigen may induce cell mediated immunity in the
intestinal mucosa and GALT. These responses were measured
using the indices of mucosal CMI described in Chapter 6 and
the migration inhibition assay discussed earlier, and were
found to occur in the absence of systemic immunity.
Oral administration of OVA to normal mice did not induce
intestinal CMI even if the animals were subsequently challenged
orally with OVA for 10 days. This concurs with several
previous, unpublished attempts to sensitise animals with fed
antigens. In contrast, the results of Chapter 11 showed clearly
that feeding OVA produced a state of systemic unresponsiveness
to parenteral immunisation.
In my experiments, CMI was observed in the GALT and/or
mucosa only if mice received CY 2 days before the initial
feed of antigen. In addition, CY pretreatment substantially
modified the tolerant state following OVA feeding. Previous
reports of the induction of mucosal CMI have identified local
production of lymphokines after oral immunisation with bacteria
or virus (Gadol et al 1976; Frederick & Bohl 1976; O'Neill &
Bienenstock 1977) and the induction of cytotoxic T cells in
Peyer's Patches after feeding allogeneic cells (Kagnoff 1978c).
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The evidence discussed earlier indicates that feeding proteins
normally results in immunological tolerance and there is only
one previous study on induction of intestinal CMI to fed
protein antigens (Huntley et al 1979)* In that report, MIF
production by lymphocytes from MLN, spleen and lamina propria
was demonstrated in normal pigs fed hapten-protein conjugates.
However, the development of MIF production was somewhat
variable and was found in the MLN after repeated feeding. In
addition, MIF was present in some cultures from control animals.
My own experiments cannot confirm the generation of local CMI
in the intestine of normal mice immunised orally with protein.
On the other hand, they indicate that a CY sensitive regulatory
system normally prevents such responses.
Migration inhibition was fully developed in the MLN of
CY treated mice within 2k hours of feeding ovalbumin and was
detectable until 14 days afterwards. This represents a rapid
development of sensitisation and is surprising at first sight.
However, after feeding OVA, activation of suppressor and helper
T cells occurs in the GALT within 2k hours (Richman, Graeff,
Yarchoan & Stro^er 198l) and it is likely that induction of
specific effector T cells may also occur very rapidly. Mucosal
changes were not examined in mice challenged orally within a
short time of sensitization and it would be of obvious
importance to perform parallel experiments of this type. The
loss of sensitisation from the MLN 14 days after feeding is
also of interest, particularly as migration inhibition and
mucosal changes were observed in mice challenged 28 days after
initial feeding. Loss of MLN sensitisation could reflect the
disappearance of a transient immune response or migration
of committed lymphocytes from the MLN to other parts of the
intestine or GALT. The ability to mount a secondary MLN
response and the abrupt rather than gradual loss of
sensitisation would argue against complete abrogation of
intestinal immunity in these mice. It' is more likely that
after oral immunisation of CY treated mice, a sequence of
T cell sensitisation in the GALT is followed by emigration
of DTH effector cells to the mucosa. In addition, the ability
to generate a secondary response is evidence for the develop¬
ment of memory cells during the period of sensitisation in
the GALT.
When CY treated OVA fed mice were challenged orally with
OVA, specific mucosal alterations were observed. This
consisted of increases in CCPR, crypt depth and IEL count
and were: therefore identical to those found during the
intestinal phase of the GvHR. These findings support the idea
that CY treatment has allowed the induction of local CMI to
a fed protein antigen. In addition, it is noteworthy that
crypt hyperplasia and lymphocytic infiltration have not been
identified as consequences of immune complex-mediated
i
intestinal damage. In this case, ulceration and acute
inflammation are found in both small intestine (Bellamy & -
Nielson 1.974) and colon (Hodg son, Potter, Skinner & Jewell
1978). Increases in CCPR and IEL count appear to be specific
to CMI reactions in the mucosa.
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In these experiments, it was hoped to mimic the severe
villous atrophy and crypt hyperplasia characteristic of
enteropathies associated with food hypersensitivity, such
as coeliac disease. The mucosal alterations observed were
considerably less severe than these lesions and I considered
that this may have been due to the use of too small a dose
of fed OVA. However, a tenfold increase in OVA dosage had
no effect on mucosal damage in CY treated mice. It is possible
that the fed doses still do not approach the intake of gluten
required to induce coeliac disease in the human infant.
Alternatively, it might have been possible to induce more
severe mucosal changes by several weeks of challenge by
feeding OVA or by challenge of isolated loops of intestine
to allow prolonged contact of antigen with the mucosa.
Despite the absence of major intestinal damage including
villous atrophy, however, the results are consistent with the
hypothesis that an increased CCPR is one end of the spectrum
of damage which can occur in the small intestine as a result
of immune responses to dietary antigens (Ferguson & MacDonald
1977).
The results of the pilot study employing oxazolone as
a fed antigen in CY treated mice were similar to those obtained
with OVA. This indicates that the phenomenon is not restricted
to protein antigens and confirms the ability of CY to allow
the induction of intestinal CMI. In addition, the study
extends an earlier report that CY pretreatment can block.the
induction of tolerance by feeding contact-sensitising agents
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(Polak, et al 1975)* It should be noted however, that in
this study, alterations in CCPR and crypt depth were observed
at a time when a residual effect of CY itself may have been
present. These findings therefore require confirmation.
The experiments described in this thesis were based on
the ability of CY to eliminate suppressor cells and reconstitut-
ion of mice with syngeneic normal thymocytes is known to
restore suppressor cell function in CY treated animals
(Mitsuoka et al 1976;L'age-Stehr & Diamantstein 1978). In
the present study, CY treated mice given thymocytes on the
day of primary feeding of OVA had mucosal changes on challenge
which were identical to unreconstituted mice. While this
might argue against elimination of suppressor cells by CY,
it has been suggested that suppressor cells should be present
in the intestine at the time of feeding antigen for effective
activation (Hanson, D.G. - personal communication). In his
experiments, Hanson found that oral tolerance to OVA was
dependent on suppressor cell activation and that this could
be abolished by prior irradiation. Unresponsiveness could
be restored by transfer of normal spleen cells, but only if
the cells were given at a time which allowed presumptive
localisation in the intestine by the time antigen was fed.
The design of my own experiment would therefore have been -
unable to.demonstrate directly a population of CY sensitive
suppressor cells responsible for preventing mucosal immunity
to dietary antigens.
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CY pretreatment may enhance systemic CMI without
significantly altering the humoral response (Askenase et al
1975) and serum antibodies were not detectable in OVA fed
mice with intestinal CMI. The results may thus reflect a
preferential enhancement of CMI in the mucosa and GAJLT.
Parallel studies employing sensitive assays for specific
secretory and serum antibody are required to confirm this
hypothesis for immunity to dietary antigens.
It is clear that systemic CMI did not develop at any
time after oral immunisation despite the presence of CMI in
the intestine and GALT. There is considerable evidence that
intestinal T cells represent a pool of lymphocytes which
has a separate' origin and route of migration from peripheral
T cells (Guy-Grand et al 197^; 1978; Cahill et al 1977;
Parrott & Rose 1978). In addition, oral presentation of
soluble antigen only rarely induces systemic CMI in adult
animals (Goldberg et al 1971; Perrotto et al 197^)* It is
entirely conceivable therefore that fed protein antigens may
induce CMI in the GALT with subsequent migration of gut-
associated T cells in the absence of systemic sensitisation.
This theory is supported by the finding that CMI may be
induced in the respiratory tract in the absence of systemic
CMI after inhalation of antigen (Henry & Valdman 1970).
Furthermore, intestinal B lymphocytes (Craig & Cebra 1971;
Guy-Grand et al 197^5 Rudzik et al 1975) and secretory
antibody responses (Dolezel & Bienenstock 1971a,b) form a
compartment which is separate from their peripheral counterparts.
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The present results are strong support for the segregation
of mucosal and systemic T cells and CMI responses. It is
important to reiterate however, that local CMI responses to
fed proteins will only occur if the immune system has been
manipulated in some way, as by CY pretreatment in my own
experiments.
Induction of tolerance by feeding ovalbumin
The development of local CMI to fed OVA is one end of
the spectrum of immunological consequences of feeding proteins.
In Chapters 11 and 13> the effects on subsequent systemic
immunity of feeding OVA were considered and a range of such
effects were demonstrated. Thus, depending on the dose of
fed protein used, both humoral and cell mediated immunity
may be tolerised; alternatively, CMI alone may be reliably
suppressed. The studies also confirmed the ability of CY
to modulate the systemic immune response to ingested antigen
with CMI apparently more susceptible to CY pretreatment
than humoral immunity. In addition, evidence was obtained
to suggest that tolerance of CMI is due to the presence of
tolerogenic fragments of protein absorbed through the intestine.
Serum containing these materials had no effect on humoral
immunity.
Several different schedules have been used to investigate
oral tolerance to ovalbumin and the present study was designed
to use a single dose of OVA known to induce tolerance reliably
(25 mg). In addition, a smaller dose (2 mg) which is nearer
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the lower limit of tolerogenic!ty was also employed (Hanson
et al 1977; Vaz et al 1977; Challacombe & Tomasi 1980). It
should also be noted that although the optimum interval
between feeding and immunisation for the demonstration of
tolerance is seven days, similar unresponsiveness is found
when a 14 day interval is employed as here ("Vaz et al 1977;
Challacombe & Tomasi 1980). The results of my experiments
are therefore compatible with those of previous studies.
In addition to the discrepancy between the susceptibility
of the systemic antibody and CMI response to reduction by
prior feeding, it is apparent that differences exist within
the humoral response itself. While it is reported that
feeding OYA inhibits subsequent total serum antibody responses
(Hanson et al 1977; 1979; Ngan & Kind 1978) and serum IgE
responses (Ngan & Kind 1978; Vaz et al 1977)> there is
evidence to suggest that IgE may be more readily suppressed
than IgG responses (Ngan & Kind 1978). No such evidence
exists on the relative susceptibilities of the IgM and IgG
phases of the serum antibody response. In this study, while
the peak IgM antibody response was suppressed by feeding both
2 and 25 mg OVA, only the higher dose was effective in
reducing IgG levels. Furthermore, mice receiving 2 mg OVA
subsequently developed normal IgG levels despite a previously
suppressed IgM response, and it is clear that IgM production
may be more readily tolerised by oral antigen. In support
of this, Kagnoff has shown that IgM PFC in the spleen are
more susceptible to modulation by repeated feeding of SRBC
(Kagnoff 1978a).
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The major discordance found in my study of oral
tolerance was that between systemic CMI and the IgG antibody
response. The results confirmed other reports in which
systemic CMI was readily tolerised by feeding OVA (Miller &
Hanson 1979; Challacombe & Tomasi 1980; Titus & Chiller 1981)
and indicated that CMI is more susceptible to tolerance than
the humoral response. Furthermore, serum taken from OVA fed
mice was effective in suppressing CMI but not humoral immunity
in recipient animals. In the context of the differing effects
of feeding OVA on systemic immunity, the consequences of CY
pretreatment of OVA fed mice are also important. In mice
fed 25 mg OVA, the similar degrees of suppression of IgM,
IgG and CMI responses were returned to a level midway between
control and tolerant mice by CY treatment. In mice fed 2 mg
OVA however, the suppressed CMI responses were returned to
control levels by CY, while the reduced IgM levels were not
completely restored to normal.
The induction of tolerance by parenteral antigen may have
discordant effects on subsequent CMI and humoral immunity
(Neveu & Borduas 197^5 Silver & Benacerraf 197^) and may
involve suppressor cells (Basten et al 197^-) > depletion of
helper T cells (Endres & Grey 1980a, b; Parks & Weigle 1980b)
and B-cell inhibition (Parks & Weigle 1980b). The present-
results are compatible with a system of oral tolerance
dependent on two or more- of these mechanisms. Indeed, it
has been suggested previously that oral tolerance may have
multiple regulatory mechanisms (Hanson et al 1979)*
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While serum antibody (Kagnoff 1978a; 1980) and immune
complexes (Andre et al 1975) have been reported to be
responsible for oral tolerance to particulate antigens, it
is likely that suppressor T cells induced in the spleen and
GALT are responsible for oral tolerance to protein antigens
(Ngan & Kind 1978; Richman et al 1978; Miller & Hanson 1979?
Challacombe & Tomasi 1980; Titus & Chiller 1981). In
particular, suppressor T cells are important in the reduction
of CMI responses after feeding OVA (Miller & Hanson 1979;
Challacombe & Tomasi 1980; Titus & Chiller 1981) and the
activation of these cells by feeding OVA is inhibited by CY
(Hanson, D.G. personal communication). Furthermore, the
induction of tolerance by feeding contact-sensitising agents
to guinea pigs is related to the appearance of suppressor cells
and is abrogated by CY (Polak et al 1975; Asherson et al 1977)*
Thus the tolerance of CMI induced by a low dose of OVA which -
was fully sensitive to CY in the present study suggests that
a suppressor cell system is entirely responsible for this
particular unresponsive state. .
The tolerance of both antibody and CMI responses induced
by the larger dose of OVA was however only partially reversible
by CY pretreatment. This may reflect the induction by larger
doses of oral protein of tolerogenic mechanisms additional'
to suppressor cells. Feeding OVA to mice is known to induce
defective helper T cell function in addition to simultaneous
activation of suppressor T cells (Titus & Chiller 1981) and
a defect of this kind may therefore be produced by larger
Ji i
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doses of oral protein. This mechanism is consistent with
the apparent disturbance in the switch from IgM to IgG
production in mice tolerised with 25 mg OVA, while a defect
in an effector or accessory T cell required for expression
of DTH may also account for the partial CY sensitivity of
the CMI tolerance in these animals.
A further level of control may be responsible for the
peculiar sensitivity of IgM synthesis to oral tolerance. It
is possible that this reflects a transient inhibition of
B cell function in fed mice. Indeed, although B cell priming
may occur (Titus & Chiller 1981) a defect of this nature
has been described after protein feeding (Vives, Parks &
Weigle 1980). If this is overcome in the presence of helper
T cells a mature antibody response will eventually ensue as
seen in the mice fed 2 mg OVA. After feeding 25 mg OVA
however, functional deletion of helper T cells would not
allow a full IgG response to occur and B cell recovery may
be manifest as a delayed IgM response, as was observed here.
Thus, these results support the presence of several regulatory
mechanisms governing systemic immune responses after feeding
protein antigens.
Influence of intestinal protein handling on immune responses
to dietary antigens
The results obtained in Chapter 13 indicate that antigenic
material, absorbed and processed by the small intestine, is
responsible for activating some of the regulatory systems
discussed above.
The transfer of tolerance by serum from protein fed
mice has not previously been described, although tolerogenic
material has been found in the serum of mice after repeated
oral doses of SRBC (Andre et al 1975; Kagnoff 1978a; Chalon,
Milne & Vaerman 1979)• In this rather different system
however, it is unlikely that these findings reflect an effect
of circulating antigen alone, since antibodies to SRBC
(Kagnoff 1978a) and immune complexes (Andre et al 1975) have
been described in the serum used in these experiments. More
recently, a serum factor has been characterised in SRBC fed
mice bearing idiotypic features similar to that found in the
serum of mice tolerised parenterally with SRBC (Kagnoff 1980)
These findings are likely to be due to an immune response to
the oral antigen. In the present study however, serum was
obtained one hour after feeding, before any immune response
could occur and the results therefore reflect a property
of circulating absorbed antigen.
In vitro digestion of bovine serum albumin produces
protein fragments which are tolerogenic in vivo, possibly via
suppressor cell activation (Dosa, Pesce, Ford, Muckerheide
& Michael 1979)* In addit ion, highly deaggregated protein
molecules are found in serum after feeding OVA (Swarbrick1979)
and deaggregated proteins are effective in the induction of
tolerance by'the parenteral route (Chiller et al 1971 )• The
results described here are therefore consistent with the
hypothesis that tolerogenic materials are produced after
processing of protein antigens by the gut and these are
important in the induction of oral tolerance. Furthermore,
this study supports the observations that antigen processing
plays an important role in both oral and systemic tolerance
(Endres & Grey 1980a,b; Vives et al 1980).
Antigen-processing in the gut occurs at several different
levels in addition to that associated with conventional
immunological accessory cells because proteins are subjected
to digestion and absorption before encountering the lymphoid
cells of the gut. All these processes are therefore likely
to influence the immunological consequences of feeding
proteins. This has been confirmed by recent work showing
that oral tolerance to OVA is abrogated if the proteolytic
activity of the intestine is inhibited by a protease inhibitor
given at the time of feeding OVA (Hanson, D.G. - personal
communication). The exact role of other luminal and mucosal
protein-handling functions remains to be clarified, and
little is known of the nature of antigen-presenting cells in
the gut. While it has been suggested that Peyer's Patches
are deficient in these cells (Challacombe et al 1979)> others
have reported that this may not be the case (Levin, Rosen-
streich, Wahl & Reynolds 197^)• The resolution of this
controversy is of obvious importance in the understanding of
intestinal immunity.
In the context of my observations of depressed CMI in
the recipients of serum from OVA fed mice, it is possible
that tolerogenic moieties produced by the functional processes
of the gut, bypass conventional processing by macrophages and
thereby directly activate suppressor T cells (Feldmann &
Kcmtiallien 1976). That the quantity of antigen absorbed
by the gut, rather than its nature could account for the
tolerant state is unlikely. Intravenous or intraperitoneal
injections of quantities of OVA similar to those absorbed
by the gut are not effective in inducing tolerance (Hanson
et al 19775 Mowat, Strobel, Pickering, Drummond & Ferguson -
in preparation).
Immune responses to fed antigen are extremely complex
in that feeding antigens may produce systemic immunisation or
tolerance and/or local immunity in the intestinal mucosa.
Induction of tolerance is perhaps one of the most important
consequences of oral administration of antigen and if so it
would not be surprising that several mechanisms have evolved,
each with a role in producing this phenomenon. Events at the
cellular level following oral administration of antigen are
known to involve macrophages, B cells, helper T cells and
suppressor T cells (Richman et al 1978;. Miller & Hanson 19795
Vives et al 1980; Titus & Chiller 1981). Furthermore, a
single feed of OVA has been shown to induce simultaneously
in the GALT, both suppressor T cells for IgG antibody synthesi
and helper T cells for IgA antibody synthesis (Richman et al
1981). This selective induction of regulatory T cells provide
a mechanism for the concurrent development of systemic
tolerance and immune exclusion of antigen due to local
production of secretory antibody (Swarbrick, Stokes & Soothill
1979; Challacombe & Tomasi 1980) and is of obvious importance.
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These diverse phenomena indicate a complex relationship
between the antigen-processing functions of the intestine
and its lymphoid tissues, the outcome of which determines
the local and systemic consequences of oral immunisation
with a protein antigen. However, the results of Chapters 11
and 13 indicate that systemic CMI may be regulated by a system
of CY-sensitive suppressor cells in fed animals and that
intestinally produced protein fragments activate these cells.
Clinical significance of mucosal CMI to dietary antigens
Several diseases cause enteropathy and malabsorption and
are associated with hypersensitivity to food antigens. Of
these, both coeliac disease and cow's milk protein intolerance
have intestinal lesions including crypt hyperplasia (Watson &
Wright 197^5 Kosnai et al 1980) and lymphocytic infiltration
of the epithelium (Ferguson 197^, Phillips et al 1979)*
Furthermore, lymphokines are produced in response to gluten
by peripheral blood lymphocytes (Bullen & Losowsky 1978) and
by cultured jejunum (Ferguson et al 1976) from patients with
coeliac disease. It is likely that the intestinal pathology
in these diseases is due to mucosal CMI to a dietary antigen.
My work, described in this thesis, indicates that after
feeding antigen, systemic CMI is regulated by a suppressor
cell system. Abrogation of this system by CY allows the
induction of local CMI in the GALT and mucosa with consequent
mucosal damage. It is possible that similar defects in
suppression may occur during early life when the body meets
many new antigens via the small intestine and this offers
a mechanism for the pathogenesis of food allergic diseases
which damage the intestine in infancy. The precise outcome
would depend on the nature of the suppressor cell defect,
whether antigen-specific, immunoglobulin class-specific,
transient or permanent and its time of onset. Causes for
such defects in suppression might include inherited immuno¬
logical deficiencies and infections or iatrogenic factors
including radiotherapy and drug treatment. This kind of
occurrence during the period of exposure to new dietary
antigens in infancy may then predispose to potentially
harmful mucosal CMI. These reactions are rare and clearly
the suppressor cell system of the GATT implicated by these
experiments and described by others is of considerable
benefit particularly in infancy. The suppressor system of
the GALT may be one of the most important homeostatic
mechanisms during early life.
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